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ABSTRACT
Suyuan Zhang, Ph.D., Purdue University, December 2017. Patient Perceptions of Their
Doctors and Hospitalization among Medicare Beneficiaries with Chronic Obstructive
Pulmonary Disease. Major Professor: Joseph Thomas III.
The objectives for this study were to determine one-year incidence of ambulatory caresensitive hospitalizations for Chronic Obstructive Pulmonary Disease (COPD) in a
Medicare population, to assess association between patient perceptions of their doctors
and COPD ambulatory care-sensitive hospitalization, and to assess association between
patient perceptions of their doctors and COPD-related hospitalization. An observational,
retrospective cohort study was conducted using data from the 2007 to 2012 Medicare
Current Beneficiary Survey (MCBS). Patient perceptions of their doctor and
hospitalization were assessed during the study period, defined as 12 months following the
year in which COPD diagnosis was identified. Individuals were included if they had a
diagnosis of COPD, had continuous coverage in Medicare Part A and Medicare Part B
during the 12-month study period and the preceding year, and had identified a usual
source of care. Individuals were excluded if they had any missing data on items used to
create the patient perceptions of doctors index, had a proxy responder, or had a diagnosis
of Alzheimer’s disease or dementia. Among 2,306 Medicare beneficiaries who met study
criteria, 52 percent were 75 years or older, 54 percent were women, and 86 percent were
White. A patient perception of their doctors index was created using MCBS survey
items. Individuals with an overall score for the patient perceptions of their doctors scale
greater or equal to the median value were categorized as having positive perceptions of
their doctors, while those with an overall score below the median value were categorized

xxv

as having less than positive perceptions of their doctors. One-year incidence of COPD
ambulatory care-sensitive hospitalizations was 4.1 percent (95% CI=3.3% to 4.9%).
Association between patient perceptions of their doctors and COPD ambulatory caresensitive hospitalization risk was assessed using multivariate logistic regression models,
adjusted for covariates selected from stepwise procedure. The associations between
patient perceptions of their doctors and number of COPD ambulatory care-sensitive
hospitalizations, COPD ambulatory care-sensitive hospital days, or COPD ambulatory
care-sensitive hospitalization expenditures were assessed using multivariate generalized
linear models, adjusted for covariates selected from stepwise procedure. Similar models
were developed to assess associations between patient perceptions of their doctors and
COPD-related hospitalization outcomes. No association was found between patient
perceptions of their doctors and COPD ambulatory care-sensitive hospitalization
outcomes. However, multivariate models revealed that oxygen users who had less than
positive perceptions of their doctors were more likely to have a COPD-related
hospitalization (odds ratio=1.73, p=0.010) and had more COPD-related hospitalizations
(average marginal effect=0.155, p=0.028) as compared to those who had positive
perceptions of their doctors.

1

INTRODUCTION
Background
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable
chronic lung disease that makes it hard to breathe (American Lung Assoication). In the
United States, the term COPD includes two main lung diseases, chronic bronchitis and
emphysema (National Heart Lung and Blood Institute 2017). It is characterized by
“gradual progression of irreversible airflow limitation that is associated with an abnormal
inflammatory response of the lung to noxious particles or gases” (Global Initiative for
Chronic Obstructive Lung Disease (GOLD) 2006).
Globally, the number of COPD patients was estimated to be 384 million among
people 30 years or older in 2010, with a prevalence of 11.7% (Adeloye, Chua et al.
2015). There was nearly a 70% increase in the number of COPD patients as compared to
the 1990 estimate of 227 million for the same age group (Adeloye, Chua et al. 2015). In
the United States, an estimated of 15 million people, or 6.3% of the adult population had
diagnosed COPD in 2011 (Centers for Disease Control and Prevention 2012). Prevalence
of COPD is approximately four times higher among people age 65 years and older
(11.7%) as compared to those age 18 to 44 years (3.2%) (Centers for Disease Control and
Prevention 2012).
In 2010, total health care expenditures for COPD were estimated at $49.9 billion,
including $29.5 billion spent on direct medical care, $8.0 billion on indirect morbidity,
and $12.4 billion on indirect mortality costs (Centers for Disease Control and Prevention
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2012). COPD poses a substantial economic burden in the U.S. Medicare population.
Menzin and colleagues estimated that Medicare beneficiaries with COPD had annual
incremental total health care costs of $20,500 compared to those without COPD, which
was primarily due to hospitalizations (Menzin, Boulanger et al. 2008).
The Agency for Healthcare Research and Quality developed a list of Prevention
Quality Indicators consisting of 14 ambulatory care-sensitive disease conditions,
including COPD (Agency for Healthcare Research and Quality 2015). These are
“conditions for which good outpatient care can potentially prevent the need for
hospitalization or for which early intervention can prevent complications or more severe
disease” (Agency for Healthcare Research and Quality 2001). The Centers for Medicare
and Medicaid Services (CMS) is applying these measures to their value-based payment
modifier program to promote more efficient and high quality care (Centers for Medicare
and Medicaid Services 2015). “Even though these indicators are based on hospital
inpatient data, they provide insight into the quality of the health care system outside the
hospital setting” (Agency for Healthcare Research and Quality 2001).
Proactive diagnosis and comprehensive COPD management, which include
smoking cessation, pulmonary rehabilitation, influenza and pneumococcal vaccination,
and appropriate maintenance pharmacotherapy based on an individual’s disease severity
can significantly reduce number of COPD exacerbations and burden of disease, and
improve patients’ quality of life (Fromer 2011). Physicians play an important role in this
patient-centered process and are key to the success of management of COPD.
The patient-doctor relationship has been defined as “meaningful therapeutic
interactions between patients and their doctors” (Mendoza, Smith et al. 2011). Parchman
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and Burge noted that in family medicine, developing a sustained relationship between
patients and physicians is a defining characteristic of the discipline, from which
interpersonal communications, accumulated knowledge of the patients, and trust are
thought to arise (Parchman and Burge 2004). Positive patient doctor relationships also
have been shown to be important in improving patient’s outcomes among individuals
with chronic disease conditions (Kaplan, Greenfield et al. 1989).
Effective doctor-patient communication, which includes gathering information to
facilitate accurate diagnosis, giving appropriate therapeutic instructions, and establishing
caring relationships with patients, is important in the delivery of high-quality health care
(Ha and Longnecker 2010). In the past, it was thought that communication between
doctors and patients was adequate. However, evidence suggested that it was quite the
opposite (Stewart 1995). In a national survey conducted by the American Academy of
Orthopedic Surgeons, 75% of orthopedic surgeons who responded to the survey believed
that they communicated satisfactorily with their patients. However, only 21% of
orthopedic patients reported satisfactory communication with their doctors (Tongue, Epps
et al. 2005). Patients who perceive their doctors as good communicators are more likely
to be satisfied with the care they receive (Kaplan, Greenfield et al. 1989, Ha and
Longnecker 2010), to share pertinent information for accurate diagnosis (Ha and
Longnecker 2010), to follow doctor’s instructions (Ha and Longnecker 2010), and adhere
to treatment (Kaplan, Greenfield et al. 1989, Harmon, Lefante et al. 2006, Ha and
Longnecker 2010).
Physician’s accumulated knowledge of patients over time is considered as a
primary care attribute that is related to the ability to develop a sustained patient provider
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relationship (Parchman and Burge 2004). Knowing patients’ medical history also can
help doctors tailor treatment decisions to individual patients (Parchman and Burge 2004).

Literature Review
Patient Perceptions of Doctors and Medication Adherence
Schoenthaler and colleagues conducted a cross-sectional study of 439 community
dwelling patients with poorly controlled hypertension to assess association between
patient perceptions of their doctors’ communication and medication adherence. Patients
who rated their communication with doctors as collaborative had better medication
adherence (β=0.11, p=0.03) (Schoenthaler, Chaplin et al. 2009).
Schoenthaler and colleagues examined whether racial composition of the patientdoctor relationship modified the association between patient perceptions of their doctor’s
communication and medication adherence. Communication rated as more collaborative
in race-discordant relationships (i.e. black patient, white provider) was associated with
better medication adherence (β=0.46, p=0.04). However, no association was found
between medication adherence and communication in race-concordant relationships (i.e.
black patient, black provider) (p=0.24) (Schoenthaler, Allegrante et al. 2012).
Ratanawongsa and colleagues conducted a cross-sectional analysis of 9,377
patients in the Diabetes Study of Northern California to examine association between
patient provider communication and adherence to cardio-metabolic medications. Patients
who reported poorer communication with their doctors had greater likelihood of not
adhering to their medications (point estimate=0.9%, p=0.01) (Ratanawongsa, Karter et al.
2013).
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Ciechanowski and colleagues examined association between patient-provider
communication and adherence to medications and glucose monitoring among 367
patients with Type 1 diabetes or Type 2 diabetes in a health maintenance organization
primary care setting. Patients who perceived their provider communication as poor had
significantly worse adherence to medications (test statistic=4.81, p<0.05) and less
frequent glucose monitoring (test statistic=8.96, p<0.01) (Ciechanowski, Katon et al.
2001).
In summary, four studies were found that examined association between patient
perceptions of doctors and medication adherence (Ciechanowski, Katon et al. 2001,
Schoenthaler, Chaplin et al. 2009, Schoenthaler, Allegrante et al. 2012, Ratanawongsa,
Karter et al. 2013). All four studies reported that negative perception of doctor’s
communication was associated with worse medication adherence rate.

Patient Perceptions of Doctors and Use of Preventive Services
Flocke and colleagues conducted a cross-sectional study to assess association
between primary care attributes from patients’ perspective and delivery of preventive
services (Flocke, Stange et al. 1998). They reported that higher interpersonal
communication scores were associated with more up to date on screening services
(p=0.003) and accumulated knowledge of the patients was associated with more up to
date on immunizations (p=0.001).
Parchman and Burge developed a path model to examine associations between
various primary care attributes from patients’ perspective and delivery of clinical
preventive services to Medicare beneficiaries (Parchman and Burge 2004). They found
that better patient-doctor communication was a predictor of accumulated knowledge of
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patients, which further predicts patients trust in doctors. Patients who had higher trust in
their doctors were more likely to have flu shots (p=0.04), mammograms (p=0.04), and
eye doctor visits (p=0.03).
In summary, two studies were found that examined association between patient
perceptions of doctors and use of preventive services (Flocke, Stange et al. 1998,
Parchman and Burge 2004). Both studies reported that positive perceptions of doctors by
patients were associated with higher likelihood of using preventive clinical services.

Demographic Characteristics and Hospitalization in COPD Patients
Age and Hospitalization
Age and All-Cause Hospitalization in COPD Patients
Farkas and colleagues assessed associations between age and all-cause
hospitalization risk among 127 clinically stable patients with COPD in Slovenia (Farkas,
Kosnik et al. 2010). No association was found between age and risk of all-cause
hospitalization.
Stuart and colleagues conducted a retrospective cohort analysis of 6,322 Medicare
beneficiaries with COPD to assess associations between age and all-cause hospitalization
(Stuart, Simoni-Wastila et al. 2010). No association was reported between age and risk
of all-cause hospitalization.
Candrilli and colleagues assessed associations between age and all-cause
rehospitalization among 140,891 COPD patients aged 40 years or older from a U.S.
managed care claims database (Candrilli, Dhamane et al. 2015). They reported that
patients aged 65 years or older were more likely to suffer an all-cause rehospitalization

7
within 90 days following an initial COPD-related hospitalization as compared to those
aged between 40 and 54 years (Odds Ratio=1.052, 95% CI=1.008-1.097, p=0.019).
Yu and colleagues conducted a retrospective cohort study on 18,282 COPD
patients from a large U.S. commercial claims database to assess associations between age
and unplanned all-cause hospital readmission within 30 days following an initial COPDrelated hospital admission (Yu, Zhou et al. 2015). No association was found between age
and all-cause hospital readmission (p=0.585).
Nguyen and colleagues assessed associations between age and 30-day all-cause
readmission risk among 4,596 COPD patients in California (Nguyen, Chu et al. 2014).
No association was reported between age and risk of 30-day all-cause hospital
readmission (p=0.89).
Sharif and colleagues examined associations between age and risk of early allcause hospital readmission, defined as any hospital admission within 30 days of
discharge, among 8,263 commercially insured patients with a diagnosis of COPD (Sharif,
Parekh et al. 2014). No association was reported between age and risk of all-cause
hospital readmission.
In summary, six studies were found that assessed association between age and allcause hospitalization (Farkas, Kosnik et al. 2010, Stuart, Simoni-Wastila et al. 2010,
Nguyen, Chu et al. 2014, Sharif, Parekh et al. 2014, Candrilli, Dhamane et al. 2015, Yu,
Zhou et al. 2015). Only one study reported that older age was associated with greater risk
of all-cause hospitalization (Candrilli, Dhamane et al. 2015). The remaining five studies
reported no association between age and all-cause hospitalization (Farkas, Kosnik et al.
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2010, Stuart, Simoni-Wastila et al. 2010, Nguyen, Chu et al. 2014, Sharif, Parekh et al.
2014, Yu, Zhou et al. 2015).

Age and COPD-Related Hospitalization
Santibanez and colleagues examined relationships between age and
hospitalizations due to COPD exacerbations among 900 patients with confirmed COPD
aged 35 years and older in Cantabria, Spain (Santibanez, Garrastazu et al. 2016). They
reported that 10 years increase in age was associated with significantly higher risk of
COPD-related hospitalizations (Odds Ratio=1.35, 95% CI=1.09-1.68).
Hunter and colleagues assessed associations between age and hospital admission
for acute exacerbation of COPD among 7,002 patients with a diagnosis of COPD in the
United Kingdom (Hunter, Lee et al. 2016). They reported that one standard deviation
(11.4 years) increase in age was associated with greater risk of hospitalization due to
acute exacerbation of COPD (Hazard Ratio=1.31, 95% CI=1.23-1.39, P<0.001).
Singh and Yu conducted a retrospective cohort study using data from the U.S.
Nationwide Emergency Department Sample (NEDS) to assess associations between age
and COPD-related hospitalization (Singh and Yu 2016). Multivariate analyses showed
that older age was associated with greater risk of COPD-related hospitalization in patients
admitted to the emergency room for COPD reasons (p<0.001).
Montserrat-Capdevila and colleagues assessed associations between age and
hospitalization for COPD exacerbation among 2,501 subjects 40 years or older with a
diagnosis of COPD in Spain (Montserrat-Capdevila, Godoy et al. 2015). They reported
that older age was associated with significantly higher risk of hospitalization for COPD
exacerbation (p=0.002).
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Kim and colleagues conducted a retrospective cohort analysis of 2,933 COPD
patients from Korea to assess associations between age and risk of hospitalization due to
respiratory problems (Kim, Noh et al. 2015). No association was found between age and
risk of hospitalization due to respiratory problems (p=0.071).
Mullerova and colleagues assessed associations between age and hospitalization
for COPD exacerbations among 2,138 COPD patients identified from the Evaluation of
COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) trial cohort
(Mullerova, Maselli et al. 2015). Multivariate regression models showed that older age
(per 10-year increment) was associated with increased risk of hospitalization due to
COPD exacerbations (Hazard Ratio=1.29, 95% CI=1.13-1.46, p<0.001).
Esteban and colleagues prospectively recruited 543 COPD patients from five
outpatient respiratory clinics in Spain to examine associations between age and COPDrelated hospitalization (Esteban, Arostegui et al. 2014). They reported that older age was
associated with greater risk of COPD-related hospitalization (Odds Ratio=1.026, 95% CI1.005-1.148, p=0.017).
Tran and colleagues conducted a cohort study with 126,019 COPD patients in
northern California to assess associations between age and COPD-related hospitalization
(Tran, Siu et al. 2011). They reported that older age (per 20 years increase) was
associated with increased risk of COPD-related hospitalization (Relative Risk=2.6, 95%
CI=2.5-2.8, p<0.001).
Cao and colleagues assessed associations between age and COPD-related
hospitalization risk among 52,274 COPD patients identified from a large U.S.
administrative claims database (Cao, Zou et al. 2011). They reported that older age was
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associated with increased risk of COPD-related hospitalization (Odds Ratio=1.021, 95%
CI=1.018-1.023, p<0.001).
Schembri and colleagues conducted a prospective observational study in 3,343
COPD patient in Scotland to assess associations between age and COPD-related
hospitalization (Schembri, Anderson et al. 2009). Compared to patients aged 70 to 79
years, those aged 60 to 69 years were less likely to be hospitalized for COPD reasons
(Hazard ratio=0.77, 95% CI=0.64-0.93) and those aged 80 years and older were more
likely to be hospitalized for COPD reasons (Hazard ratio=1.25, 95% CI=1-1.57).
Tsai and colleagues assessed associations between age and hospitalization for
COPD exacerbations among 384 COPD patients who participated in a multicenter
prospective study in the U.S. and Canada (Tsai, Clark et al. 2007). They reported that
older age (per 10 years increase) was associated with a greater risk of hospitalization for
COPD exacerbations (Odds ratio=1.58, 95% CI=1.10-2.28).
Candrilli and colleagues examined associations between age and risk of COPD-related
rehospitalization in a sample of COPD patients drawn from a large U.S. managed care
claims database (Candrilli, Dhamane et al. 2015). They reported that patients aged
between 55 and 64 years (Odds Ratio=1.267, 95% CI=1.186-1.354, p<0.001) and patients
aged 65 years or older (Odds Ratio=1.580, 95% CI=1.483-1.684, p<0.001) were more
likely to have a COPD-related hospital readmission within 90 days following an initial
COPD hospital admission as compared to those aged between 40 and 54 years.
Yu and colleagues assessed associations between age and COPD-related
rehospitalization among 18,282 COPD patients who had a commercial health plan in the
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United States (Yu, Zhou et al. 2015). No association was found between age and risk of
30-day unplanned COPD-related rehospitalization (p=0.881).
In summary, thirteen studies assessed association between age and COPD-related
hospitalization (Niewoehner, Lokhnygina et al. 2007, Tsai, Clark et al. 2007, Schembri,
Anderson et al. 2009, Cao, Zou et al. 2011, Tran, Siu et al. 2011, Esteban, Arostegui et al.
2014, Candrilli, Dhamane et al. 2015, Kim, Noh et al. 2015, Montserrat-Capdevila,
Godoy et al. 2015, Mullerova, Maselli et al. 2015, Yu, Zhou et al. 2015, Hunter, Lee et
al. 2016, Singh and Yu 2016). Eleven out of thirteen studies found positive association
between age and risk of having COPD-related hospitalization (Niewoehner, Lokhnygina
et al. 2007, Tsai, Clark et al. 2007, Schembri, Anderson et al. 2009, Cao, Zou et al. 2011,
Tran, Siu et al. 2011, Esteban, Arostegui et al. 2014, Candrilli, Dhamane et al. 2015,
Montserrat-Capdevila, Godoy et al. 2015, Mullerova, Maselli et al. 2015, Hunter, Lee et
al. 2016, Singh and Yu 2016). Two remaining studies did not find any association
between age and COPD-related hospitalization (Kim, Noh et al. 2015, Yu, Zhou et al.
2015).

Gender and Hospitalization
Gender and All-Cause Hospitalization in COPD Patients
Stuart and colleagues assessed relationships between gender and all-cause
hospitalization among 6,322 individuals covered by Medicare who were diagnosed with
COPD (Stuart, Simoni-Wastila et al. 2010). Multivariate logistic models showed that
women were less likely to have all-cause hospitalization as compared to men (Odds
Ratio=0.82, 95% CI=0.72-0.93).
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Farkas and colleagues conducted a prospective cohort study in 127 clinically
stable COPD patients to assess associations between gender and risk of all-cause
hospitalization (Farkas, Kosnik et al. 2010). No association was reported between gender
and all-cause hospitalization risk.
Candrilli and colleagues assessed associations between gender and risk of allcause hospital readmission among 140,891 U.S. managed care patients with a diagnosis
of COPD (Candrilli, Dhamane et al. 2015). No association was found between gender
and risk of all-cause hospital readmission within 90 days following an initial COPDrelated hospital admission.
Yu and colleagues conducted a retrospective cohort analysis of 18,282
commercially insured COPD patients identified from a large U.S. administrative claims
database to examine associations between gender and all-cause hospital readmission (Yu,
Zhou et al. 2015). No association was reported between gender and 30-day all-cause
hospital readmission (p=0.060).
Sharif and colleagues assessed associations between gender and risk of 30-day
all-cause rehospitalization following an initial COPD-related hospitalization in a sample
of commercially insured COPD patients enrolled in a large national private health
insurance plan (Sharif, Parekh et al. 2014). They reported that women had a significant
lower risk for 30-day all-cause rehospitalization (Odds Ratio=0.90, p=0.025).
Nguyen and colleagues examined associations between gender and risk of 30-day
all-cause readmission among 4,596 patients age 40 years or older with a diagnosis of
COPD in California (Nguyen, Chu et al. 2014). No association was found between
gender and risk of 30-day all-cause hospital readmission (p=0.48).
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In summary, six studies were found that assessed association between gender and
all-cause hospitalization (Liu, Lin et al. 2007, Farkas, Kosnik et al. 2010, Stuart, SimoniWastila et al. 2010, Nguyen, Chu et al. 2014, Sharif, Parekh et al. 2014, Candrilli,
Dhamane et al. 2015, Yu, Zhou et al. 2015). Two out of seven studies reported that men
had higher risk of all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010, Sharif,
Parekh et al. 2014). The remaining four studies reported no association between gender
and all-cause hospitalization (Liu, Lin et al. 2007, Farkas, Kosnik et al. 2010, Nguyen,
Chu et al. 2014, Candrilli, Dhamane et al. 2015, Yu, Zhou et al. 2015).

Gender and COPD-Related Hospitalization
Santibanez and colleagues conducted a retrospective cohort study to assess
associations between gender and risk of COPD-related hospitalizations from a simple
random sample of COPD patients in Northern Spain (Santibanez, Garrastazu et al. 2016).
No association was found between gender and risk of COPD-related hospitalizations.
Hunter and colleagues assessed associations between gender and hospitalization
for COPD exacerbations in a cohort of 7,002 patients from 72 general practices in
Scotland (Hunter, Lee et al. 2016). Multivariate regression models revealed no
association between gender and risk of hospitalization for COPD exacerbations.
Singh and Yu examined associations between gender and risk of COPD-related
hospitalization using data from the U.S. Nationwide Emergency Department Sample
(NEDS) in patients admitted to the emergency room with COPD (Singh and Yu 2016).
They reported that men had significantly lower risk of COPD-related hospitalization as
compared to women (Odds Ratio=0.91, 95% CI=0.89-0.93, p<0.001).
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Montserrat-Capdevila and colleagues assessed associations between gender and
risk of hospital admission for COPD exacerbations in a sample of COPD patients drawn
from a hospital discharge database in Spain (Montserrat-Capdevila, Godoy et al. 2015).
Multivariate analyses revealed that women had significantly lower risk of hospital
admission due to COPD exacerbations as compared to men (Odds Ratio=0.71, 95%
CI=0.57-0.88, p=0.002).
Tran and colleagues assessed associations between gender and risk of COPDrelated hospitalization among 126,019 patients with a diagnosis of COPD identified from
a large health plan in northern California (Tran, Siu et al. 2011). They reported that men
had significantly higher risk of being hospitalized for COPD reasons as compared to
women (Relative Risk=1.2, 95% CI=1.0-1.3, p<0.05).
Cao and colleagues examined associations between gender and COPD-related
hospitalization risk among 52,274 COPD patients identified from a large U.S.
administrative claims database (Cao, Zou et al. 2011). No association was found between
gender and risk of COPD-related hospitalization.
Tsai and colleagues assessed associations between gender and hospitalization for
COPD exacerbations among 384 COPD patients enrolled in a multicenter study in the
U.S. and Canada (Tsai, Clark et al. 2007). They reported that women had significantly
higher risk of being hospitalized for COPD exacerbations as compared to men (Odds
Ratio=2.13, 95% CI=1.20-3.78).
Candrilli and colleagues conducted a retrospective cohort study on 140,891
COPD patients identified through a large U.S. managed care claims database to assess
associations between gender and COPD-related hospital readmission (Candrilli,
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Dhamane et al. 2015). No association was found between gender and risk of COPDrelated hospital readmission within 90 days following an initial hospital admission for
COPD reasons.
Yu and colleagues examined relationships between gender and risk of unplanned
30-day hospital readmission for COPD reasons among 18,282 U.S. commercially insured
patients with a diagnosis of COPD (Yu, Zhou et al. 2015). No association was reported
between gender and risk of COPD-related hospital readmission (p=0.148).
In summary, nine studies assessed association between gender and COPD-related
hospitalization (Tsai, Clark et al. 2007, Cao, Zou et al. 2011, Tran, Siu et al. 2011,
Candrilli, Dhamane et al. 2015, Montserrat-Capdevila, Godoy et al. 2015, Yu, Zhou et al.
2015, Hunter, Lee et al. 2016, Santibanez, Garrastazu et al. 2016, Singh and Yu 2016).
Among those studies, two reported that men had greater risk of COPD-related
hospitalization (Tran, Siu et al. 2011, Montserrat-Capdevila, Godoy et al. 2015). Another
two studies, however, reported that women had greater risk of COPD-related
hospitalization (Tsai, Clark et al. 2007, Singh and Yu 2016). Five remaining studies
found no association between gender and COPD-related hospitalization (Cao, Zou et al.
2011, Candrilli, Dhamane et al. 2015, Yu, Zhou et al. 2015, Hunter, Lee et al. 2016,
Santibanez, Garrastazu et al. 2016).

Race and Hospitalization
Race and All-Cause Hospitalization in COPD Patients
Stuart and colleagues assessed associations between race and all-cause
hospitalization risk in a cohort of Medicare beneficiaries with a diagnosis of COPD
(Stuart, Simoni-Wastila et al. 2010). Multivariate analyses revealed that Hispanic
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patients were at lower risk of all-cause hospitalization as compared to non-Hispanic white
patients (Odds Ratio=0.66, 95% CI=0.49-0.88).
Nguyen and colleagues examined relationships between race and all-cause
hospital readmission in a sample of Californian patients with a diagnosis of COPD
(Nguyen, Chu et al. 2014). No association was found between race and all-cause
readmission risk.
In summary, two studies were found that assessed association between race and
all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010, Nguyen, Chu et al. 2014).
One of them reported that Hispanic patients had lower risk of all-cause hospitalization as
compared to non-Hispanic White patients (Stuart, Simoni-Wastila et al. 2010). The other
study found no association between race and all-cause hospitalization (Nguyen, Chu et al.
2014).

Race and COPD-Related Hospitalization
Tran and colleagues conducted a cohort study with 126,019 individuals who were
diagnosed with COPD in northern California to examine relationships between race and
COPD-related hospitalization (Tran, Siu et al. 2011). Multivariate analyses revealed that
Hispanic participants (Relative Risk=0.6, 95% CI=0.3-0.9) and Asian participants
(Relative Risk=0.4, 95% CI=0.3-0.6) had significantly lower risk of COPD-related
hospitalization as compared to white participants.
Tsai and colleagues examined associations between race and hospitalization due
to COPD exacerbations among 384 U.S. and Canadian patients with COPD (Tsai, Clark
et al. 2007). No association was found between race and risk of hospitalization for
COPD exacerbations.
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In summary, two studies assessed association between race and COPD-related
hospitalization (Tsai, Clark et al. 2007, Tran, Siu et al. 2011). One study reported that
Hispanics and Asians had significantly lower risk of COPD-related hospitalizations than
Whites (Tran, Siu et al. 2011). The other study found no association between race and
COPD-related hospitalization (Tsai, Clark et al. 2007).

Marital Status and Hospitalization
Marital Status and All-Cause Hospitalization in COPD Patients
Stuart and colleagues conducted a retrospective cohort study using data from
Medicare Current Beneficiary Survey to assess associations between marital status and
all-cause hospitalization in COPD patients (Stuart, Simoni-Wastila et al. 2010). No
association was found between marital status and all-cause hospitalization.
Nguyen and colleagues assessed associations between marital status and risk of all-cause
readmission using data from a large integrated health care system in Southern California
(Nguyen, Chu et al. 2014). No association was reported between marital status and allcause readmission risk.
Wong and colleagues assessed relationships between marital status and risk of allcause readmission among 109 COPD patients who were admitted to St. Paul’s hospital in
Vancouver, Canada (Wong, Gan et al. 2008). They reported that single patients were at
higher risk of all-cause readmission as compared to non-single patients (Odds
Ratio=4.18, 95% CI=1.03-17.02).
In summary, three studies were found that assessed association between marital
status and all-cause hospitalization (Wong, Gan et al. 2008, Stuart, Simoni-Wastila et al.
2010, Nguyen, Chu et al. 2014). One out of three studies reported that patients who were
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single had greater risk of all-cause hospitalization as compared to patients who were not
single (Wong, Gan et al. 2008). The remaining two studies found no association between
marital status and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010, Nguyen,
Chu et al. 2014).

Education and Hospitalization
Education and All-Cause Hospitalization in COPD Patients
Stuart and colleagues conducted a retrospective cohort study using data from the
Medicare Current Beneficiary Survey to examine associations between educational level
and all-cause hospitalization in COPD patients (Stuart, Simoni-Wastila et al. 2010). No
association was found between educational level and all-cause hospitalization risk.
In summary, only one study was found that assessed the relationship between education
and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010). That study reported no
association between education and all-cause hospitalization (Stuart, Simoni-Wastila et al.
2010).

Education and COPD-Related Hospitalization
Tran and colleagues examined relationships between education level and risk of
COPD-related hospitalization among 126,019 patients with a diagnosis of COPD
identified from a large health plan in northern California (Tran, Siu et al. 2011).
Multivariate regression models showed that individuals who graduated from college had
significantly lower COPD-related hospitalization risk as compared to those did not attend
college (Relative Risk=0.6, 95% CI=0.5-0.8, p<0.001).
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In summary, only one study assessed the association between education and
COPD-related hospitalization (Tran, Siu et al. 2011). That study found that patients
without a college degree were at higher risk of having COPD-related hospitalization than
those with a college degree (Tran, Siu et al. 2011).

Region and Hospitalization
Region and All-Cause Hospitalization in COPD Patients
Stuart and colleagues examined relationships between region and risk of all-cause
hospitalization among 6,322 Medicare beneficiaries who were diagnosed with COPD
(Stuart, Simoni-Wastila et al. 2010). They reported that Medicare beneficiaries from the
Northeast, the South and the West were at lower risk of all-cause hospitalization as
compared to those from the Midwest (all p<0.05).
Candrilli and colleagues examined associations between region and all-cause
rehospitalization in a sample of U.S. managed care patients with COPD (Candrilli,
Dhamane et al. 2015). Multivariate regression models showed that patients from the
Midwest (Odds Ratio=0.903, 95% CI=0.873-0.934, p<0.001), the South (Odds
Ratio=0.901, 95% CI=0.870-0.933, p<0.001), and the West (Odds Ratio=0.937, 95%
CI=0.891-0.985, p=0.010) had significantly lower risk of all-cause rehospitalization
within 90 days following an initial COPD-related hospitalization as compared to those
from the Northeast.
Yu and colleagues assessed associations between region and all-cause hospital
readmission among 18,282 commercially insured COPD patients in the United States
(Yu, Zhou et al. 2015). No association was reported between region and 30-day all-cause
hospital readmission.
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In summary, three studies assessed association between region and all-cause
hospitalization (Stuart, Simoni-Wastila et al. 2010, Candrilli, Dhamane et al. 2015, Yu,
Zhou et al. 2015). One study reported that patients from the Northeast region had higher
risk of all-cause hospitalization as compared to patients from other regions (Candrilli,
Dhamane et al. 2015). Another study reported that patients from the Midwest region
were more likely to have all-cause hospitalization than those from other regions in the
country (Stuart, Simoni-Wastila et al. 2010). The remaining study found no association
between region and all-cause hospitalization (Yu, Zhou et al. 2015).

Region and COPD-Related Hospitalization
Singh and Yu assessed associations between region and COPD-related
hospitalizations using data from a large U.S. claims database (Singh and Yu 2016). They
reported that individuals from the Midwest (Odds Ratio=0.60, 95% CI=0.51-0.71,
p<0.001), the South (Odds Ratio=0.80, 95% CI=0.67-0.95, p=0.011), and the West (Odds
Ratio=0.63, 95% CI=0.52-0.76, p<0.001) had significantly lower risk of COPD-related
hospitalization as compared to those from the Northeast.
Cao and colleagues examined associations between region and COPD-related
hospitalization in a sample of COPD patients drawn from a large United States
administrative claims database (Cao, Zou et al. 2011). Multivariate analyses revealed
that patients from the West had significantly higher risk of COPD-related hospitalization
as compared to those from the South (Odds Ratio=0.706, 95% CI=0.646-0.771, p<0.001).
Candrilli and colleagues assessed associations between region and COPD-related
hospital readmission among 140,891 U.S. managed care patients with COPD (Candrilli,
Dhamane et al. 2015). They reported that patients from the South (Odds Ratio=0.901,
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95% CI=0.870-0.933, p<0.001) and the West (Odds Ratio=0.937, 95% CI=0.891-0.985,
p=0.010) had significantly lower risk of COPD-related hospital readmission within 90
days following an initial COPD-related hospitalization as compared to those from the
Northeast.
Yu and colleagues conducted a retrospective cohort study on 18,282 COPD
patients who were covered under a commercial health plan in the United States to assess
associations between region and COPD-related hospital readmission within 30 days
following an initial COPD-related hospitalization (Yu, Zhou et al. 2015). No association
was reported between region and 30-day COPD-related hospital readmission.
In summary, four studies assessed association between region and COPD-related
hospitalization (Cao, Zou et al. 2011, Candrilli, Dhamane et al. 2015, Yu, Zhou et al.
2015, Singh and Yu 2016). Two out of four studies reported that patients from the
Northeast region had greater risk of COPD-related hospitalization than patients from
other regions in the country (Candrilli, Dhamane et al. 2015, Singh and Yu 2016). One
study found that patients from the South were more likely to be hospitalized due to
COPD as compared to those from the West (Cao, Zou et al. 2011). One remaining study
found no association between region and COPD-related hospitalization (Yu, Zhou et al.
2015).

Residence Status and Hospitalization
Residence Status and All-Cause Hospitalization in COPD Patients
Stuart and colleagues conducted a retrospective cohort study using data from
Medicare Current Beneficiary Survey to assess associations between residence status (i.e.
metro area versus non-metro area) and all-cause hospitalization risk in patients with
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COPD (Stuart, Simoni-Wastila et al. 2010). No association was found between residence
status and risk of all-cause hospitalization.
In summary, only one study was found that assessed the relationship between
residence and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010). That study
reported no association between residence and all-cause hospitalization (Stuart, SimoniWastila et al. 2010).

Residence Status and COPD-Related Hospitalization
Singh and Yu conducted a retrospective study using data from the U.S.
Nationwide Emergency Department Sample (NEDS) to assess association between
residence and risk of COPD-related hospitalization in patients admitted to the emergency
rooms (Singh and Yu 2016). Multivariate analyses revealed that patients who resided in
metropolitan areas were more likely to be hospitalized for COPD reasons as compared to
those who resided in non-metropolitan areas (Odds Ratio=1.42, 95% CI=1.27-1.58,
p<0.001).
Cao and colleagues examined relationships between residence and COPD-related
hospitalization risk in a sample of COPD patients drawn from a large U.S. administrative
claims database (Cao, Zou et al. 2011). They reported that individuals who resided in
urban areas had significantly lower risk of COPD-related hospitalization as compared to
those who resided in rural areas (Odds Ratio=0.897, 95% CI=0.844-0.953, p<0.001).
In summary, two studies assessed association between residence and COPD-related
hospitalizations (Cao, Zou et al. 2011, Singh and Yu 2016). One of the studies reported
that patients who resided in metropolitan areas had greater risk of having COPD-related
hospitalization (Singh and Yu 2016). The other study, however, reported that patients
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resided in rural areas were more likely to be hospitalized for COPD reasons (Cao, Zou et
al. 2011).

Income and Hospitalization
Income and All-Cause Hospitalization in COPD Patients
Stuart and colleagues assessed associations between income and all-cause
hospitalization risk among 6,322 Medicare beneficiaries with a diagnosis of COPD
identified from Medicare Current Beneficiary Survey (Stuart, Simoni-Wastila et al.
2010). No association was found between income and all-cause hospitalization risk.
In summary, only one study assessed the relationship between income and all-cause
hospitalization (Stuart, Simoni-Wastila et al. 2010). That study found no association
between income and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010).

Income and COPD-Related Hospitalization
Singh and Yu conducted a retrospective study using a large U.S. claims database
to assess associations between income and COPD-related hospitalization (Singh and Yu
2016). Multivariate regression models showed that individuals with a median household
income in the third quartile ($48,000 to $62,999) or in the fourth quartile ($63,000 or
more) were more likely to be hospitalized due to COPD reasons as compared to those
with a median household income in the first quartile (less than $38,999, p<0.001).
In summary, only one study was found that assessed association between income and
COPD-related hospitalization (Singh and Yu 2016). That study reported that higher
household income was associated with greater risk of COPD-related hospitalization
(Singh and Yu 2016).
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Clinical Characteristics and Hospitalization in COPD Patients
Smoking and Hospitalization
Smoking and All-Cause Hospitalization in COPD Patients
Stuart and colleagues examined relationships between smoking status and allcause hospitalization risk in a sample of Medicare beneficiaries with COPD (Stuart,
Simoni-Wastila et al. 2010). Multivariate logistic regression models showed that nonsmokers had significantly lower risk of all-cause hospitalization as compared to current
smokers (Odds Ratio=0.79, 95% CI=0.65-0.95).
Nguyen and colleagues assessed associations between smoking status and risk of
30-day all-cause hospital readmission among 4,596 COPD patients in California
(Nguyen, Chu et al. 2014). Multivariate analyses revealed no association between
smoking status and all-cause hospital readmission risk.
In summary, two studies were found that assessed association between smoking
and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010, Nguyen, Chu et al.
2014). One of the studies reported that smoking was associated with greater risk of allcause hospitalization (Stuart, Simoni-Wastila et al. 2010). The other study found no
association between smoking and all-cause hospitalization (Nguyen, Chu et al. 2014).

Smoking and COPD-Related Hospitalization
Santibanez and colleagues assessed associations between smoking status and risk
of hospitalizations due to COPD exacerbations in a cohort of 900 COPD patients in
Northern Spain (Santibanez, Garrastazu et al. 2016). They did not find significant
difference in hospitalization risks between current smokers, former smokers, and never
smokers.
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Hunter and colleagues conducted a retrospective cohort study using electronic
primary care data in the U.K. to assess associations between smoking status and hospital
admissions for acute exacerbations of COPD among 7,002 patients with a diagnosis of
COPD (Hunter, Lee et al. 2016). Multivariate analyses showed that both former smokers
(Hazard Ratio=0.86, 95% CI=0.78-0.96) and never smokers (Hazard Ratio=0.47, 95%
CI=0.35-0.65) had significantly lower risk of hospitalization due to COPD exacerbations
as compared to current smokers (p<0.001).
Montserrat-Capdevila and colleagues examined associations between smoking
status and risk of hospital admission for COPD exacerbations among 2,501 Spanish
patients with COPD (Montserrat-Capdevila, Godoy et al. 2015). They reported that
smokers had significantly higher risk of being hospitalized for COPD exacerbations as
compared to non-smokers (Odds Ratio=1.94, 95% CI=1.56-2.41, p=0.001).
Kim and colleagues conducted a retrospective cohort analysis of 2,933 COPD
patients presenting at the Asan Medical Center in Korea to assess associations between
smoking and hospitalization due to respiratory problems (Kim, Noh et al. 2015).
Multivariate analyses revealed that current smokers had significantly higher risk of being
hospitalized due to respiratory problems as compared to non-smokers (Hazard
Ratio=1.528, 95% CI=1.277-1.828, p<0.001).
Calderon-Larranaga and colleagues conducted a cross-sectional analysis of
53,676,051 patients from 8,064 practices in the U.K. to assess associations between
smoking and COPD-related hospitalization (Calderon-Larranaga, Carney et al. 2011).
They reported that smoking was associated with increased risk of COPD-related
hospitalization (p<0.001).
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Tran and colleagues assessed associations between smoking and COPD-related
hospitalization risk in a sample of COPD patients in northern California (Tran, Siu et al.
2011). Multivariate regression models showed that both current smokers and ex-smokers
were at greater risk of COPD-related hospitalization as compared to those who never
smoked (all p<0.001).
Tsai and colleagues examined associations between smoking history and risk of
hospitalization for COPD exacerbations among 384 COPD patients who participated in a
multicenter prospective study in the U.S. and Canada (Tsai, Clark et al. 2007). They
reported that smoking history per 10 pack-year increase was associated with increased
risk of hospitalization due to COPD exacerbations (Odds Ratio=1.09, 95% CI=1.011.17).
In summary, seven studies assessed association between smoking and COPDrelated hospitalization (Tsai, Clark et al. 2007, Calderon-Larranaga, Carney et al. 2011,
Tran, Siu et al. 2011, Kim, Noh et al. 2015, Montserrat-Capdevila, Godoy et al. 2015,
Hunter, Lee et al. 2016, Santibanez, Garrastazu et al. 2016). Six out of seven studies
found positive association between smoking and risk of having COPD-related
hospitalization (Tsai, Clark et al. 2007, Calderon-Larranaga, Carney et al. 2011, Tran, Siu
et al. 2011, Kim, Noh et al. 2015, Montserrat-Capdevila, Godoy et al. 2015, Hunter, Lee
et al. 2016). One remaining study, however, did not find any association between
smoking and COPD-related hospitalization (Santibanez, Garrastazu et al. 2016).
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Health Status and Hospitalization
Health Status and All-Cause Hospitalization in COPD Patients
Stuart and colleagues examined relationships between self-reported health status
and all-cause hospitalization risk among 6,322 Medicare beneficiaries with COPD
(Stuart, Simoni-Wastila et al. 2010). Compared to patients who reported excellent or
very good health, those who reported poor health were more likely to be hospitalized for
any reasons (Odds Ratio=1.45, 95% CI=1.19-1.78).
Farkas and colleagues assessed associations between self-rated health and allcause hospitalization risk among 127 clinically stable patients with COPD in Slovenia
(Farkas, Kosnik et al. 2010). Multivariate regression analyses revealed that patients who
reported poor or very poor health had significantly higher risk of all-cause hospitalization
as compared to those who reported fair or better health (Hazard Ratio=1.93, 95%
CI=1.12-3.68).
Benzo and colleagues assessed associations between self-rated health and allcause hospitalization risk among 597 COPD patients in a randomized clinical trial in the
United States (Benzo, Chang et al. 2010). Multivariate analyses showed that individuals
who reported fair or poor health were at greater risk of all-cause hospitalization as
compared to those who reported good, very good or excellent health (Odds Ratio=1.57,
95% CI=1.10-2.23, p<0.01).
In summary, three studies were found that assessed association between self-rated
health status and all-cause hospitalization (Benzo, Chang et al. 2010, Farkas, Kosnik et
al. 2010, Stuart, Simoni-Wastila et al. 2010). All three studies reported that worse self-
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rated health status was associated with greater risk of all-cause hospitalization (Benzo,
Chang et al. 2010, Farkas, Kosnik et al. 2010, Stuart, Simoni-Wastila et al. 2010).

Health Status and COPD-Related Hospitalization
Mullerova and colleagues assessed associations between health status and
hospitalization due to COPD exacerbations among 2,138 COPD patients who participated
in a multicenter, prospective clinical trial (Mullerova, Maselli et al. 2015). Health status
was measured using the St. George’s Respiratory Questionnaire (SGRQ) for COPD
patients. Multivariate analyses showed that poorer health status, as indicated by lower
SGRQ total score, was associated with greater risk of hospitalization for COPD
exacerbations (Hazard Ratio=1.08, 95% CI=1.06-1.10, p<0.001).
In summary, only one study assessed the association between health status and
COPD-related hospitalization (Mullerova, Maselli et al. 2015). That study found that
worse health status, as indicated by lower St. George's Respiratory Questionnaire
(SGRQ) scores, was associated with higher risk of being hospitalized for COPD reasons
(Mullerova, Maselli et al. 2015).

Vaccination and Hospitalization
Vaccination and All-Cause Hospitalization in COPD Patients
Stuart and colleagues assessed associations between vaccination and risk of allcause hospitalization in a cohort of Medicare beneficiaries who were diagnosed with
COPD (Stuart, Simoni-Wastila et al. 2010). Multivariate analyses revealed that influenza
vaccination was associated with reduced risk of all-cause hospitalization (Odds
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Ratio=0.82, 95% CI=0.72-0.94). However, no association was reported between
pneumococcal vaccination and risk of all-cause hospitalization.
Yu and colleagues conducted a retrospective cohort analysis of 18,282
commercially insured COPD patients identified from a large U.S. administrative claims
database to assess associations between influenza vaccination and all-cause hospital
readmission within 30 days following an initial COPD-related hospital admission (Yu,
Zhou et al. 2015). No association was reported between influenza vaccination and allcause hospital readmission (p=0.453).
Nguyen and colleagues examined associations between vaccination and 30-day
all-cause readmission risk using data from a large integrated health care system in
Southern California (Nguyen, Chu et al. 2014). They reported that pneumococcal
vaccination within the past five years was associated with significantly lower risk of allcause hospital readmission (p=0.03). However, no association was found between
influenza vaccination and all-cause readmission risk.
In summary, three studies were found that assessed association between
vaccination and all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010, Nguyen,
Chu et al. 2014, Yu, Zhou et al. 2015). One study reported that pneumococcal
vaccination, but not influenza vaccination was associated with lower risk of all-cause
hospitalization (Nguyen, Chu et al. 2014). Another study, on the other hand, reported
that influenza vaccination, but not pneumococcal vaccination was associated with
reduced risk of all-cause hospitalization (Stuart, Simoni-Wastila et al. 2010). The
remaining study reported no association between influenza vaccination and all-cause
hospitalization (Yu, Zhou et al. 2015).
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Vaccination and COPD-Related Hospitalization
Montserrat-Capdevila and colleagues conducted a retrospective cohort study on
2,501 COPD patients identified from a hospital discharge database in Spain to assess
associations between influenza vaccination and risk of hospitalization due to COPD
exacerbations (Montserrat-Capdevila, Godoy et al. 2015). Multivariate regression
models showed that severe or very severe COPD patients who had flu shot were less
likely to be hospitalized for COPD exacerbations as compared to those who did not have
flu shot (Odds Ratio=0.54, 95% CI=0.30-0.96, p=0.036).
Calderon-Larranaga and colleagues assessed associations between influenza
vaccination and COPD-related hospitalization using data from a national cross-sectional
study in the United Kingdom (Calderon-Larranaga, Carney et al. 2011). Multivariate
regression analyses showed that influenza vaccination was associated with reduced risk
of COPD-related hospitalization (p=0.036).
Cao and colleagues conducted a retrospective cohort analysis of 52,274 COPD
patients with at least one long acting bronchodilators to assess associations between
vaccination and COPD-related hospitalization (Cao, Zou et al. 2011). No association was
found between influenza vaccination, or pneumococcal vaccination and risk of COPDrelated hospitalization.
Schembri and colleagues assessed associations between influenza vaccination and
COPD-related hospitalization risk among 3,343 COPD patients selected from a clinic
network in Scotland (Schembri, Anderson et al. 2009). They reported that not having
influenza vaccination was associated with increased risk of COPD-related hospitalization
(Hazard Ratio=1.60, 95% CI=1.37-1.87).
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Roberts and colleagues examined associations between influenza or
pneumococcal vaccination and risk of COPD-related rehospitalization in 3,612 U.S.
patients with diagnosed COPD who had a COPD-related hospital admission (Roberts,
Clerisme-Beaty et al. 2016). Multivariate regression models showed that neither
influenza vaccination nor pneumococcal vaccination was associated with COPD-related
rehospitalization.
Yu and colleagues conducted a retrospective cohort study using a sample of U.S.
commercially insured COPD patients to assess associations between influenza
vaccination and 30-day COPD-related hospital readmission (Yu, Zhou et al. 2015). No
association was reported between influenza vaccination and COPD-related hospital
readmission (p=0.881).
In summary, six studies assessed association between vaccination and COPDrelated hospitalization (Schembri, Anderson et al. 2009, Cao, Zou et al. 2011, MontserratCapdevila, Godoy et al. 2015, Yu, Zhou et al. 2015, Roberts, Clerisme-Beaty et al. 2016).
Two out of six studies found positive association between influenza vaccination and
reduced risk of COPD-related hospitalization (Schembri, Anderson et al. 2009,
Montserrat-Capdevila, Godoy et al. 2015). Two studies found that neither pneumococcal
vaccination nor influenza vaccination was associated with COPD-related hospitalization
(Cao, Zou et al. 2011, Roberts, Clerisme-Beaty et al. 2016). The remaining study
reported no association between influenza vaccination and risk of having COPD-related
hospitalization (Yu, Zhou et al. 2015).
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Comorbidity and Hospitalization
Comorbidity and All-Cause Hospitalization in COPD Patients
Kendzerska and colleagues assessed associations between history of asthma and
all-cause hospitalizations among 9,053 patients with physician diagnosed COPD between
the ages 40 and 55 years in Ontario, Canada (Kendzerska, To et al. 2017). Multivariate
regressions revealed that history of asthma was associated with higher risk of all-cause
hospitalization (Hazard Ratio=1.08, 95% CI=1.01-1.15, p=0.027).
Dalal and colleagues assessed associations between depression/anxiety and allcause hospitalization in a cohort of 7,522 COPD patients drawn from a U.S. managed
care claims database (Dalal, Shah et al. 2011). Patients with depression/anxiety had
significantly higher number of all-cause hospitalizations as compared to those without
depression/anxiety (0.42 vs 0.28, p<0.05).
Stuart and colleagues examined associations between selected comorbidities and
risk of all-cause hospitalization among 6,322 Medicare beneficiaries with COPD (Stuart,
Simoni-Wastila et al. 2010). Individual comorbidities that were associated with all-cause
hospitalization were hypertension, asthma, ischemic heart disease, congestive heart
failure, depression, anxiety, and osteoporosis (all p<0.05).
Benzo and colleagues assessed relationships between self-reported anxiety and
risk of all-cause hospitalization in 597 COPD patients from 17 clinics in the Unites States
(Benzo, Chang et al. 2010). They reported that patients with self-reported anxiety were
at greater risk of all-cause hospitalization as compared to those without anxiety (Odds
Ratio=1.75, 95% CI=1.13-2.70, p<0.01).
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Candrilli and colleagues assessed associations between comorbidities and allcause hospital readmission using data from a large U.S. managed care claims database
(Candrilli, Dhamane et al. 2015). They reported that patients with Charlson Comorbidity
Index score of 3 or higher were more likely to have an all-cause hospital readmission
within 90 days following an initial COPD-related hospitalization as compared to those
with Charlson Comorbidity Index score 0 (Odds Ratio=2.182, 95% CI=2.063-2.309,
p<0.001). Individual comorbidities that were associated with all-cause hospital
readmission were ischemic heart disease, cancer, and chronic renal failure (all p<0.001).
Yu and colleagues examined associations between selected comorbidities and 30day all-cause hospital readmission among 18,282 commercially insured COPD patients in
the United States (Yu, Zhou et al. 2015). Individual comorbidities that were associated
with 30-day all-cause hospital readmission were anemia, depression, heart disease, heart
failure, and chronic kidney disease (all p<0.05).
Sharif and colleagues conducted a retrospective cohort analysis of 8,263
commercially insured COPD patients identified from a large private insurance plan
claims database to examine associations between selected comorbidities and all-cause
hospital readmission (Sharif, Parekh et al. 2014). They reported that anxiety, depression,
congestive heart failure, lung cancer, and osteoporosis were associated with increased
risk of all-cause hospital readmission (all p<0.05).
Nguyen and colleagues assessed associations between comorbidities and risk of
all-cause hospital readmission among 4,596 COPD patients in California (Nguyen, Chu
et al. 2014). Multivariate analyses showed that patients with Charlson Comorbidity
Index score three or higher were at greater risk of all-cause hospital readmission as
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compared to those with Charlson Comorbidity Index score 0 or 1 (Relative Risk=1.44
95% CI=1.17-1.78, p<0.001). They also reported that anemia was associated with
increased risk of all-cause hospital readmission (Relative Risk=1.59 95% CI=1.33-1.90,
p<0.001).
Baker and colleagues examined associations between selected comorbidities and
all-cause hospital readmission among 6,095 commercially insured COPD patients in the
United States (Baker, Zou et al. 2013). Multivariate analyses revealed that heart failure,
diabetes mellitus, and metastatic solid tumor were associated with increased risk of allcause hospital readmission (all p<0.05).
Nantsupawat and colleagues assessed associations between selected comorbidities
and risk of 30-day all-cause hospital readmission using medical records data from 81
COPD patients in Texas (Nantsupawat, Limsuwat et al. 2012). Multivariate regression
models showed that coronary artery disease and unilateral pulmonary infiltrates were
associated with increased risk of early all-cause readmission (all p<0.05).
Wong and colleagues assessed associations between number of comorbidities and
risk of all-cause readmission among 109 COPD patients in Canada (Wong, Gan et al.
2008). They reported that higher number of comorbidities was associated with greater
risk of all-cause readmission (Odds Ratio=1.47, 95% CI=1.10-1.97, p<0.001).
In summary, eleven studies assessed association between comorbidity and allcause hospitalization (Wong, Gan et al. 2008, Benzo, Chang et al. 2010, Stuart, SimoniWastila et al. 2010, Dalal, Shah et al. 2011, Nantsupawat, Limsuwat et al. 2012, Baker,
Zou et al. 2013, Nguyen, Chu et al. 2014, Sharif, Parekh et al. 2014, Candrilli, Dhamane
et al. 2015, Yu, Zhou et al. 2015, Santibanez, Garrastazu et al. 2016, Kendzerska, To et
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al. 2017). Two studies reported that higher Charlson Comorbidity Index scores were
associated with greater risk of all-cause hospitalization in patients with COPD (Nguyen,
Chu et al. 2014, Candrilli, Dhamane et al. 2015). Congestive heart failure was one of the
most commonly reported comorbidities in COPD patients that were associated with
increased risk of all-cause hospitalization, as seen in four studies (Stuart, Simoni-Wastila
et al. 2010, Baker, Zou et al. 2013, Sharif, Parekh et al. 2014, Yu, Zhou et al. 2015).
Depression was also frequently reported as a comorbidity in COPD patients and four
studies found its correlation with greater risk of all-cause hospitalization (Stuart, SimoniWastila et al. 2010, Dalal, Shah et al. 2011, Sharif, Parekh et al. 2014, Yu, Zhou et al.
2015). Other comorbidities that were found associated with all-cause hospitalization in
COPD patients include asthma, atrial fibrillation, anxiety, hypertension, heart disease,
diabetes, cancer, osteoporosis, chronic kidney disease, and anemia.

Comorbidity and COPD-Related Hospitalization
Kendzerska and colleagues examined the impact of asthma on COPD-related
hospitalizations in 9,053 COPD patients in Canada (Kendzerska, To et al. 2017). They
reported that individuals with a history of asthma had higher risk of COPD-related
hospitalizations as compared to those without a history of asthma (Hazard Ratio=1.53,
95% CI=1.30-1.79, p<0.001).
Santibanez and colleagues conducted a retrospective population-based cohort
study to assess associations between comorbidities and hospitalizations due to COPD
exacerbations among 900 COPD patients in Northern Spain (Santibanez, Garrastazu et al.
2016). Multivariate logistic regression models showed that individuals who had at least
one comorbid conditions were more likely to be hospitalized due to COPD exacerbations
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(Odds Ratio=3.32, 95% CI=1.41-7.84). Individual comorbidities that were associated
with hospitalization for COPD were atrial fibrillation, heart failure, diabetes, and lung
cancer (all p<0.05).
Hunter and colleagues examined relationship between comorbidities and risk of
hospital admissions due to COPD exacerbations in 7,002 patients from Scotland (Hunter,
Lee et al. 2016). They reported that respiratory comorbidities other than asthma (Hazard
Ratio=1.47, 95% CI=1.26-1.72, p<0.001) and non-respiratory comorbidities (Hazard
Ratio=1.36, 95% CI=1.24-1.55, p<0.001) were associated with increased risk of
hospitalization due to COPD exacerbations.
Singh and Yu assessed associations between comorbidities and risk of COPDrelated hospitalization in a sample of COPD patients who were admitted to the
emergency room in the United States (Singh and Yu 2016). Multivariate analyses
showed that hypertension, hyperlipidemia, coronary heart disease, heart failure, diabetes,
chronic renal failure, and osteoporosis were associated with increased risk of COPDrelated hospitalization (all p<0.001).
Kim and colleagues assessed associations between asthma overlap syndrome and
hospitalization due to respiratory problems in a sample of COPD patients from Korea
(Kim, Noh et al. 2015). They reported that patients with an overlap syndrome of asthma
and COPD had significantly higher risk of hospitalization due to respiratory problems as
compared to those without an overlap syndrome (Hazard Ratio=2.183, 95% CI=1.8212.618, p<0.001).
Ito and colleagues assessed associations between depression and hospitalization
for COPD exacerbations among 85 patients aged 40 years and over with stable COPD in
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Japan (Ito, Kawayama et al. 2012). They reported that depression was associated with
increased risk of hospitalization due to COPD exacerbations (p=0.008).
Dalal and colleagues examined relationships between depression/anxiety and
COPD-related hospitalization in a cohort of 7,522 COPD patients drawn from a U.S.
managed care claims database (Dalal, Shah et al. 2011). Adjusted regression models
showed that individuals with depression/anxiety had significantly higher number of
COPD-related hospitalizations as compared to those without depression/anxiety (0.05 vs
0.03, p<0.05).
Cao and colleagues examined associations between comorbidities and COPDrelated hospitalization risk among 52,274 COPD patients identified from a large U.S.
administrative claims database (Cao, Zou et al. 2011). They reported that congestive
heart failure was associated with increased risk of COPD-related hospitalization (Odds
Ratio=1.202, 95% CI=1.111-1.301, p<0.001).
Xu and colleagues assessed associations between anxiety/depression and
hospitalization due to COPD exacerbations in 491 patients with stable COPD in a
multicenter prospective study (Xu, Collet et al. 2008). They reported that depression,
measured by Hospital Anxiety and Depression Scale, was associated with increased risk
of hospitalization for COPD exacerbations (p=0.03). No association was found between
anxiety and COPD-related hospitalization.
Candrilli and colleagues examined relationships between comorbidities and
COPD-related hospital readmission among 140,891 COPD patients who enrolled in a
managed care health plan (Candrilli, Dhamane et al. 2015). They reported that
individuals with Charlson Comorbidity Index score 3 or higher had significantly higher
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risk of COPD-related hospital readmission within 90 days following an initial COPDrelated hospitalization as compared to those with Charlson Comorbidity Index score 0
(Odds Ratio=1.300, 95% CI=1.207-1.401, p<0.001). Individual comorbidities that were
associated with COPD-related hospital readmission were asthma and chronic renal failure
(all p<0.05).
Roberts and colleagues assessed associations between comorbidities and COPDrelated hospital readmissions in a sample of 3,612 COPD patients drawn from a national
US claims database (Roberts, Clerisme-Beaty et al. 2016). Multivariate analyses showed
that Charlson Comorbidity Index was not associated with COPD-related hospital
readmissions. However, asthma, anxiety, depression, hypertension, ischemic heart
disease, heart failure, diabetes, and osteoporosis were individually found to be associated
with greater risk of COPD-related hospital readmissions (all p<0.05).
Yu and colleagues examined associations between selected comorbidities and 30day COPD-related hospital readmission among 18,282 commercially insured COPD
patients in the United States (Yu, Zhou et al. 2015). Individual comorbidities that were
associated with 30-day COPD-related rehospitalization were anemia, depression, heart
disease, and heart failure (all p<0.05).
Baker and colleagues examined associations between selected comorbidities and
COPD-related hospital readmission among 6,095 commercially insured COPD patients in
the United States (Baker, Zou et al. 2013). Multivariate regression models showed that
only metastatic solid tumor was associated with increased risk of COPD-related hospital
readmission (p=0.026).
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In summary, thirteen studies were found that assessed association between
comorbidity and COPD-related hospitalization (Xu, Collet et al. 2008, Cao, Zou et al.
2011, Dalal, Shah et al. 2011, Ito, Kawayama et al. 2012, Baker, Zou et al. 2013,
Candrilli, Dhamane et al. 2015, Kim, Noh et al. 2015, Montserrat-Capdevila, Godoy et al.
2015, Mullerova, Maselli et al. 2015, Yu, Zhou et al. 2015, Roberts, Clerisme-Beaty et al.
2016, Santibanez, Garrastazu et al. 2016, Singh and Yu 2016, Kendzerska, To et al.
2017). Two out of fourteen studies assessed the association between Charlson
Comorbidity Index scores and COPD-related hospitalization, of which one study reported
that higher Charlson Comorbidity Index scores were associated with increased risk of
COPD-related hospitalization (Candrilli, Dhamane et al. 2015) while the other study
reported no association between Charlson Comorbidity Index scores and COPD-related
hospitalization (Roberts, Clerisme-Beaty et al. 2016). Six studies reported that having
congestive heart failure was associated with greater risk of COPD-related hospitalization
(Cao, Zou et al. 2011, Montserrat-Capdevila, Godoy et al. 2015, Yu, Zhou et al. 2015,
Roberts, Clerisme-Beaty et al. 2016, Santibanez, Garrastazu et al. 2016, Singh and Yu
2016). Another five studies reported that having asthma was associated with increased
risk of COPD-related hospitalization (Candrilli, Dhamane et al. 2015, Kim, Noh et al.
2015, Mullerova, Maselli et al. 2015, Roberts, Clerisme-Beaty et al. 2016, Kendzerska,
To et al. 2017). Other comorbidities that were associated with COPD-related
hospitalization include anxiety, atrial fibrillation, depression, hypertension, heart disease,
diabetes, cancer, osteoporosis, chronic kidney disease, and anemia.
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Prior Hospitalization and Hospitalization
Prior Hospitalization and All-Cause Hospitalization in COPD Patients
Sharif and colleagues assessed associations between prior all-cause
hospitalization and risk of early all-cause readmission, defined as a hospitalization within
30 days of discharge, among 8,263 COPD patients covered by commercial health plan
(Sharif, Parekh et al. 2014). Multivariate regression models showed that individuals with
less than three all-cause hospitalizations during the pre-index year had a significantly
lower risk of early all-cause readmission as compared to those with three or more prior
all-cause hospitalizations (p<0.001).
Nguyen and colleagues conducted a retrospective cohort analysis of 4,596 COPD
patients from California to examine relationships between prior all-cause hospitalization
and 30-day all-cause readmission risk (Nguyen, Chu et al. 2014). They reported that both
all-cause prior hospitalization (Relative Risk=1.60, 95% CI=1.31-1.94, p<0.001) and
COPD-related prior hospitalization (Relative Risk=1.53, 95% CI=1.29-1.82, p<0.001)
were associated with greater risk of 30-day all-cause readmission.
Baker and colleagues conducted a retrospective cohort study using claims data
from Truven MarketScan commercial claims and encounters database to assess
associations between prior COPD-related hospitalization and risk of all-cause
readmission (Baker, Zou et al. 2013). Patients who had two or more pre-index COPDrelated hospitalizations were more likely to have all-cause readmissions as compared to
those who had no pre-index hospitalization (Odds Ratio=1.39, 95% CI=1.14-1.69,
p=0.001).
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In summary, three studies assessed the relationship between prior hospitalization
and all-cause hospitalization in COPD patients (Baker, Zou et al. 2013, Nguyen, Chu et
al. 2014, Sharif, Parekh et al. 2014). One study reported that both patients with prior allcause hospitalization and patients with prior COPD-related hospitalization had greater
risk of all-cause hospitalization (Nguyen, Chu et al. 2014). Another study reported that
patients who had any COPD-related hospitalization in the pre-index period were at
greater risk of all-cause hospitalization (Baker, Zou et al. 2013). The last study reported
that patients with prior all-cause hospital admission were more likely to have all-cause
hospitalization during the study period (Sharif, Parekh et al. 2014).

Prior Hospitalization and COPD-Related Hospitalization
Santibanez and colleagues conducted a cohort study to assess associations
between prior COPD-related hospitalizations and risk of hospitalized exacerbations
among 900 patients with diagnosed COPD in Spain (Santibanez, Garrastazu et al. 2016).
Compared to individuals with no prior COPD-related hospitalization, those with one
COPD admission (Odds Ratio=3.12, 95% CI=1.88-5.18) and those with two or more
COPD admissions (Odds Ratio=6.73, 95% CI=3.53-12.83) during the pre-index year had
significantly higher risk of hospitalized exacerbations.
Hunter and colleagues assessed associations between prior admission with COPD
and risk of hospitalization for acute exacerbations of COPD in a cohort of 7,002 patients
from 72 general practices in Scotland (Hunter, Lee et al. 2016). Multivariate analyses
revealed that prior admission with COPD was associated with higher risk of
hospitalization due to COPD exacerbations (Hazard Ratio=1.94, 95% CI=1.75-2.17,
p<0.001).
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Mullerova and colleagues assessed associations between prior COPD-related
hospitalization and risk of hospitalization due to COPD exacerbations among 2,138
COPD patients who participated in a multicenter, prospective clinical trial (Mullerova,
Maselli et al. 2015). They reported that patients who had COPD-related hospitalization
in the previous year were more likely to experience a hospitalization due to COPD
exacerbations (Hazard Ratio=2.71, 95% CI=2.24-3.29, p<0.001).
Esteban and colleagues examined associations between COPD-related
hospitalization in the 2 years prior to enrollment and risk of hospital admission for COPD
exacerbations among 543 ambulatory COPD patients in Spain (Esteban, Arostegui et al.
2014). Multivariate Poisson models showed that patients who had prior COPD-related
hospitalization were more likely to be hospitalized due to COPD exacerbations as
compared to those who had no prior COPD-related hospitalization (p<0.001).
Cao and colleagues assessed associations between pre-index respiratory-related
hospital admission and COPD-related hospitalization risk among 52,274 COPD patients
prescribed with long-acting bronchodilators (Cao, Zou et al. 2011). They reported that
patients who had one or more pre-index respiratory-related hospital admissions were
more likely to be hospitalized for COPD reasons as compared to those who had no preindex hospitalization (p<0.001).
Schembri and colleagues assessed associations between prior respiratory-related
admissions and COPD-related hospitalization risk among 3,343 COPD patients selected
from a clinic network in Scotland (Schembri, Anderson et al. 2009). Multivariate
analyses revealed that patients who had prior respiratory-related hospital admissions were

43
more likely to be hospitalized for COPD reasons as compared to those who had no prior
hospitalization (Hazard Ratio=2.68, 95% CI=2.27-3.16).
Roberts and colleagues examined associations between prior all-cause or COPDrelated hospitalizations and risk of COPD-related hospital readmissions among 3,612
patients with diagnosed COPD from a large U.S. claims database (Roberts, ClerismeBeaty et al. 2016). They reported that all-cause hospitalization in the prior year (Odds
Ratio=2.10, 95% CI=1.72-2.55, p<0.001) and COPD-related hospitalization in the prior
year (Odds Ratio=3.64, 95% CI=2.65-4.99, p<0.001) were both associated with greater
risk of COPD-related hospital readmissions.
Baker and colleagues conducted a retrospective cohort study in 6,095
commercially insured patients who were diagnosed with COPD to assess associations
between pre-index COPD-related hospitalization and COPD-related readmission (Baker,
Zou et al. 2013). Individuals who had two or more pre-index COPD-related
hospitalizations were more likely to have COPD-related readmission as compared to
those who had no pre-index hospitalization (Odds Ratio=1.61, 95% CI=1.29-2.01,
p<0.001).
In summary, nine studies were found that assessed association between prior
hospitalization and COPD-related hospitalization (Niewoehner, Lokhnygina et al. 2007,
Schembri, Anderson et al. 2009, Cao, Zou et al. 2011, Baker, Zou et al. 2013, Esteban,
Arostegui et al. 2014, Mullerova, Maselli et al. 2015, Hunter, Lee et al. 2016, Roberts,
Clerisme-Beaty et al. 2016, Santibanez, Garrastazu et al. 2016). One of the eight studies
reported that both patients with prior all-cause hospitalization and patients with prior
COPD-related hospitalization had greater risk of COPD-related hospitalization during the
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study period (Roberts, Clerisme-Beaty et al. 2016). The remaining eight studies all found
that patients who had prior hospital admissions due to COPD were more likely to have
COPD-related hospitalization (Niewoehner, Lokhnygina et al. 2007, Schembri, Anderson
et al. 2009, Cao, Zou et al. 2011, Baker, Zou et al. 2013, Esteban, Arostegui et al. 2014,
Hunter, Lee et al. 2016, Santibanez, Garrastazu et al. 2016).

Number of Doctor Visits and Hospitalization
Number of Doctor Visits and COPD-Related Hospitalization
Montserrat-Capdevila and colleagues assessed associations between number of
doctor visits and hospital admission for COPD exacerbations among 2,501 Spanish
patients with a diagnosis of COPD (Montserrat-Capdevila, Godoy et al. 2015).
Individuals who had 25 to 50 doctor visits (Odds Ratio=1.78, 95% CI=1.44-2.16,
p=0.001) or more than 50 doctor visits (Odds Ratio=2.21, 95% CI=1.56-3.13, p=0.001)
were more likely to be hospitalized due to COPD exacerbations than those who only had
less than 25 doctor visits in the prior year.
In summary, only one study was found that assessed the relationship between
number of doctor visits and COPD-related hospitalization (Montserrat-Capdevila, Godoy
et al. 2015). That study concluded that higher number of doctor visits in the previous
year was associated with greater risk of being hospitalized for COPD (MontserratCapdevila, Godoy et al. 2015).
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COPD Disease Severity and Hospitalization
COPD Disease Severity and All-Cause Hospitalization in COPD Patients
Farkas and colleagues assessed associations between COPD disease severity and
all-cause hospitalization risk among 127 COPD patients in a prospective cohort study in
Slovenia (Farkas, Kosnik et al. 2010). COPD disease severity was categorized as mild,
moderate, severe, and very severe according to GOLD guidelines. No association was
reported between COPD disease severity and risk of all-cause hospitalization.
Candrilli and colleagues assessed associations between COPD disease severity
and all-cause hospital readmission in a sample of U.S. managed care patients with a
diagnosis of COPD (Candrilli, Dhamane et al. 2015). COPD complexity was utilized to
serve as a proxy for COPD disease severity following a method described by Mapel and
colleagues (Mapel, Dutro et al. 2011). Patients were assigned to three categories (i.e.
low, moderate, and severe) based on their comorbid respiratory conditions, medications,
and procedures observed during the pre-study period. Multivariate analyses showed that
individuals who had severe complexity had greater risk of all-cause hospital readmission
as compared to those who had low complexity (Odds Ratio=1.177, 95% CI=1.123-1.233,
p<0.001).
Yu and colleagues examined associations between COPD disease severity and 30day all-cause rehospitalization in a sample of COPD patients covered by commercial
health plans (Yu, Zhou et al. 2015). The COPD severity score, which was developed by
Wu and colleagues, was utilized as a proxy for COPD disease severity in the absence of
direct lab data (Wu, Birnbaum et al. 2006). The COPD severity score is a composite
measure of 12 items including pharmacotherapy and medical services use where higher
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scores represent more severe COPD. Multivariate analyses showed that a one-unit
increase in the COPD severity score was associated with greater risk of all-cause
rehospitalization (Odds Ratio=1.27, 95% CI=1.17-1.37, p<0.001).
Wong and colleagues assessed associations between COPD disease severity and
risk of all-cause hospital readmission using data from a hospital electronic database in
Canada (Wong, Gan et al. 2008). COPD disease severity was classified as mild,
moderate, severe, and very severe based on GOLD guidelines. Multivariate regression
models showed that individuals with more severe COPD were at greater risk of all-cause
readmission (Odds Ratio=6.23, 95% CI=2.47-15.72, p<0.001).
In summary, four studies were found that assessed association between COPD
disease severity and all-cause hospitalization in COPD patients (Wong, Gan et al. 2008,
Farkas, Kosnik et al. 2010, Candrilli, Dhamane et al. 2015, Yu, Zhou et al. 2015). Three
out of four studies reported that more severe COPD patients, as measured by GOLD
criteria, had greater risk of all-cause hospitalization (Wong, Gan et al. 2008, Candrilli,
Dhamane et al. 2015, Yu, Zhou et al. 2015). The remaining study found no association
between COPD disease severity and risk of all-cause hospitalization (Farkas, Kosnik et
al. 2010).

COPD Disease Severity and COPD-Related Hospitalization
Santibanez and colleagues examined relationships between COPD disease
severity and COPD-related hospitalizations in a sample of 900 patients with diagnosed
COPD in Northern Spain (Santibanez, Garrastazu et al. 2016). COPD disease severity
was classified as mild, moderate, severe, and very severe according to the GOLD
guidelines. Multivariate analyses revealed that individuals with very severe COPD had
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significantly higher risk of hospitalized exacerbations as compared to those with mild
COPD (Odds Ratio=4.39, 95% CI=1.36-14.11).
Montserrat-Capdevila and colleagues assessed associations between COPD
disease severity and risk of hospital admission for COPD exacerbations in a cohort of
2,501 COPD patients from Spain (Montserrat-Capdevila, Godoy et al. 2015). Patients
were classified as mild, moderate, severe, and very severe based on GOLD criteria. They
reported that patients with moderate to very severe COPD had greater risk of
hospitalization due to COPD exacerbations as compared to those with mild COPD
(p=0.001).
Hunter and colleagues conducted a retrospective cohort study using primary care
data from 72 general practices in the U.K. to assess associations between COPD disease
severity and hospitalization for acute exacerbations of COPD (Hunter, Lee et al. 2016).
COPD disease severity was categorized as mild, moderate, severe, and very severe
according to GOLD guidelines. They reported that individuals with moderate to very
severe COPD had greater risk of hospitalization due to COPD exacerbations than those
with mild COPD (p<0.001).
Candrilli and colleagues examined relationships between COPD disease severity
and COPD-related rehospitalization among 140,891 U.S. managed care patients with
COPD (Candrilli, Dhamane et al. 2015). Using a claims-based methodology developed
by Mapel and colleagues, patients were classified into three disease complexity
categories (i.e. severe, moderate, and low) that were used as proxies for disease severity
(Mapel, Dutro et al. 2011). They reported that patients who had severe disease
complexity (Odds Ratio=2.323, 95% CI=2.148-2.513, p<0.001) or moderate disease
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complexity (Odds Ratio=1.749, 95% CI=1.627-1.880, p<0.001) were more likely to be
hospitalized for COPD reasons within 90 days following an initial COPD-related
hospitalization as compared to those who had low disease complexity.
Yu and colleagues examined associations between COPD disease severity and 30day COPD-related hospital readmission among 18,282 commercially insured patients
with a diagnosis of COPD (Yu, Zhou et al. 2015). Using a claims-based methodology
described by Wu and colleagues, patients were assigned a COPD severity score where
higher score indicated more severe state of COPD (Wu, Birnbaum et al. 2006).
Multivariate analyses showed that a one-unit increase in the COPD severity score was
associated with greater risk of 30-day COPD-related rehospitalization (Odds Ratio=1.34,
95% CI=1.23-1.46, p<0.001).
In summary, five studies assessed relationship between COPD disease severity
and COPD-related hospitalization (Candrilli, Dhamane et al. 2015, Montserrat-Capdevila,
Godoy et al. 2015, Yu, Zhou et al. 2015, Hunter, Lee et al. 2016, Santibanez, Garrastazu
et al. 2016). All five studies reported that more severe COPD patients, as measured by
GOLD criteria, had greater risk of COPD-related hospitalization (Candrilli, Dhamane et
al. 2015, Montserrat-Capdevila, Godoy et al. 2015, Yu, Zhou et al. 2015, Hunter, Lee et
al. 2016, Santibanez, Garrastazu et al. 2016).

Need for Research
Patients with COPD may be hospitalized if their conditions are not well managed.
These potentially avoidable hospitalizations have significant impact on health care
expenditures and patients’ quality of life. Examining hospitalizations for COPD offers a
useful window on the quality of outpatient care for patients with COPD. No study was
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found that has calculated rates of hospitalizations for COPD in the Medicare population
based on Agency for Healthcare Research and Quality prevention quality indicator
algorithm. This study was intended to fill the gap.
The patient-doctor relationship is considered as the seventh element of health care
quality by the Institute of Medicine, following the other six elements: effective, patient
centered, timely, efficient, equitable, and safe (Mendoza, Smith et al. 2011). Since most
patients seek usual medical care at an outpatient setting, patient-doctor relationship is
crucial to the effective management of disease. Patients who perceive their doctors as
effective and knowledgeable communicators are more likely to adhere to their therapy
and use preventive services (Parchman and Burge 2004, Schoenthaler, Allegrante et al.
2012). However, evidence is lacking on associations between patient perceptions of
doctors and hospitalizations for ambulatory care sensitive conditions. Evaluating these
associations will provide important information on how patient perceptions of their
doctors affect their health outcomes. Findings may also lead to change in practice to
improve patient-doctor relationship and enhance the quality of outpatient care for
Medicare beneficiaries with COPD.

Conceptual Framework
A behavioral model of health service use developed by Anderson and Newman
was used as a conceptual basis for understanding the use of ambulatory care-sensitive
hospitalizations (Andersen 1995). The model suggests that individuals’ use of health
services is a function of their propensity to use services (predisposing factors), factors
that enable or impede use of health services (enabling factors), and their need for care
(need factors) (Andersen 1995). The model is presented in Figure 1.
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Predisposing

Demographic
Age
Marital status

Enabling

Personal/Family
Income
Insurance
Usual source of care

Need

COPD hospitalization

Perceived
Perceived health status

Social Structure
Community
Gender
Race
Education

Region
Residence

Evaluated
Comorbidity
Prior hospitalization
Number of doctor visits
Disease severity

Belief
Patient perceptions of
their doctors

Possible additions
Smoking
Vaccination
Figure 1. Anderson and Newman Model of Health Services Utilization
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Objectives
Study Objectives were to:
1. To determine one-year incidence of ambulatory care-sensitive hospitalizations for
COPD in a Medicare population.
2. To assess association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization.
2a) To assess association between patient perception of doctors and risk of having
a COPD ambulatory care-sensitive hospitalization. It is hypothesized that
individuals with more positive perceptions of their doctors are likely to have
lower risk of having a COPD ambulatory care-sensitive hospitalization.
2b) To access association between patient perception of doctors and number of
COPD ambulatory care-sensitive hospitalizations. It is hypothesized that
individuals with more positive perceptions of their doctors are likely to have
lower number of COPD ambulatory care-sensitive hospitalizations.
2c) To assess association between patient perception of doctors and COPD
ambulatory care-sensitive hospital days. It is hypothesized that individuals
with more positive perceptions of their doctors are likely to have lower
number of COPD ambulatory care-sensitive hospital days.
2d) To assess association between patient perception of doctors and COPD
ambulatory care-sensitive hospitalization expenditures. It is hypothesized that
individuals with more positive perceptions of their doctors are likely to have
lower expenditures resulting from COPD ambulatory care-sensitive
hospitalizations.
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3. To assess association between patient perceptions of their doctors and COPD-related
hospitalization.
3a) To assess association between patient perception of doctors and risk of having
a COPD-related hospitalization. It is hypothesized that individuals with more
positive perceptions of their doctors are likely to have lower risk of having a
COPD-related hospitalization.
3b) To access association between patient perception of doctors and number of
COPD-related hospitalizations. It is hypothesized that individuals with more
positive perceptions of their doctors are likely to have lower number of
COPD-related hospitalizations.
3c) To assess association between patient perception of doctors and COPD-related
hospital days. It is hypothesized that individuals with more positive
perceptions of their doctors are likely to have lower number of COPD-related
hospital days.
3d) To assess association between patient perception of doctors and COPDrelated hospitalization expenditures. It is hypothesized that individuals with
more positive perceptions of their doctors are likely to have lower
expenditures resulting from COPD-related hospitalizations.
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METHODS
Data Source
Data for analysis were obtained from the 2007 to 2012 Medicare Current
Beneficiary Survey (MCBS). The MCBS is a continuous, multipurpose survey of a
representative sample of the Medicare population in the United States maintained by the
Centers for Medicare & Medicaid Services (CMS). The survey is conducted using
Computer-Assisted Personal Interviewing (CAPI) techniques. Beneficiaries are selected
from the Medicare enrollment files using multistage, stratified sampling to create a
representative sample of Medicare population (Adler 1994).

Ethical Considerations
Permission for use of the Medicare Current Beneficiary Survey data was obtained
through a data use agreement. Application for human subjects research was approved by
the Institutional Review Board at Purdue University, West Lafayette, IN.

Study Design
An observational, retrospective cohort study of Medicare beneficiaries with a
diagnosis of COPD was conducted to assess associations between patient perceptions of
their doctors and COPD ambulatory care-sensitive hospitalizations. Survey items
assessing patient perceptions of doctors were linked to Medicare claims data using unique
identifiers for each Medicare beneficiary. Patient perceptions of their doctor and COPD
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ambulatory care-sensitive hospitalizations were assessed during the study period, defined
as 12 months following the year in which COPD diagnosis was identified.

Study Variables
Predictor Variables
Patient Perceptions of Their Doctors
Patient perceptions of their doctors was assessed using a previously validated
index created using the MCBS survey items (Ward 2013). Some example items were
“Your doctor often does not explain your medical problems to you” and “Your doctor
tells you all you want to know about your condition and treatment.” A list of survey
items in the MCBS that were used to create the index is presented in Appendix Table A.
All questions included in the index must have been answered by the beneficiary
for the index to be created. For positively worded items, such as “Your doctor has a good
understanding of your medical history,” the responses were coded so that one indicated
strongly disagree, two indicated disagree, three indicated agree, and four indicated
strongly agree. For negatively worded items, such as “Your doctor often does not explain
your medical problems to you,” the responses were reverse coded so that four indicated
strongly disagree, three indicated disagree, two indicated agree, and one indicated
strongly agree. All item values were summed to create an overall score for the patient
perceptions of their doctors. The index had a theoretical range of 12 to 48 and a higher
score indicated more positive perceptions of doctors. A binary variable was created by
using the median split method (DeCoster, Iselin et al. 2009). Individuals with an overall
score for the patient perceptions of their doctors greater or equal to the median value
were categorized as having positive perceptions of their doctors, while those with an
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overall score below median value were categorized as not having positive perceptions of
their doctors.

Response Variables
COPD Ambulatory Care-Sensitive Hospitalization (ACSH) Risk
COPD ambulatory care-sensitive hospitalization risk was based on hospital
inpatient events with a primary discharge ICD-9-CM diagnosis code for COPD based on
the AHRQ Prevention Quality Indicator algorithm presented in Appendix Table B
(Agency for Healthcare Research and Quality 2016). If an individual had at least one
COPD ambulatory care-sensitive hospitalization, a value of ‘1’ was assigned to this
variable. If an individual had no COPD ambulatory care-sensitive hospitalization, a
value of ‘0’ was assigned to this variable. COPD ACSH risk was assessed during the 12month study period.

Number of COPD Ambulatory Care-Sensitive Hospitalizations
The number of COPD ambulatory care-sensitive hospitalizations that occurred
during the 12-month study period were assessed for all COPD ambulatory care-sensitive
hospitalizations. The number of COPD ambulatory care-sensitive hospitalizations was
calculated by summing all qualified hospitalizations for each individual.

COPD Ambulatory Care-Sensitive Hospital Days
COPD ambulatory care sensitive hospital days was assessed for all COPD
ambulatory care-sensitive hospitalizations that occurred during the 12-month study
period. If the individual had more than one qualified hospitalization, total hospital days
was calculated by summing hospital days from all admissions.
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COPD Ambulatory Care-Sensitive Hospitalization Expenditures
COPD ambulatory care-sensitive hospitalization expenditures were assessed for
all COPD ambulatory care-sensitive hospitalizations during the 12-month study period.
Total ACSH expenditures were calculated by summing expenditures for each qualified
hospitalization. Expenditures were adjusted to reflect 2012 US dollars using the medical
component of the Consumer Price Index.

COPD-Related Hospitalization Risk
COPD-related hospitalization risk was based on hospital inpatient events with a
primary or secondary discharge ICD-9-CM diagnosis code for COPD based on the
AHRQ Prevention Quality Indicator algorithm presented in Appendix Table B (Agency
for Healthcare Research and Quality 2016). If an individual had at least one COPDrelated hospitalization, a value of ‘1’ was assigned to this variable. If an individual had
no COPD-related hospitalization, a value of ‘0’ was assigned to this variable. The
variable was assessed during the 12-month study period.

Number of COPD-Related Hospitalizations
The number of COPD-related hospitalizations that occurred during the 12-month
study period were assessed for all COPD-related hospitalizations. The number of COPDrelated hospitalizations was calculated by summing all qualified hospitalizations for each
individual.

COPD-Related Hospital Days
COPD-related hospital days was assessed for all COPD-related hospitalizations
that occurred during the 12-month study period. If the individual had more than one
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qualified hospitalization, total hospital days was calculated by summing hospital days
from all admissions.

COPD-Related Hospitalization Expenditures
COPD-related hospitalization expenditures were assessed for all COPD-related
hospitalizations during the 12-month study period. Total COPD-related hospital
expenditures were calculated by summing expenditures for each qualified hospitalization.
Expenditures were adjusted to reflect 2012 US dollars using the medical component of
the Consumer Price Index.

Study Covariates
Demographic Variables
Age and Gender
Age values were calculated based on age as of January 1 of the study period. Age
was categorized into four categories: less than 65 years, 65 to 74 years, 75 to 84 years,
and 85 years or older. Gender was coded as man and woman.

Race
Race was coded in the MCBS raw data as Asian, African American, Native
Hawaiian or Pacific Islander, white, American Indian or Alaska Native, other race, or
more than one race. Race was recoded as white and non-white due to low counts in each
non-white categories. The non-white category included all racial groups but white.

63
Marital Status
Marital status was coded in the MCBS raw data as married, widowed, divorced,
separated, and never married. Marital status was recoded as married and non-married
due to low counts in each non-married category. The non-married category included all
marital groups but married.

Education
Education was coded in the MCBS raw data as no schooling, nursery to eighth
grade, ninth to twelfth grade but no diploma, high school graduate,
vocational/technical/business, some college but no degree, associate’s degree, bachelor’s
degree, and post graduate degree. Education was recoded into four categories: less than
high school, high school graduates, some college, and bachelor’s degree or higher to
ensure sufficient observations in each category.

Region
Region was coded in the MCBS raw data as New England, Middle Atlantic, East
North Central, West North Central, South Atlantic, East South Central, West South
Central, Mountain, Pacific, and Puerto Rico. Region was recoded into four categories:
Midwest, Northeast, South, and West as defined by the United States Census Bureau.
Midwest included East North Central and West North Central. Northeast included New
England and Middle Atlantic. South included South Atlantic, East South Central, West
South Central, and Puerto Rico. West included Mountain and Pacific.
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Residence
Residence status was determined based on a single MCBS survey item asking
each respondent if they lived in the metro area or the non-metro area. Residence status
was coded as metro and non-metro.

Individual Income
Individual income was coded in the MCBS raw data as less than $5,000, $5,000
to $9,999, $10,000 to $14,999, $15,000 to 19,999, $20,000 to $24,999, $25,000 to
$29,999, $30,000 to $39,999, $40,000 to $49,999, and $50,000 or more. Income was
recoded into three categories: $0 to $14,999, $15,000 to $29,999, and $30,000 or more to
ensure sufficient observations in each category.

Clinical Variables
Smoking Status
Smoking status was determined based on two MCBS survey items. Individuals
who answered ‘yes’ to the item “Do you smoke now?” were classified as current
smokers. Individuals who answered ‘no’ to the item “Do you smoke now?” but answered
‘yes’ to the item “Have you ever smoked cigarettes/cigars/tobacco?” were classified as
ex-smokers. Individuals who answered ‘no’ to the item “Have you ever smoked
cigarettes/cigars/tobacco?” were classified as non-smokers.

Perceived Health
Perceived health status was determined based on a single MCBS survey item
“Compared to other people your age, would you say that your health is excellent, very
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good, good, fair or poor?” Perceived health status was coded into four categories:
excellent or very good, good, fair, and poor.

Influenza Vaccine
Influenza vaccine status was determined based on a single MCBS survey item,
“Did you have a flu shot for last winter?” Individuals who answered ‘yes’ to this item
were assigned a value of ‘1’ for this variable. Individuals who answered ‘no’ to this item
were assigned a value of ‘0’ for this variable.

Pneumococcal Vaccine
Pneumococcal vaccine status was determined based on a single MCBS survey
item, “Have you ever had a shot for pneumonia?” Individuals who answered ‘yes’ to this
item were assigned a value of ‘1’ for this variable. Individuals who answered ‘no’ to this
item were assigned a value of ‘0’ for this variable.

Comorbidities
Two indicators were developed for comorbidities: self-reported status for selected
individual clinical conditions and the Charlson Comorbidity Index score. Five selfreported clinical conditions from the MCBS survey that have been commonly reported as
risk factors for hospitalization in COPD patients were included. The selected conditions
were heart diseases (Montserrat-Capdevila, Godoy et al. 2015, Roberts, Clerisme-Beaty
et al. 2016), heart failure (Stuart, Simoni-Wastila et al. 2010, Baker, Zou et al. 2013,
Sharif, Parekh et al. 2014, Yu, Zhou et al. 2015), diabetes mellitus (Baker, Zou et al.
2013, Montserrat-Capdevila, Godoy et al. 2015, Roberts, Clerisme-Beaty et al. 2016,
Santibanez, Garrastazu et al. 2016), depression (Dalal, Shah et al. 2011, Sharif, Parekh et
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al. 2014, Yu, Zhou et al. 2015), and osteoporosis (Stuart, Simoni-Wastila et al. 2010,
Sharif, Parekh et al. 2014, Roberts, Clerisme-Beaty et al. 2016). Individuals who
answered ‘yes’ to MCBS survey items pertaining to each medical condition were
classified as having that condition (e.g. Have a doctor ever told you that you had
diabetes?)
The Charlson Comorbidity Index score was calculated using methods developed
by Romano and colleagues (Romano, Roos et al. 1993). The Charlson Comorbidity
Index consists of seventeen disease categories, which were weighted to adjust for the risk
of one-year mortality. ICD-9-CM diagnosis codes in Medicare Part A and Medicare Part
B claims were used to identify each disease condition. The algorithm was modified to
remove ICD-9-CM diagnosis codes for COPD. The interval for calculating Charlson
Comorbidity Index score was from January 1 through December 31 of the year preceding
study period. The coding algorithm for Charlson Comorbidity Index is presented in
Appendix Table C.

Prior Hospitalization
Prior hospitalizations were defined as all-cause hospital admissions that occurred
from January 1 through December 31 of the year preceding study period. If the
individual had any all-cause prior hospitalization, the variable was coded as “yes.”
Otherwise, the variable was coded as “no.”

Number of Doctor Visits
Number of doctor visits for each individual were calculated from outpatient
hospital claims and physician office claims from January 1 through December 31 of the
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year preceding study period. Claims for services on the same visit were excluded to
prevent double counting. Total number of doctor visits was calculated by summing all
doctor visits for each individual. The variable was coded into three categories: less than
15 visits, 15 to 30 visits, more than 30 visits to ensure sufficient observations in each
category.

Disease Severity
The direct measure of COPD disease severity, Forced Expiratory Volume in one
second over Forced Vital Capacity, is not available in the MCBS data. Therefore,
oxygen use was used as a proxy measure to capture disease severity in this study.
Oxygen use is indicative of very severe COPD (i.e. stage IV COPD) and thus can be used
to distinguish the most severe COPD patients from the other patients (Rabe, Hurd et al.
2007). Individuals who had any claim for supplemental oxygen from January 1 through
December 31 of the year preceding the study period were assigned a value of ‘1’ for the
variable, which represented very severe COPD patients. Otherwise, a value of ‘0’ was
assigned to this variable, which represented not very severe COPD patients.

Study Sample
Sample Inclusion Criteria
To be included in the sample, individuals had to have a diagnosis of COPD based
on having at least one Medicare Part A claim (inpatient) or at least two Medicare Part B
claims (outpatient) from January 1, 2007 through December 31, 2011, with an ICD-9-CM
Code of 491.xx, 492.xx, 494.xx, or 496.xx. Other inclusion criteria included being
enrolled in Medicare Part A and Medicare Part B during the 12-month study period and
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the preceding year, and having had a usual source of care. Individuals were considered to
have a usual source of care if they answered “yes” to the MCBS survey item “Is there a
particular medical person or a clinic you usually go to when you are sick or for advice
about your health?” Continuous Medicare enrollment was required because hospital
events may not be captured otherwise. Having a usual source of care was required
because those without a usual source of care were not asked questions used to create the
patient perceptions of doctors index.

Sample Exclusion Criteria
Individuals were excluded if they had any missing data on items used to create the
patient perceptions of doctors index, had a proxy responder, or had a diagnosis of
Alzheimer’s disease or dementia. Individuals who had any missing data on items used to
create the patient perceptions of doctors index were excluded. Individuals who had a
proxy responder were excluded because the proxy might be less likely to report reliable
information on the beneficiary’s perception of the doctor. Individuals with Alzheimer’s
disease or dementia were excluded because they were considered less likely to provide
reliable information due to memory loss.

Statistical Analysis
Data were analyzed using SAS version 9.4 for Unix and STATA version 12.1 for
Unix. An a priori alpha of 0.05 was used to determine significance for all analyses.

Sample Characteristics
The PROC FREQ procedure in SAS was used to develop frequency tabulations
on all demographic and clinical variables including age, gender, race, marital status,
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education, region, residence, income, smoking status, comorbidities (heart diseases, heart
failure, diabetes mellitus, depression, osteoporosis, and Charlson Comorbidity Index
score), influenza vaccination, pneumococcal vaccination, prior hospitalizations, number
of doctor visits, and COPD disease severity proxy (i.e. oxygen use).

Incidence of Ambulatory Care-Sensitive Hospitalizations for COPD
One-year incidence of COPD ambulatory care-sensitive hospitalizations was
determined using data from the 12-month study period from January 1 through December
31. The total number of individuals and the proportion of individuals in the sample
having COPD ambulatory care-sensitive hospitalizations were calculated. The total
number of individuals having COPD ambulatory care-sensitive hospitalizations was
calculated by summing all individuals having at least one qualifying hospitalization. The
proportion of individuals having COPD ambulatory care-sensitive hospitalizations was
calculated by dividing the total number of individuals having at least one COPD
ambulatory care-sensitive hospitalization by the total number of individuals in the study
sample. A 95 percent confidence interval was calculated for the incidence estimate.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization Risk
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Risk
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospitalization risk by demographic variables age, gender, race, marital status, education,
income, region, residence, and clinical variables smoking status, perceived health,
influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
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and oxygen use. The PROC FREQ procedure with CHISQ option in SAS was used to
develop frequency tabulations and perform chi-square tests assessing associations
between variables in the cross tabulations. In each bivariate model, COPD ambulatory
care-sensitive hospitalization risk was the response variable, and a single demographic or
clinical variable was the predictor variable.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospitalization risk by whether patients had positive perceptions of their doctors. The
PROC FREQ procedure with CHISQ option in SAS was used to develop frequency
tabulations and perform chi-square tests assessing associations between variables in the
cross tabulations. In the bivariate model, COPD ambulatory care-sensitive
hospitalization risk was the response variable, and patient perceptions of their doctors
was the predictor variable.

Bivariate Associations with Number of COPD Ambulatory Care-Sensitive
Hospitalizations
Bivariate Associations between Study Covariates and Number of COPD Ambulatory
Care-Sensitive Hospitalizations
Bivariate cross tabulations were developed for number of COPD ambulatory caresensitive hospitalizations by demographic variables age, gender, race, marital status,
education, income, region, residence, and clinical variables smoking status, perceived
health, influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
and oxygen use. The PROC NPAR1WAY procedure in SAS was used to perform non-
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parametric tests between variables in the cross tabulations. In each bivariate model,
number of COPD ambulatory care-sensitive hospitalizations was the response variable,
and a single demographic or clinical variable was the predictor variable.

Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
Bivariate cross tabulations were developed for number of COPD ambulatory caresensitive hospitalizations by whether patients had positive perceptions of their doctors.
The PROC NPAR1WAY procedure in SAS was used to perform non-parametric tests
between variables in the cross tabulations. In the bivariate model, number of COPD
ambulatory care-sensitive hospitalizations was the response variable, and patient
perceptions of their doctors was the predictor variable.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospital Days
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospital Days
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospital days by demographic variables age, gender, race, marital status, education,
income, region, residence, and clinical variables smoking status, perceived health,
influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
and oxygen use. The PROC NPAR1WAY procedure in SAS was used to perform nonparametric tests between variables in the cross tabulations. In each bivariate model,
COPD ambulatory care-sensitive hospital days was the response variable, and a single
demographic or clinical variable was the predictor variable.

72
Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospital days by whether patients had positive perceptions of their doctors. The PROC
NPAR1WAY procedure in SAS was used to perform non-parametric tests between
variables in the cross tabulations. In the bivariate model, COPD ambulatory caresensitive hospital days was the response variable, and patient perceptions of their doctors
was the predictor variable.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization
Expenditures
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Expenditures
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospitalization expenditures by demographic variables age, gender, race, marital status,
education, income, region, residence, and clinical variables smoking status, perceived
health, influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
and oxygen use. The PROC NPAR1WAY procedure in SAS was used to perform nonparametric tests between variables in the cross tabulations. In each bivariate model,
COPD ambulatory care-sensitive hospitalization expenditures was the response variable,
and a single demographic or clinical variable was the predictor variable.
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Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
Bivariate cross tabulations were developed for COPD ambulatory care-sensitive
hospitalization expenditures by whether patients had positive perceptions of their doctors.
The PROC NPAR1WAY procedure in SAS was used to perform non-parametric tests
between variables in the cross tabulations. In the bivariate model, COPD ambulatory
care-sensitive hospitalization expenditures was the response variable, and patient
perceptions of their doctors was the predictor variable.

Bivariate Associations with COPD-Related Hospitalization Risk
Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Risk
Bivariate cross tabulations were developed for COPD-related hospitalization risk
by demographic variables age, gender, race, marital status, education, income, region,
residence, and clinical variables smoking status, perceived health, influenza vaccination,
pneumococcal vaccination, individual self-reported clinical conditions, Charlson
Comorbidity Index, prior hospitalization, number of doctor visits, and oxygen use. The
PROC FREQ procedure with CHISQ option in SAS was used to develop frequency
tabulations and perform chi-square tests assessing associations between variables in the
cross tabulations. In each bivariate model, COPD-related hospitalization risk was the
response variable, and a single demographic or clinical variable was the predictor
variable.
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Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Risk
Bivariate cross tabulations were developed for COPD-related hospitalization risk
by whether patients had positive perceptions of their doctors. The PROC FREQ
procedure with CHISQ option in SAS was used to develop frequency tabulations and
perform chi-square tests assessing associations between variables in the cross tabulations.
In the bivariate model, COPD-related hospitalization risk was the response variable, and
patient perceptions of their doctors was the predictor variable.

Bivariate Associations with Number of COPD-Related Hospitalizations
Bivariate Associations between Study Covariates and Number of COPD-Related
Hospitalizations
Bivariate cross tabulations were developed for number of COPD-related
hospitalizations by demographic variables age, gender, race, marital status, education,
income, region, residence, and clinical variables smoking status, perceived health,
influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
and oxygen use. The PROC NPAR1WAY procedure in SAS was used to perform nonparametric tests between variables in the cross tabulations. In each bivariate model,
number of COPD-related hospitalizations was the response variable, and a single
demographic or clinical variable was the predictor variable.

Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
Bivariate cross tabulations were developed for number of COPD-related
hospitalizations by whether patients had positive perceptions of their doctors. The PROC
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NPAR1WAY procedure in SAS was used to perform non-parametric tests between
variables in the cross tabulations. In the bivariate model, number of COPD-related
hospitalizations was the response variable, and patient perceptions of their doctors was
the predictor variable.

Bivariate Associations with COPD-Related Hospital Days
Bivariate Associations between Study Covariates and COPD-Related Hospital Days
Bivariate cross tabulations were developed for COPD-related hospital days by
demographic variables age, gender, race, marital status, education, income, region,
residence, and clinical variables smoking status, perceived health, influenza vaccination,
pneumococcal vaccination, individual self-reported clinical conditions, Charlson
Comorbidity Index, prior hospitalization, number of doctor visits, and oxygen use. The
PROC NPAR1WAY procedure in SAS was used to perform non-parametric tests
between variables in the cross tabulations. In each bivariate model, COPD-related
hospital days was the response variable, and a single demographic or clinical variable
was the predictor variable.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospital Days
Bivariate cross tabulations were developed for COPD-related hospital days by
whether patients had positive perceptions of their doctors. The PROC NPAR1WAY
procedure in SAS was used to perform non-parametric tests between variables in the
cross tabulations. In the bivariate model, COPD-related hospital days was the response
variable, and patient perceptions of their doctors was the predictor variable.
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Bivariate Associations with COPD-Related Hospitalization Expenditures
Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Expenditures
Bivariate cross tabulations were developed for COPD-related hospitalization
expenditures by demographic variables age, gender, race, marital status, education,
income, region, residence, and clinical variables smoking status, perceived health,
influenza vaccination, pneumococcal vaccination, individual self-reported clinical
conditions, Charlson Comorbidity Index, prior hospitalization, number of doctor visits,
and oxygen use. The PROC NPAR1WAY procedure in SAS was used to perform nonparametric tests between variables in the cross tabulations. In each bivariate model,
COPD-related hospitalization expenditures was the response variable, and a single
demographic or clinical variable was the predictor variable.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Expenditures
Bivariate cross tabulations were developed for COPD-related hospitalization
expenditures by whether patients had positive perceptions of their doctors. The PROC
NPAR1WAY procedure in SAS was used to perform non-parametric tests between
variables in the cross tabulations. In the bivariate model, COPD-related hospitalization
expenditures was the response variable, and patient perceptions of their doctors was the
predictor variable.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
Multivariate logistic regression was used to assess association between patient
perceptions of their doctors and COPD ambulatory care-sensitive hospitalization risk
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using PROC LOGISTIC procedure in SAS. In the regression model, COPD ambulatory
care-sensitive hospitalization risk was the response variable and patient perceptions of
their doctors was the predictor variable. Stepwise selection with entry alpha 0.30 and
stay alpha 0.15 was used to select covariates for the regression model. Similar regression
models were developed for a subgroup of individuals with oxygen claims and for a
subgroup of individuals with no oxygen claim to see if patient perceptions of doctors had
different impact on COPD ambulatory care-sensitive hospitalization risk among very
severe COPD patients versus not very severe COPD patients. In the subgroup analysis,
the same covariates were used as the full model.

Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and number of COPD ambulatory caresensitive hospitalizations. A systematic approach was used to select an appropriate
statistical technique for analysis based on examination of data distribution and
assessment of model fit for alternative models. In the regression model, number of
COPD ambulatory care-sensitive hospitalizations was the response variable and patient
perceptions of their doctors was the predictor variable. Stepwise selection with entry
alpha 0.30 and stay alpha 0.15 was used to select covariates for the regression model.
Similar regression models were developed for a subgroup of individuals with oxygen
claims and for a subgroup of individuals with no oxygen claim to see if patient
perceptions of doctors had different impact on number of COPD ambulatory caresensitive hospitalizations among very severe COPD patients versus not very severe
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COPD patients. In the subgroup analysis, the same covariates were used as the full
model.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospital days. A systematic approach was used to select an appropriate statistical
technique for analysis based on examination of data distribution and assessment of model
fit for alternative models. In the regression model, COPD ambulatory care-sensitive
hospital days was the response variable and patient perceptions of their doctors was the
predictor variable. Stepwise selection with entry alpha 0.30 and stay alpha 0.15 was used
to select covariates for the regression model. Similar regression models were developed
for a subgroup of individuals with oxygen claims and for a subgroup of individuals with
no oxygen claim to see if patient perceptions of doctors had different impact on COPD
ambulatory care-sensitive hospital days among very severe COPD patients versus not
very severe COPD patients. In the subgroup analysis, the same covariates were used as
the full model.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization expenditures. A systematic approach was used to select an appropriate
statistical technique for analysis based on examination of data distribution and
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assessment of model fit for alternative models. In the regression model, COPD
ambulatory care-sensitive hospitalization expenditures was the response variable and
patient perceptions of their doctors was the predictor variable. Stepwise selection with
entry alpha 0.30 and stay alpha 0.15 was used to select covariates for the regression
model. Similar regression models were developed for a subgroup of individuals with
oxygen claims and for a subgroup of individuals with no oxygen claim to see if patient
perceptions of doctors had different impact on COPD ambulatory care-sensitive
hospitalization expenditures among very severe COPD patients versus not very severe
COPD patients. In the subgroup analysis, the same covariates were used as the full
model.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Risk
Multivariate logistic regression was used to assess association between patient
perceptions of their doctors and COPD-related hospitalization risk using PROC
LOGISTIC procedure in SAS. In the regression model, COPD-related hospitalization
risk was the response variable and patient perceptions of their doctors was the predictor
variable. Stepwise selection with entry alpha 0.30 and stay alpha 0.15 was used to select
covariates for the regression model. Similar regression models were developed for a
subgroup of individuals with oxygen claims and for a subgroup of individuals with no
oxygen claim to see if patient perceptions of doctors had different impact on COPDrelated hospitalization risk among very severe COPD patients versus not very severe
COPD patients. In the subgroup analysis, the same covariates were used as the full
model.
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Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and number of COPD-related
hospitalizations. A systematic approach was used to select an appropriate statistical
technique for analysis based on examination of data distribution and assessment of model
fit for alternative models. In the regression model, number of COPD-related
hospitalizations was the response variable and patient perceptions of their doctors was the
predictor variable. Stepwise selection with entry alpha 0.30 and stay alpha 0.15 was used
to select covariates for the regression model. Similar regression models were developed
for a subgroup of individuals with oxygen claims and for a subgroup of individuals with
no oxygen claim to see if patient perceptions of doctors had different impact on number
of COPD-related hospitalizations among very severe COPD patients versus not very
severe COPD patients. In the subgroup analysis, the same covariates were used as the
full model.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospital Days
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD-related hospital days. A
systematic approach was used to select an appropriate statistical technique for analysis
based on examination of data distribution and assessment of model fit for alternative
models. In the regression model, COPD-related hospital days was the response variable
and patient perceptions of their doctors was the predictor variable. Stepwise selection
with entry alpha 0.30 and stay alpha 0.15 was used to select covariates for the regression

81
model. Similar regression models were developed for a subgroup of individuals with
oxygen claims and for a subgroup of individuals with no oxygen claim to see if patient
perceptions of doctors had different impact on COPD-related hospital days among very
severe COPD patients versus not very severe COPD patients. In the subgroup analysis,
the same covariates were used as the full model.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Expenditures
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD-related hospitalization
expenditures. A systematic approach was used to select an appropriate statistical
technique for analysis based on examination of data distribution and assessment of model
fit for alternative models. In the regression model, COPD-related hospitalization
expenditures was the response variable and patient perceptions of their doctors was the
predictor variable. Stepwise selection with entry alpha 0.30 and stay alpha 0.15 was used
to select covariates for the regression model. Similar regression models were developed
for a subgroup of individuals with oxygen claims and for a subgroup of individuals with
no oxygen claim to see if patient perceptions of doctors had different impact on COPDrelated hospitalization expenditures among very severe COPD patients versus not very
severe COPD patients. In the subgroup analysis, the same covariates were used as the
full model.
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RESULTS
Study Sample
A total of 35,755 Medicare beneficiaries in the Medicare Current Beneficiary
Survey (MCBS) 2007, 2008, 2009, 2010, or 2011 were identified. Among those
beneficiaries, 5,299 had a diagnosis of COPD. Among the 5,299 beneficiaries diagnosed
with COPD, 3,362 had continuous enrollment in Medicare Part A and Medicare Part B
during the 12-month study period and the preceding year. Among those beneficiaries,
2,956 were identified as having had a usual source of care. Of those 2,956 beneficiaries
who met study inclusion criteria, 238 were excluded due to missing data on items used to
create the patient perceptions of doctors index, 290 were excluded due to having a proxy
responder, and 122 were excluded due to having Alzheimer’s disease or dementia. The
final sample was comprised of 2,306 Medicare beneficiaries who met all study selection
criteria. The sample selection flow chart is shown in Figure 2.

Sample Demographic Characteristics
Age
Age values were calculated based on age as of January 1 of the study period. The
mean (± standard deviation) age was 72.77 (± 11.91) years. Sixteen percent were less
than 65 years of age, thirty-two percent were ages 65 to 74, and forty-one percent were
ages 75 to 84. Approximately twelve percent of the sample was age 85 years or older.
The sample distribution by age is presented in Table 1.
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Number of individuals in 2007-2011
Medicare Current Beneficiary Survey
35,755
Individuals without a COPD diagnosis
30,456
Individuals with a COPD diagnosis
5,299

Individuals without continuous Medicare
Part A and Part B coverage
1,937

Individuals with continuous Medicare
Part A and Part B coverage
3,362
Individuals had no usual source of care
406
Individuals identified a usual source of
care
2,956
Individuals with missing data on items
used to create patient perceptions of
doctors index
238
Individuals who had a proxy responder
290
Individuals who had Alzheimer’s disease
or dementia
122

Individuals satisfying all study selection
criteria
2,306
Figure 2. Sample selection flow chart
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Table 1. Sample Distribution by Age
Age

Number of individuals
(N=2,306)

Percent

less than 65 years

367

15.9

65 to 74 years

730

31.7

75 to 84 years

924

40.1

85 years or older

285

12.3
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Gender
Approximately fifty-five percent of Medicare enrollees are women in the general
Medicare population (U.S. Department of Health and Human Services 2014). As shown
in Table 2, a majority of the sample was women (53.7%).

Race
Race was coded as white and non-white. Non-white category included
individuals who were Asian, African American, Native Hawaiian or Pacific Islander,
American Indian or Alaska Native, other race, or more than one race. As shown in Table
3, approximately eighty-six percent of the sample was white.

Marital status
Marital status was coded as married and non-married. Non-married category
included individuals who were widowed, divorced, separated, or never married. As
shown in Table 4, approximately forty-three percent of the sample was married.

Education
Education was coded as less than high school, high school graduates, post high
school excluding college, and college graduates/post graduates. Approximately thirtyone percent of the sample was poorly educated, with an educational level less than high
school. The sample distribution by education is presented in Table 5.

Region
Region was coded as Midwest, Northeast, South, and West. Approximately
twenty-six percent of individuals in the sample were from the Midwest, sixteen percent
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Table 2. Sample Distribution by Gender
Gender

Number of individuals
(N=2,306)

Percent

Man

1,068

46.3

Woman

1,238

53.7
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Table 3. Sample Distribution by Race
Race

White
Non-White1
1

Number of individuals
(N=2,301)

Percent

1,988

86.4

313

13.6

Non-White includes African American, American Indian, Asian or Pacific Islander,
other race, or more than one race.
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Table 4. Sample Distribution by Marital Status
Marital status

Married
Non-married1
1

Number of individuals
(N=2,305)

Percent

998

43.3

1,307

56.7

Non-married includes divorced, separated, windowed, or never married.
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Table 5. Sample Distribution by Education
Education

1

Number of individuals
(N=2,300)

Percent

Less than high school

711

30.9

High school graduates

736

32.0

Post high school excluding college1

577

25.1

College grad/Post grad

276

12.0

Post high school excluding college includes some college, vocational school, and
Associate’s Degree.
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were from the Northeast, nearly forty-nine percent were from the South, and ten percent
were from the West. The sample distribution by region is presented in Table 6.

Residence
Residence status was determined based on a single MCBS survey item asking
each respondent if they live in the metro area or the non-metro area. Residence was
coded as metro and non-metro. As shown in Table 7, sixty-four percent of the sample
lived in metro areas.

Individual Income
Individual income was coded as $0 to $14,999, $15,000 to $29,999, and $30,000
or more. As shown in Table 8, thirty-seven percent of the sample had individual income
less than $15,000.

Sample Clinical Characteristics
Smoking Status
Smoking status was coded as current-smoker, ex-smoker, and non-smoker. The
majority of the sample was ex-smokers (56.8%), followed by current smokers (23.0%),
and non-smokers (20.2%). The sample distribution by smoking status is presented in
Table 9.

Perceived Health
Perceived health status was coded as excellent/very good, good, fair, and poor.
As shown in Table 10, approximately forty percent of the sample rated their health as fair
or poor.
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Table 6. Sample Distribution by Region
Region

1

Number of individuals
(N=2,306)

Percent

Midwest1

587

25.5

Northeast2

377

16.3

South3

1,124

48.7

West4

218

9.5

Midwest includes Illinois, Indiana, Michigan, Ohio, Wisconsin,
Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.
2
Northeast includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island,
Vermont, New Jersey, New York, and Pennsylvania.
3
South includes Delaware, Florida, Georgia, Maryland, North Carolina, South
Carolina, Virginia, Washington D.C., West Virginia, Alabama, Kentucky, Mississippi,
Tennessee, Arkansas, Louisiana, Oklahoma, Texas, and Puerto Rico.
4
West includes Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah,
Wyoming, Alaska, California, Hawaii, Oregon, and Washington.
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Table 7. Sample Distribution by Residence
Residence

Metro area
Non-metro area

Number of individuals
(N=2,306)

Percent

1,465

63.5

841

36.5
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Table 8. Sample Distribution by Individual Income
Individual income

Number of individuals
(N=1,971)

Percent

$0 to $14,999

727

36.9

$15,000 to $29,999

643

32.6

$30,000 or more

601

30.5
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Table 9. Sample Distribution by Smoking Status
Smoking status

Current smoker

Number of individuals
(N=2,305)

Percent

530

23.0

Ex-smoker

1,310

56.8

Non-smoker

465

20.2
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Table 10. Sample Distribution by Perceived Health
Perceived health

Number of individuals
(N=2,298)

Percent

Excellent/Very good

596

25.9

Good

786

34.2

Fair

599

26.1

Poor

317

13.8
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Influenza Vaccine
Influenza vaccine was coded as yes or no based on responses to the MCBS survey
item “Did you get flu shot for last winter?” As shown in Table 11, approximately eighty
percent of the sample had received influenza vaccine.

Pneumococcal Vaccine
Pneumococcal vaccine was coded as yes or no based on responses to the MCBS
survey item “Have you ever had a shot for pneumonia?” As shown in Table 12,
approximately eighty-seven percent of the sample had received pneumococcal vaccine.

Individual Clinical Conditions
Five clinical conditions that were commonly reported as risk factors for
hospitalizations in COPD patients were examined, which included heart diseases, heart
failure, diabetes, depression, and osteoporosis. Sixty percent of the sample had heart
diseases. Nearly twenty percent had heart failure. Approximately twenty-eight percent
had diabetes. Over thirty percent of the sample had depression. Approximately twentynine percent had osteoporosis. The sample distribution by the presence of seven
individual clinical conditions is presented in Table 13.

Charlson Comorbidity Index
The Charlson Comorbidity Index score was calculated by examining ICD-9-CM
diagnosis codes in Medicare Part A and Medicare Part B claims. Thirty-six percent of
the sample had a Charlson Comorbidity Index score 0 or 1. The sample distribution by
Charlson Comorbidity Index is presented in Table 14.
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Table 11. Sample Distribution by Influenza Vaccine
Influenza vaccine

Number of individuals
(N=2,295)

Percent

Yes

1,831

79.8

No

464

20.2

100
Table 12. Sample Distribution by Pneumococcal Vaccine
Pneumococcal vaccine

Number of individuals
(N=2,299)

Percent

Yes

1,998

86.9

No

301

13.1
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Table 13. Sample Distribution by Individual Clinical Conditions
Clinical condition

Number of individuals
(N=2,306)

Percent

Heart diseases
Yes
No

1,384
922

60.0
40.0

Heart failure
Yes
No

445
1,861

19.3
80.7

Diabetes
Yes
No

649
1,657

28.1
71.9

Depression
Yes
No

695
1,611

30.1
69.9

Osteoporosis
Yes
No

663
1,643

28.8
71.2
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Table 14. Sample Distribution by Charlson Comorbidity Index
Charlson Comorbidity
Index

Number of individuals
(N=2,306)

Percent

0

347

15.1

1

482

20.9

2

422

18.3

3

316

13.7

4 or higher

739

32.0
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Prior Hospitalization
Prior hospitalization was coded as yes or no based on whether having any allcause hospital admissions during the year preceding study period. As shown in Table 15,
approximately thirty-nine percent of the sample had prior hospitalization.

Number of Doctor Visits
Number of doctor visits was calculated by counting all medical doctor visits from
outpatient hospital claims and physician office claims during the year preceding study
period. The mean number of doctor visits was 26.6 with a standard deviation of 19.8.
Approximately one-third of the sample had more than 30 doctor visits. The sample
distribution by number of doctor visits is presented in Table 16.

Oxygen Use
Oxygen use was used as a proxy measure to capture disease severity and was
coded as yes or no based on whether having any claim for supplemental oxygen during
the year preceding study period. As shown in Table 17, twenty-three percent had used
supplemental oxygen.

Incidence of Ambulatory Care-Sensitive Hospitalizations for COPD
The total number of individuals having COPD ambulatory care-sensitive
hospitalizations in the sample was 94. One-year incidence of ambulatory care-sensitive
hospitalizations for COPD was calculated by dividing the total number of individuals
having at least one COPD ambulatory care-sensitive hospitalization by the total number
of individuals in the study sample. As shown in Table 18, the incidence estimate was
approximately four percent.
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Table 15. Sample Distribution by Prior Hospitalization
Prior hospitalization

Number of individuals
(N=2,306)

Percent

Yes

894

38.8

No

1,412

61.2
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Table 16. Sample Distribution by Number of Doctor Visits
Number of doctor visits

Number of individuals
(N=2,306)

Percent

Less than 15

700

30.3

15 to 30

848

36.8

More than 30

758

32.9
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Table 17. Sample Distribution by Oxygen Use
Oxygen use

Number of individuals
(N=2,306)

Percent

Yes

535

23.2

No

1,771

76.8

107
Table 18. Point Estimate and 95 Percent Confidence Interval of One-Year Incidence of
ambulatory care-sensitive hospitalizations for COPD
Variable
Proportion of individuals
having ACSH for COPD (%)

Point estimate

95% Confidence interval

4.1

3.3 – 4.9
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Patient Perceptions of Their Doctors
A patient perceptions of their doctors index score was calculated by summing
scores from all 12 items used to construct the index. The mean index score was 39.2 with
a standard deviation of 5.3 (Table 19). Individuals with an overall score for the patient
perceptions of their doctors greater or equal to the median value were categorized as
having positive perceptions of their doctors, and those with an overall score below
median value were categorized as not having positive perceptions of their doctors. As
shown in Table 20, approximately fifty-two percent of the sample had positive
perceptions of their doctors.

COPD Ambulatory Care-Sensitive Hospitalization Risk
COPD ambulatory care-sensitive hospitalization risk was based on hospital
inpatient events with a primary discharge ICD-9-CM diagnosis code for COPD based on
AHRQ Prevention Quality Indicator algorithm presented in Appendix Table B (Agency
for Healthcare Research and Quality 2016). Individuals were categorized as having risk
for COPD ambulatory care-sensitive hospitalization if they had at least one COPD
ambulatory care-sensitive hospitalization during the 12-month study period. Otherwise,
individuals were categorized as not having risk for COPD ambulatory care-sensitive
hospitalization. As shown in Table 21, approximately four percent of the sample had risk
for COPD ambulatory care-sensitive hospitalization.

Number of COPD Ambulatory Care-Sensitive Hospitalizations
The number of COPD ambulatory care-sensitive hospitalizations was calculated
by summing all COPD ambulatory care-sensitive hospitalizations for each individual
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Table 19. Mean and Standard Deviation of Patient Perceptions of Their Doctors Index
Scores
Variable
Patient perceptions of their
doctors index

Number of
individuals

Mean

Standard
deviation

2,306

39.2

5.3
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Table 20. Sample Distribution by Whether Patient Had Positive Perceptions of Their
Doctors
Patient perceptions of their doctors

Number of individuals
(N=2,306)

Percent

Positive

1,203

52.2

Not positive

1,103

47.8
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Table 21. Sample Distribution by COPD Ambulatory Care-Sensitive Hospitalization Risk
COPD ambulatory caresensitive hospitalization risk

Number of individuals
(N=2,306)

Percent

Yes

94

4.1

No

2,212

95.9
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during the 12-month study period. The mean number of COPD ambulatory caresensitive hospitalizations was 0.049 with a standard deviation of 0.26 (Table 22.)

COPD Ambulatory Care-Sensitive Hospital Days
COPD ambulatory care-sensitive hospital days was calculated by summing
hospital days from all COPD ambulatory care-sensitive hospitalizations for each
individual during the 12-month study period. The mean COPD ambulatory care-sensitive
hospital days was 0.21 with a standard deviation of 0.36 (Table 23.)

COPD Ambulatory Care-Sensitive Hospitalization Expenditures
COPD ambulatory care-sensitive hospitalization expenditures were calculated by
summing expenditures from all COPD ambulatory care-sensitive hospitalizations for
each individual during the 12-month study period. Expenditures were adjusted to reflect
2012 US dollars using the medical component of the Consumer Price Index. The mean
COPD ambulatory care-sensitive hospitalization expenditures were $343.7 with a
standard deviation of $2,218.7 (Table 24.)

COPD-Related Hospitalization Risk
COPD-related hospitalization risk was based on hospital inpatient events with a
primary or secondary discharge ICD-9-CM diagnosis code for COPD based on AHRQ
Prevention Quality Indicator algorithm presented in Appendix Table B (Agency for
Healthcare Research and Quality 2016). Individuals were categorized as having risk for
COPD-related hospitalization if they had at least one COPD-related hospitalization
during the 12-month study period. Otherwise, individuals were categorized as not having
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Table 22. Mean and Standard Deviation of Number of COPD Ambulatory Care-Sensitive
Hospitalizations
Variable
Number of COPD Ambulatory
Care-Sensitive Hospitalizations

Number of individuals

Mean

Standard
deviation

2,306

0.049

0.26
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Table 23. Mean and Standard Deviation of COPD Ambulatory Care-Sensitive Hospital
Days
Variable
COPD ambulatory care-sensitive
hospital days

Number of individuals

Mean

Standard
deviation

2,306

0.21

1.36
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Table 24. Mean and Standard Deviation of COPD Ambulatory Care-Sensitive
Hospitalization Expenditures
Variable
COPD ambulatory care-sensitive
hospitalization expenditures

Number of individuals

Mean

Standard
deviation

2,306

$343.7

2218.7
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risk for COPD-related hospitalization. As shown in Table 25, approximately fifteen
percent of the sample had risk for COPD-related hospitalization.

Number of COPD-Related Hospitalizations
The number of COPD-related hospitalizations was calculated by summing all
COPD-related hospitalizations for each individual during the 12-month study period.
The mean number of COPD-related hospitalizations was 0.24 with a standard deviation
of 0.68 (Table 26.)

COPD-Related Hospital Days
COPD-related hospital days was calculated by summing hospital days from all
COPD-related hospitalizations for each individual during the 12-month study period.
The mean COPD-related hospital days was 1.20 with a standard deviation of 4.35 (Table
27.)

COPD-Related Hospitalization Expenditures
COPD-related hospitalization expenditures were calculated by summing
expenditures from all COPD-related hospitalizations for each individual during the 12month study period. Expenditures were adjusted to reflect 2012 US dollars using the
medical component of the Consumer Price Index. The mean COPD-related
hospitalization expenditures were $2,115 with a standard deviation of $7,509 (Table 28.)
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Table 25. Sample Distribution by COPD-Related Hospitalization Risk
COPD-related
hospitalization risk

Number of individuals
(N=2,306)

Percent

Yes

347

15.0

No

1,959

85.0
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Table 26. Mean and Standard Deviation of Number of COPD-Related Hospitalizations
Variable
Number of COPD-related
hospitalizations

Number of individuals

Mean

Standard
deviation

2,306

0.24

0.68
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Table 27. Mean and Standard Deviation of COPD-Related Hospital Days
Variable
COPD-related hospital days

Number of individuals

Mean

Standard
deviation

2,306

1.20

4.35
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Table 28. Mean and Standard Deviation of COPD-Related Hospitalization Expenditures
Variable
COPD-related hospitalization
expenditures

Number of individuals

Mean

Standard
deviation

2,306

$2,115

7,509
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Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization Risk
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Risk
Bivariate associations between demographic variables and COPD ambulatory
care-sensitive hospitalization risk are presented in Table 29. Individuals who had lower
educational level (p=0.023), had lower individual income (p=0.012), or resided in nonmetro areas (p=0.034) had significantly higher risk of COPD ambulatory care-sensitive
hospitalization. No association was found between age, gender, race, marital status,
region, and COPD ambulatory care-sensitive hospitalization risk in the bivariate analyses.
Bivariate associations between clinical variables and COPD ambulatory caresensitive hospitalization risk are presented in Table 30. Individuals who were current or
ex-smokers (p<0.001), perceived their health as fair or poor (p<0.001), had received
pneumococcal vaccine (p=0.024), had heart diseases (p=0.007), had heart failure
(p=0.004), had depression (p=0.007), had prior hospitalization (p<0.001), or had oxygen
use (p<0.001) had significantly higher risk of COPD ambulatory care-sensitive
hospitalization. No association was found between influenza vaccine, Charlson
Comorbidity Index, diabetes, osteoporosis, number of doctor visits, and COPD
ambulatory care-sensitive hospitalization risk in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
Bivariate association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization risk is presented in Table 31. No association
was found between patient perceptions of their doctors and COPD ambulatory caresensitive hospitalization risk in the bivariate analysis.
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Table 29. Bivariate Associations between Demographic Variables and COPD
Ambulatory Care-Sensitive Hospitalization Risk
1 or more ACSH
hospitalizations

No ACSH
hospitalization

N=94

N=2,212

Demographic Variable

Number

Percent

Number

Percent

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older

18
30
33
13

19.2
31.9
35.1
13.8

349
700
891
272

15.8
31.6
40.3
12.3

Gender
Man
Woman

46
48

48.9
51.1

1,022
1,190

46.2
53.8

Race
White
Non-White
Marital status
Married
Non-married
Education
Less than high school
High school graduates
Post high school
excluding college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more

p-value1,2

0.701

0.603

0.709
80
14

85.1
14.9

1,908
299

86.5
13.5
0.065

32
62

34.0
66.0

966
1,245

43.7
56.3

41
28
14

44.1
30.1
15.1

670
708
563

30.4
32.1
26.5

10

10.7

266

12.0

0.023

0.012
41
23
15

51.9
29.1
19.0

686
620
586

36.3
32.7
31.0
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Table 29. Continued

Demographic
Variable

1 or more ACSH
hospitalizations

No ACSH
hospitalization

N=94

N=2,212

Number
Region
Midwest
Northeast
South
West
Residence
Metro area
Non-metro area
1

Percent

Number

Percent
0.134

22
11
56
5

23.4
11.7
59.6
5.3

565
366
1,068
213

25.5
16.6
48.3
9.6
0.034

50
44

53.2
46.8

1,415
797

Chi-square test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

p-value1,2

64.0
36.0
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Table 30. Bivariate Associations between Clinical Variables and COPD Ambulatory
Care-Sensitive Hospitalization Risk
1 or more ACSH
hospitalizations

No ACSH
hospitalization

N=94

N=2,212

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker

Number

Percent

Number

Percent

25
65
4

26.6
69.1
4.3

505
1,245
461

22.8
56.4
20.8

p-value1,2

<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

<0.001
8
24
34
28

8.5
25.5
36.2
29.8

588
762
565
289

26.7
34.6
25.6
13.1

Influenza vaccine
Yes
No

74
18

80.4
19.6

1,757
446

79.8
20.2

Pneumococcal vaccine
Yes
No

88
5

94.6
5.4

1,910
296

86.6
13.4

0.874

0.024

Charlson Comorbidity
Index
0
1
2
3
4 or higher

0.376
10
18
14
17
35

10.6
19.2
14.9
18.1
37.2

337
464
408
299
704

15.2
21.0
18.4
13.5
31.8

Heart diseases
Yes
No

69
25

73.4
26.6

1,315
897

59.5
40.5

0.007
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Table 30. Continued
1 or more ACSH
hospitalizations

No ACSH
hospitalization

N=94

N=2,212

Clinical Variable

Number
Heart failure
Yes
No

1

Percent

Percent
0.004

29
65

30.9
69.1

416
1,796

18.8
81.2

Diabetes
Yes
No

0.565
24
70

25.5
74.5

625
1,587

28.3
71.7

Depression
Yes
No

40
54

42.5
57.5

655
1,557

29.6
70.4

Osteoporosis
Yes
No

24
70

25.5
74.5

639
1,573

28.9
71.1

Prior hospitalizations
Yes
No

52
42

55.3
44.7

842
1,370

38.1
61.9

0.007

0.481

<0.001

Number of doctor visits
Less than 15
15 to 30
More than 30

0.053
18
41
35

19.2
43.6
37.2

682
807
723

30.8
36.5
32.7

Oxygen use
Yes
No

46
48

48.9
51.1

489
1,723

22.1
77.9

<0.001

Chi-square test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

Number

p-value1,2
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Table 31. Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk

Patient perceptions of
their doctors

1 or more ACSH
hospitalizations

No ACSH
hospitalization

N=94

N=2,212

Number

Percent

Number

p-value1,2

Percent
0.090

Positive perception
Not positive perception
1

41
53

43.6
56.4

Chi-square test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

1,162
1,050

52.5
47.5
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Bivariate Associations with Number of COPD Ambulatory Care-Sensitive
Hospitalizations
The distribution of the variable number of COPD ambulatory care-sensitive
hospitalizations was examined. Significant Shapiro-Wilk normality test (p<0.001) and
the Kolmogorov-Smirnov normality test (p<0.001) indicated that the variable was not
normally distributed. A non-parametric, Wilcoxon-Mann-Whitney test, was selected to
assess bivariate associations with number of COPD ambulatory care-sensitive
hospitalizations.

Bivariate Associations between Study Covariates and Number of COPD Ambulatory
Care-Sensitive Hospitalizations
Bivariate associations between demographic variables and number of COPD
ambulatory care-sensitive hospitalizations are presented in Table 32. Individuals who
had lower educational level (p=0.022), had lower individual income (p=0.011), or resided
in non-metro areas (p=0.031) had significantly higher number of COPD ambulatory caresensitive hospitalizations. No association was found between age, gender, race, marital
status, region, and number of COPD ambulatory care-sensitive hospitalizations in the
bivariate analyses.
Bivariate associations between clinical variables and number of COPD
ambulatory care-sensitive hospitalizations are presented in Table 33. Individuals who
were current or ex-smokers (p<0.001), perceived their health as fair or poor (p<0.001),
had received pneumococcal vaccine (p=0.026), had heart diseases (p=0.007), had heart
failure (p=0.004), had depression (p=0.007), had prior hospitalization (p<0.001), or had
oxygen use (p<0.001) had significantly higher number of COPD ambulatory caresensitive hospitalizations. No association was found between influenza vaccine,
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Table 32. Bivariate Associations between Demographic Variables and Number of COPD
Ambulatory Care-Sensitive Hospitalizations

Demographic Variable

Number of
individuals
(N=2,306)

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Mean number of
COPD ACSHs

0.687
367
730
924
285

0.065
0.047
0.040
0.063
0.609

1,068
1,238

0.052
0.046

Race
White
Non-White

1,988
313

0.049
0.048

Marital status
Married
Non-married

998
1,307

0.035
0.060

711
736
577

0.075
0.042
0.026

276

0.043

727
643
601

0.070
0.047
0.027

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.721

0.062

0.022

0.011

0.128
587
377
1,124
218

0.041
0.029
0.064
0.028
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Table 32. Continued

Residence

Number of
individuals
(N=2,306)

Mean number of
COPD ACSHs

p-value1,2

0.031
Metro area
Non-metro area
1

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

0.038
0.069
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Table 33. Bivariate Associations between Clinical Variables and Number of COPD
Ambulatory Care-Sensitive Hospitalizations

Clinical Variable

Number of
individuals
(N=2,306)

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Mean number of
COPD ACSHs

p-value1,2

<0.001
465
1,310
530

0.060
0.058
0.011

596
786
599
317

0.013
0.039
0.062
0.117

1,831
464

0.049
0.045

<0.001

0.868

0.026
1,998
301

0.052
0.030
0.375

347
482
422
316
739

0.032
0.050
0.038
0.057
0.060
0.007

1,384
922

0.059
0.035
0.004

445
1,861

0.081
0.041
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Table 33. Continued

Clinical Variable

Number of
individuals
(N=2,306)

Diabetes
Yes
No

649
1,657

0.040
0.053

Depression
Yes
No

695
1,611

0.078
0.037

Osteoporosis
Yes
No

663
1,643

0.047
0.050

Prior hospitalizations
Yes
No

894
1,412

0.068
0.037

Number of doctor visits
Less than 15
15 to 30
More than 30
Oxygen use
Yes
No
1

p-value1,2

0.553

0.007

0.499

<0.001

0.052
700
848
758

0.031
0.059
0.054

535
1,771

0.099
0.034

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

Mean number of
COPD ACSHs
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Charlson Comorbidity Index, diabetes, osteoporosis, number of doctor visits, and number
of COPD ambulatory care-sensitive hospitalizations in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
Bivariate association between patient perceptions of their doctors and number of
COPD ambulatory care-sensitive hospitalizations is presented in Table 34. No
association was found between patient perceptions of their doctors and number of COPD
ambulatory care-sensitive hospitalizations in the bivariate analysis.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospital Days
The distribution of the variable COPD ambulatory care-sensitive hospital days
was examined. Significant Shapiro-Wilk normality test (p<0.001) and the KolmogorovSmirnov normality test (p<0.001) indicated that the variable was not normally
distributed. A non-parametric, Wilcoxon-Mann-Whitney test, was selected to assess
bivariate associations with COPD ambulatory care-sensitive hospital days.

Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospital Days
Bivariate associations between demographic variables and COPD ambulatory
care-sensitive hospital days are presented in Table 35. Individuals who had lower
educational level (p=0.022), had lower individual income (p=0.011), or resided in nonmetro areas (p=0.032) had significantly higher COPD ambulatory care-sensitive hospital
days. No association was found between age, gender, race, marital status, region, and
COPD ambulatory care-sensitive hospital days in the bivariate analyses.
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Table 34. Bivariate Association between Patient Perceptions of Their Doctors and
Number of COPD Ambulatory Care-Sensitive Hospitalizations

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean number of
COPD ACSHs

p-value1,2

0.089
Positive perception
Not positive perception
1

1,203
1,103

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

0.040
0.059
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Table 35. Bivariate Associations between Demographic Variables and COPD
Ambulatory Care-Sensitive Hospital Days

Demographic Variable

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Number of
individuals
(N=2,306)

Mean COPD
ambulatory-care
sensitive
hospital days

0.689
367
730
924
285

0.23
0.20
0.19
0.26
0.604

1,068
1,238

0.24
0.18

Race
White
Non-White

1,988
313

0.21
0.18

Marital status
Married
Non-married

998
1,307

0.14
0.26

711
736
577

0.34
0.18
0.09

276

0.16

727
643
601

0.27
0.25
0.09

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.726

0.061

0.022

0.011

0.122
587
377
1,124
218

0.20
0.11
0.27
0.09
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Table 35. Continued

Residence

Number of
individuals
(N=2,306)

Mean COPD
ambulatory-care
sensitive hospital
days

p-value1,2

0.032
Metro area
Non-metro area
1
2

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant

0.15
0.31
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Bivariate associations between clinical variables and COPD ambulatory caresensitive hospital days are presented in Table 36. Individuals who were current or exsmokers (p<0.001), perceived their health as fair or poor (p<0.001), had received
pneumococcal vaccine (p=0.024), had heart diseases (p=0.006), had heart failure
(p=0.004), had depression (p=0.006), had prior hospitalization (p<0.001), had more
doctor visits (p=0.048), or had oxygen use (p<0.001) had significantly higher COPD
ambulatory care-sensitive hospital days. No association was found between influenza
vaccine, Charlson Comorbidity Index, diabetes, osteoporosis, and COPD ambulatory
care-sensitive hospital days in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
Bivariate association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days is presented in Table 37. No association was
found between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospital days in the bivariate analysis.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization
Expenditures
The distribution of the variable COPD ambulatory care-sensitive hospitalization
expenditures was examined. Significant Shapiro-Wilk normality test (p<0.001) and the
Kolmogorov-Smirnov normality test (p<0.001) indicated that the variable was not
normally distributed. A non-parametric, Wilcoxon-Mann-Whitney test, was selected to
assess bivariate associations with COPD ambulatory care-sensitive hospitalization
expenditures.
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Table 36. Bivariate Associations between Clinical Variables and COPD Ambulatory
Care-Sensitive Hospital Days

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Number of
individuals
(N=2,306)

Mean COPD
ambulatory-care
sensitive hospital
days

p-value1,2

<0.001
465
1,310
530

0.20
0.27
0.05

596
786
599
317

0.04
0.15
0.29
0.53

1,831
464

0.21
0.19

<0.001

0.871

0.024
1,998
301

0.22
0.10
0.377

347
482
422
316
739

0.10
0.20
0.18
0.22
0.28
0.006

1,384
922

0.27
0.12
0.004

445
1,861

0.31
0.19
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Table 36. Continued

Clinical Variable

649
1,657

0.18
0.22

Depression
Yes
No

695
1,611

0.37
0.14

Osteoporosis
Yes
No

663
1,643

0.17
0.22

Prior hospitalizations
Yes
No

894
1,412

0.30
0.15

Oxygen use
Yes
No

2

(N=2,306)

Mean COPD
ambulatory-care
sensitive hospital
days

Diabetes
Yes
No

Number of doctor visits
Less than 15
15 to 30
More than 30

1

Number of
individuals

p-value1,2

0.578

0.006

0.490

<0.001

0.048
700
848
758

0.11
0.28
0.22

535
1,771

0.47
0.13

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant.
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Table 37. Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean COPD
ambulatory-care
sensitive hospital
days

p-value1,2

0.087
Positive perception
Not positive perception
1
2

1,203
1,103

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant

0.17
0.25
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Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Expenditures
Bivariate associations between demographic variables and COPD ambulatory
care-sensitive hospitalization expenditures are presented in Table 38. Individuals who
were not married (p=0.046), had lower educational level (p=0.019), had lower individual
income (p=0.009), or resided in non-metro areas (p=0.027) had significantly higher
COPD ambulatory care-sensitive hospitalization expenditures. No association was found
between age, gender, race, region, and COPD ambulatory care-sensitive hospitalization
expenditures in the bivariate analyses.
Bivariate associations between clinical variables and COPD ambulatory caresensitive hospitalization expenditures are presented in Table 39. Individuals who were
current or ex-smokers (p<0.001), perceived their health as fair or poor (p<0.001), had
received pneumococcal vaccine (p=0.028), had heart diseases (p=0.008), had heart failure
(p=0.003), had depression (p=0.011), had prior hospitalization (p<0.001), had more
doctor visits (p=0.030), or had oxygen use (p<0.001) had significantly higher COPD
ambulatory care-sensitive hospitalization expenditures. No association was found
between influenza vaccine, Charlson Comorbidity Index, diabetes, osteoporosis, and
COPD ambulatory care-sensitive hospitalization expenditures in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
Bivariate association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures is presented in Table 40. No
association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures in the bivariate analysis.
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Table 38. Bivariate Associations between Demographic Variables and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures

Demographic Variable

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Number of
individuals
(N=2,306)

Mean COPD
ACSH
expenditures

367
730
924
285

$414.4
312.4
331.9
370.9

0.792

0.532
1,068
1,238

417.6
279.9

Race
White
Non-White

1,988
313

344.9
341.8

Marital status
Married
Non-married

998
1,307

212.0
444.5

711
736
577

557.8
274.4
158.9

276

322.2

727
643
601

491.8
335.1
159.9

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.677

0.046

0.019

0.009

0.166
587
377
1,124
218

304.5
282.4
408.7
220.1
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Table 38. Continued

Residence

Number of
individuals
(N=2,306)

Mean COPD
ACSH
expenditures

p-value1,2

0.027
Metro area
Non-metro area
1

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

$270.3
471.5

143
Table 39. Bivariate Associations between Clinical Variables and COPD Ambulatory
Care-Sensitive Hospitalization Expenditures

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Number of
individuals
(N=2,306)

Mean COPD
ACSH
expenditures

465
1,310
530

$375.2
424.1
82.0

596
786
599
317

106.0
266.9
516.2
664.0

1,831
464

348.6
293.9

p-value1,2

<0.001

<0.001

0.721

0.028
1,998
301

367.6
170.4
0.336

347
482
422
316
739

178.4
301.2
355.6
346.7
440.9
0.008

1,384
922

427.2
218.3
0.003

445
1,861

465.8
314.5
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Table 39. Continued

Clinical Variable

Number of
individuals
(N=2,306)

Diabetes
Yes
No

649
1,657

$246.7
381.7

Depression
Yes
No

695
1,611

498.1
277.1

Osteoporosis
Yes
No

663
1,643

286.8
366.6

Prior hospitalizations
Yes
No

894
1,412

525.1
228.8

Number of doctor visits
Less than 15
15 to 30
More than 30
Oxygen use
Yes
No
1

p-value1,2

0.605

0.011

0.521

<0.001

0.030
700
848
758

144.9
519.9
330.1

535
1,771

718.5
230.4

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2

Mean COPD
ACSH
expenditures
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Table 40. Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean COPD
ACSH
expenditures ($)

1,203
1,103

309.8
380.6

p-value1,2

0.110
Positive perception
Not positive perception
1

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
ACSH = Ambulatory Care-Sensitive Hospitalization
2
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Bivariate Associations with COPD-Related Hospitalization Risk
Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Risk
Bivariate associations between demographic variables and COPD-related
hospitalization risk are presented in Table 41. Individuals who were 75 to 84 years old
(p=0.010), were not married (p=0.032), had lower educational level (p=0.031), or had
lower individual income (p=0.012) had significantly higher risk of COPD-related
hospitalization. No association was found between gender, race, region, residence, and
COPD-related hospitalization risk in the bivariate analyses.
Bivariate associations between clinical variables and COPD-related
hospitalization risk are presented in Table 42. Individuals who were current or exsmokers (p<0.001), perceived their health as fair or poor (p<0.001), had received
influenza vaccine (p=0.011), had received pneumococcal vaccine (p<0.001), had higher
Charlson Comorbidity Index scores (p<0.001), had heart diseases (p<0.001), had heart
failure (p<0.001), had prior hospitalization (p<0.001), had more doctor visits (p<0.001),
or had oxygen use (p<0.001) had significantly higher risk of COPD-related
hospitalization. No association was found between diabetes, depression, osteoporosis,
and COPD-related hospitalization risk in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Risk
Bivariate association between patient perceptions of their doctors and COPDrelated hospitalization risk is presented in Table 43. Individuals who did not have
positive perceptions of their doctors were at greater risk for COPD-related hospitalization
(p=0.027).
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Table 41. Bivariate Associations between Demographic Variables and COPD-Related
Hospitalization Risk

Demographic Variable

1 or more COPDrelated
hospitalizations

No COPD-related
hospitalization

N=347

N=1,959

Number

Percent

p-value1,2
Number

Percent

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older

49
96
159
43

14.1
27.7
45.8
12.4

318
634
765
242

16.2
32.4
39.0
12.4

Gender
Man
Woman

169
178

48.7
51.3

899
1,060

45.9
54.1

Race
White
Non-White

298
49

85.9
14.1

1,690
264

86.5
13.5

Marital status
Married
Non-married

132
215

38.0
62.0

866
1,092

44.2
55.8

Education
Less than high school
High school graduates
Post high school
excluding college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more

0.010

0.333

0.760

0.032

0.031
128
109
70

37.0
31.5
20.2

583
627
507

29.8
32.1
26.0

39

11.3

237

12.1

123
108
70

40.9
35.9
15.2

604
535
531

36.2
32.0
31.8

0.012
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Table 41. Continued

Demographic
Variable

1
2

1 or more COPDrelated
hospitalizations

No COPD-related
hospitalization

N=347

N=1,959

p-value1,2

Number

Percent

Number

Percent

Region
Midwest
Northeast
South
West

86
59
180
22

24.8
17.0
51.9
6.3

501
318
944
196

25.6
16.2
48.2
10.0

Residence
Metro area
Non-metro area

213
134

61.4
38.6

1,252
707

63.9
36.1

0.159

0.367

Chi-square test
p-value less than 0.05 was considered significant.
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Table 42. Bivariate Associations between Clinical Variables and COPD-Related
Hospitalization Risk

Clinical Variable

1 or more COPDrelated
hospitalizations

No COPD-related
hospitalization

N=347

N=1,959

Number

Percent

p-value1,2
Number

Percent

Smoking status
Current smoker
Ex-smoker
Non-smoker

82
224
41

23.6
64.6
11.8

448
1,086
424

22.9
55.5
21.6

Perceived health
Excellent/Very good
Good
Fair
Poor

49
104
114
80

14.1
30.0
32.9
23.0

547
682
485
237

28.0
35.0
24.9
12.1

Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity
Index
0
1
2
3
4 or more
Heart diseases
Yes
No

<0.001

<0.001

0.011
291
52

84.8
15.2

1,540
412

78.9
21.1
<0.001

324
21

93.9
6.1

1,674
280

85.7
14.3
<0.001

33
58
61
56
139

9.5
16.7
17.6
16.1
40.1

314
424
361
260
600

16.0
21.6
18.4
13.3
30.6
<0.001

245
102

70.6
29.4

1,139
820

58.1
41.9
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Table 42. Continued

Clinical Variable

N=347

N=1,959

p-value1,2

Percent

Number

Percent

Heart failure
Yes
No

109
238

31.4
68.6

336
1,623

17.2
82.8

Diabetes
Yes
No

97
250

28.0
72.0

552
1,407

28.2
71.8

Osteoporosis
Yes
No

<0.001

0.932

0.115
117
230

33.7
66.3

578
1,381

29.5
70.5
0.384

93
254

26.8
73.2

570
1,389

29.1
70.9

Prior hospitalizations
Yes
No

181
166

52.2
47.8

713
1,246

36.4
63.6

Number of doctor visits
Less than 15
15 to 30
More than 30

72
130
145

20.7
37.5
41.8

628
718
613

32.1
36.7
31.3

Oxygen use
Yes
No

2

No COPD-related
hospitalization

Number

Depression
Yes
No

1

1 or more COPDrelated
hospitalizations

<0.001

<0.001

<0.001
137
210

39.5
60.5

Chi-square test
p-value less than 0.05 was considered significant

398
1,561

20.3
79.7
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Table 43. Bivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Risk

Patient perceptions of
their doctors

1 or more COPDrelated
hospitalizations

No COPD-related
hospitalization
N=1,959

N=347
Number

Percent

Number

Percent

162
185

46.7
53.3

1,041
918

53.1
46.9

p-value1,2

0.027
Positive perception
Not positive perception
1
2

Chi-square test
p-value less than 0.05 was considered significant
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Bivariate Associations with Number of COPD-Related Hospitalizations
The distribution of the variable number of COPD-related hospitalizations was examined.
Significant Shapiro-Wilk normality test (p<0.001) and the Kolmogorov-Smirnov
normality test (p<0.001) indicated that the variable was not normally distributed. A nonparametric, Wilcoxon-Mann-Whitney test, was selected to assess bivariate associations
with number of COPD-related hospitalizations.

Bivariate Associations between Study Covariates and Number of COPD-Related
Hospitalizations
Bivariate associations between demographic variables and number of COPDrelated hospitalizations are presented in Table 44. Individuals who were not married
(p=0.028), had lower educational level (p=0.026), or had lower individual income
(p=0.010) had significantly higher number of COPD-related hospitalization. No
association was found between age, gender, race, region, residence, and number of
COPD-related hospitalizations in the bivariate analyses.
Bivariate associations between clinical variables and number of COPD-related
hospitalizations are presented in Table 45. Individuals who were current or ex-smokers
(p<0.001), perceived their health as fair or poor (p<0.001), had received influenza
vaccine (p=0.011), had received pneumococcal vaccine (p<0.001), had higher Charlson
Comorbidity Index scores (p<0.001), had heart diseases (p<0.001), had heart failure
(p<0.001), had prior hospitalization (p<0.001), had more doctor visits (p<0.001), or had
oxygen use (p<0.001) had significantly higher number of COPD-related hospitalizations.
No association was found between diabetes, depression, osteoporosis, and number of
COPD-related hospitalizations in the bivariate analyses.
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Table 44. Bivariate Associations between Demographic Variables and Number of COPDRelated Hospitalizations

Demographic Variable

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Number of
individuals
(N=2,306)

Mean number of
COPD-related
hospitalizations

367
730
924
285

0.21
0.21
0.27
0.24

0.106

0.329
1,068
1,238

0.25
0.23

Race
White
Non-White

1,988
313

0.23
0.26

Marital status
Married
Non-married

998
1,307

0.19
0.27

711
736
577

0.30
0.24
0.18

276

0.21

727
643
601

0.28
0.27
0.16

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.793

0.028

0.026

0.010

0.144
587
377
1,124
218

0.21
0.24
0.26
0.16
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Table 44. Continued

Residence

Number of
individuals
(N=2,306)

Mean number of
COPD-related
hospitalizations

p-value1,2

0.375
Metro area
Non-metro area
1
2

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant.

0.23
0.25
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Table 45. Bivariate Associations between Clinical Variables and Number of COPDRelated Hospitalizations

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Number of
individuals
(N=2,306)

Mean number of
COPD-related
hospitalizations

465
1,310
530

0.25
0.27
0.13

596
786
599
317

0.10
0.20
0.31
0.47

1,831
464

0.25
0.17

p-value1,2

<0.001

<0.001

0.011

<0.001
1,998
301

0.25
0.11
<0.001

347
482
422
316
739

0.14
0.20
0.20
0.26
0.32
<0.001

1,384
922

0.29
0.16
<0.001

445
1,861

0.40
0.20
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Table 45. Continued

Clinical Variable

Number of
individuals
(N=2,306)

Diabetes
Yes
No

649
1,657

0.22
0.24

Depression
Yes
No

695
1,611

0.28
0.22

Osteoporosis
Yes
No

663
1,643

0.24
0.24

Prior hospitalizations
Yes
No

894
1,412

0.35
0.17

Number of doctor visits
Less than 15
15 to 30
More than 30
Oxygen use
Yes
No
1
2

Mean number of
COPD-related
hospitalizations

p-value1,2

0.903

0.108

0.442

<0.001

<0.001
700
848
758

0.15
0.23
0.33

535
1,771

0.40
0.19

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
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Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
Bivariate association between patient perceptions of their doctors and number of
COPD-related hospitalizations is presented in Table 46. Individuals who did not have
positive perceptions of their doctors had significantly higher number of COPD-related
hospitalizations (p=0.029).

Bivariate Associations with COPD-Related Hospital Days
The distribution of the variable COPD-related hospital days was examined.
Significant Shapiro-Wilk normality test (p<0.001) and the Kolmogorov-Smirnov
normality test (p<0.001) indicated that the variable was not normally distributed. A nonparametric, Wilcoxon-Mann-Whitney test, was selected to assess bivariate associations
with COPD-related hospital days.

Bivariate Associations between Study Covariates and COPD-Related Hospital Days
Bivariate associations between demographic variables and COPD-related hospital
days are presented in Table 47. Individuals who were not married (p=0.021), had lower
educational level (p=0.037), or had lower individual income (p=0.012) had significantly
higher COPD-related hospital days. No association was found between age, gender, race,
region, residence, and COPD-related hospital days in the bivariate analyses.
Bivariate associations between clinical variables and COPD-related hospital days
are presented in Table 48. Individuals who were current or ex-smokers (p<0.001),
perceived their health as fair or poor (p<0.001), had received influenza vaccine
(p=0.011), had received pneumococcal vaccine (p<0.001), had higher Charlson
Comorbidity Index scores (p<0.001), had heart diseases (p<0.001),
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Table 46. Bivariate Association between Patient Perceptions of Their Doctors and
Number of COPD-Related Hospitalizations

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean number of
COPD-related
hospitalizations

1,203
1,103

0.21
0.27

p-value1,2

0.029
Positive perception
Not positive perception
1
2

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
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Table 47. Bivariate Associations between Demographic Variables and COPD-Related
Hospital Days

Demographic Variable

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Number of
individuals
(N=2,306)

Mean COPDrelated hospital
days

367
730
924
285

0.86
1.14
1.34
1.31

0.076

0.325
1,068
1,238

1.21
1.19

Race
White
Non-White

1,988
313

1.21
1.11

Marital status
Married
Non-married

998
1,307

0.82
1.48

711
736
577

1.36
1.18
0.91

276

1.37

727
643
601

1.42
1.41
0.84

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.817

0.021

0.037

0.012

0.135
587
377
1,124
218

0.93
1.32
1.39
0.68
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Table 47. Continued

Residence

Number of
individuals
(N=2,306)

Mean COPDrelated hospital
days

p-value1,2

0.396
Metro area
Non-metro area
1
2

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant.

1.21
1.17
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Table 48. Bivariate Associations between Clinical Variables and COPD-Related Hospital
Days

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Number of
individuals
(N=2,306)

Mean COPDrelated hospital
days

465
1,310
530

0.98
1.46
0.69

596
786
599
317

0.52
0.96
1.56
2.37

1,831
464

1.24
0.89

p-value1,2

<0.001

<0.001

0.011

<0.001
1,998
301

1.30
0.43
<0.001

347
482
422
316
739

0.79
0.91
0.96
1.37
1.63
<0.001

1,384
922

1.46
0.80
<0.001

445
1,861

2.05
0.99
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Table 48. Continued

Clinical Variable

Number of
individuals
(N=2,306)

Diabetes
Yes
No

649
1,657

1.01
1.27

Depression
Yes
No

695
1,611

1.41
1.10

Osteoporosis
Yes
No

663
1,643

1.32
1.15

Prior hospitalizations
Yes
No

894
1,412

1.79
0.82

Number of doctor visits
Less than 15
15 to 30
More than 30
Oxygen use
Yes
No
1
2

Mean COPDrelated hospital
days

p-value1,2

0.848

0.131

0.498

<0.001

<0.001
700
848
758

0.73
1.17
1.66

535
1,771

2.14
0.91

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
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had heart failure (p<0.001), had prior hospitalization (p<0.001), had more doctor visits
(p<0.001), or had oxygen use (p<0.001) had significantly higher COPD-related hospital
days. No association was found between diabetes, depression, osteoporosis, and COPDrelated hospital days in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospital Days
Bivariate association between patient perceptions of their doctors and COPDrelated hospital days is presented in Table 49. Individuals who did not have positive
perceptions of their doctors had significantly higher COPD-related hospital days
(p=0.031).

Bivariate Associations with COPD-Related Hospitalization Expenditures
The distribution of the variable COPD-related hospitalization expenditures was
examined. Significant Shapiro-Wilk normality test (p<0.001) and the KolmogorovSmirnov normality test (p<0.001) indicated that the variable was not normally
distributed. A non-parametric, Wilcoxon-Mann-Whitney test, was selected to assess
bivariate associations with COPD-related hospitalization expenditures.

Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Expenditures
Bivariate associations between demographic variables and COPD-related
hospitalization expenditures are presented in Table 50. Individuals who were not married
(p=0.012) or had lower individual income (p=0.020) had significantly higher COPDrelated hospitalization expenditures. No association was found between age, gender,
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Table 49. Bivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospital Days

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean COPDrelated hospital
days

1,203
1,103

1.13
1.27

p-value1,2

0.031
Positive perception
Not positive perception
1
2

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant
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Table 50. Bivariate Associations between Demographic Variables and COPD-Related
Hospitalization Expenditures

Demographic Variable

Age
less than 65 years
65 to 74 years
75 to 84 years
85 years or older
Gender
Man
Woman

Number of
individuals
(N=2,306)

Mean COPDrelated
hospitalization
expenditures

0.051
367
730
924
285

$1,775
1,850
2,461
2,112
0.336

1,068
1,238

2,287
1,967

Race
White
Non-White

1,988
313

2,151
1,921

Marital status
Married
Non-married

998
1,307

1,586
2,520

711
736
577

2,438
2,041
1,628

276

2,455

727
643
601

2,529
2,416
1,549

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Income
$0 to $14,999
$15,000 to $29,999
$30,000 or more
Region
Midwest
Northeast
South
West

p-value1,2

0.679

0.012

0.050

0.020

0.209
587
377
1,124
218

1,809
2,787
2,160
1,549

166
Table 50. Continued

Residence

Number of
individuals
(N=2,306)

Mean COPDrelated
hospitalization
expenditures

p-value1,2

0.404
Metro area
Non-metro area
1
2

1,465
841

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant

$2,167
2,024
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race, education, region, residence, and COPD-related hospitalization expenditures in the
bivariate analyses.
Bivariate associations between clinical variables and COPD-related
hospitalization expenditures are presented in Table 51. Individuals who were current or
ex-smokers (p<0.001), perceived their health as fair or poor (p<0.001), had received
influenza vaccine (p=0.008), had received pneumococcal vaccine (p<0.001), had higher
Charlson Comorbidity Index scores (p<0.001), had heart diseases (p<0.001), had heart
failure (p<0.001), had prior hospitalization (p<0.001), had more doctor visits (p<0.001),
or had oxygen use (p<0.001) had significantly higher COPD-related hospitalization
expenditures. No association was found between diabetes, depression, osteoporosis, and
COPD-related hospitalization expenditures in the bivariate analyses.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Expenditures
Bivariate association between patient perceptions of their doctors and COPDrelated hospitalization expenditures is presented in Table 52. Individuals who did not
have positive perceptions of their doctors had significantly higher COPD-related
hospitalization expenditures (p=0.031).

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
A multivariate logistic regression model was developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization risk. The predictor variable was patient perceptions of their doctors as a
binary variable, with “1” indicating positive perceptions and “0” indicating not positive
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Table 51. Bivariate Associations between Clinical Variables and COPD-Related
Hospitalization Expenditures

Clinical Variable

Smoking status
Current smoker
Ex-smoker
Non-smoker
Perceived health
Excellent/Very good
Good
Fair
Poor
Influenza vaccine
Yes
No
Pneumococcal vaccine
Yes
No
Charlson Comorbidity Index
0
1
2
3
4 or higher
Heart diseases
Yes
No
Heart failure
Yes
No

Number of
individuals
(N=2,306)

Mean COPDrelated
hospitalization
expenditures

p-value1,2

<0.001
465
1,310
530

$1,942
2,537
1,127
<0.001

596
786
599
317

922
1,590
3,099
3,854

1,831
464

2,207
1,586

0.008

<0.001
1,998
301

2,280
931
<0.001

347
482
422
316
739

1,544
1,516
1,935
2,103
2,882
<0.001

1,384
922

2,631
1,340
<0.001

445
1,861

3,567
1,768
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Table 51. Continued

Clinical Variable

649
1,657

$1,833
2,225

Depression
Yes
No

695
1,611

2,301
2,035

Osteoporosis
Yes
No

663
1,643

2,161
2,097

Prior hospitalizations
Yes
No

894
1,412

3,145
1,463

Oxygen use
Yes
No

2

(N=2,306)

Mean COPDrelated
hospitalization
expenditures

Diabetes
Yes
No

Number of doctor visits
Less than 15
15 to 30
More than 30

1

Number of
individuals

p-value1,2

0.968

0.177

0.609

<0.001

<0.001
700
848
758

1,240
2,202
2,826

535
1,771

3,304
1,756

<0.001

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant.
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Table 52. Bivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Expenditures

Patient perceptions of their doctors

Number of
individuals
(N=2,306)

Mean COPDrelated
hospitalization
expenditures

p-value1,2

0.031
Positive perception
Not positive perception
1
2

1,203
1,103

Wilcoxon-Mann-Whitney test
p-value less than 0.05 was considered significant

$1,983
2,259
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perceptions. The response variable was COPD ambulatory care-sensitive hospitalization
risk as a binary variable, with “1” indicating having at least one COPD ambulatory caresensitive hospitalization and “0” indicating having no COPD ambulatory care-sensitive
hospitalization. Covariates selected from stepwise selection procedure were marital
status, education, smoking status, perceived health, pneumococcal vaccine, heart
diseases, diabetes, prior hospitalization, and oxygen use.
The global likelihood ratio test was significant indicating good model fit
(p<0.001). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.399). The results of the multiple logistic regression model for association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization risk is presented in Table 53.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization risk after adjusting for covariates (odds
ratio=1.28, p=0.282). Other significant covariates in the regression model included
smoking status, perceived health, diabetes, prior hospitalization, and oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospitalization risk among oxygen users,
the same covariates except oxygen use were used in the regression model.
The global likelihood ratio test was significant indicating good model fit
(p=0.003). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.444). The results of the multiple logistic regression model for association
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Table 53. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Risk
Variable

Odds ratio

Patient perceptions of their
doctors
Positive
Not positive

Reference
1.23

Marital status
Married
Non-married

0.67
Reference

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
Smoking status
Current smoker
Ex-smoker
Non-smoker

95% Confidence
interval

p-value1,2
0.282

0.82 – 1.97
0.087
0.43 – 1.06
0.167

Reference
0.77
0.48

0.46 – 1.29
0.26 – 0.92

0.89

0.42 – 1.86

6.09
6.12
Reference

2.08 – 17.90
2.19 – 17.11

0.002

Perceived health
Excellent/Very good
Good
Fair
Poor

<0.001
0.21
0.39
0.64
Reference

Pneumococcal vaccine
Yes
No

Reference
0.46

Heart diseases
Yes
No

Reference
0.63

0.09 – 0.50
0.21 – 0.71
0.37 – 1.10
0.102
0.18 – 1.17
0.064
0.38 – 1.03
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Table 53. Continued
Variable
Diabetes
Yes
No

1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.042

Reference
1.68

Prior hospitalizations
Yes
No

Reference
0.62

Oxygen use
Yes
No

Reference
0.41

1.02 – 2.76
0.033
0.40 – 0.96
<0.001
0.26 – 0.63

Multivariate logistic regression
p-value less than 0.05 was considered significant
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between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization risk among oxygen users is presented in Table 54.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization risk among oxygen users after adjusting for
covariates (odds ratio=1.56, p=0.187). Prior hospitalization was the only significant
covariate in the regression model.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospitalization risk among non-oxygen
users, the same covariates except oxygen use were used in the regression model.
The global likelihood ratio test was significant indicating good model fit
(p<0.001). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.052). The results of the multiple logistic regression model for association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization risk among non-oxygen users is presented in Table 55.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization risk among non-oxygen users after adjusting for
covariates (odds ratio=1.05, p=0.872). Perceived health was the only significant
covariate in the regression model.

Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and number of COPD ambulatory care-
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Table 54. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Risk (Oxygen Users
Subgroup)
Variable
Patient perceptions of their
doctors
Positive
Not positive
Marital status
Married
Non-married
Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad

Odds ratio

95% Confidence
interval

0.187
Reference
1.56

0.81 – 3.00
0.065

0.51
Reference

0.25 – 1.04
0.243

Reference
0.71
0.37

0.34 – 1.50
0.14 – 0.97

0.79

0.24 – 2.58

Smoking status
Current smoker
Ex-smoker
Non-smoker

2.34
3.12
Reference

0.65 – 8.49
1.02 – 9.54

Perceived health
Excellent/Very good
Good
Fair
Poor

0.24
0.33
0.70
Reference

0.05 – 1.12
0.13 – 0.84
0.33 – 1.50

Pneumococcal vaccine
Yes
No
Heart diseases
Yes
No

p-value1,2

0.130

0.061

0.560
Reference
0.63

0.14 – 2.93
0.129

Reference
0.56

0.26 – 1.18
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Table 54. Continued
Variable
Diabetes
Yes
No
Prior hospitalizations
Yes
No
1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.250

Reference
1.50

0.75 – 3.01
0.010

Reference
0.41

0.21 – 0.81

Multivariate logistic regression
p-value less than 0.05 was considered significant.
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Table 55. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Risk (Non-Oxygen Users
Subgroup)
Variable
Patient perceptions of their
doctors
Positive
Not positive
Marital status
Married
Non-married
Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad

Odds ratio

95% Confidence
interval

0.872
Reference
1.05

0.58 – 1.91
0.603

0.85
Reference

0.47 – 1.56
0.664

Reference
0.85
0.59

0.42 – 1.74
0.25 – 1.40

0.99

0.37 – 2.62

Smoking status
Current smoker
Ex-smoker
Non-smoker

----Reference

-----

Perceived health
Excellent/Very good
Good
Fair
Poor

0.17
0.35
0.50
Reference

0.06 – 0.48
0.16 – 0.81
0.22 – 1.13

Pneumococcal vaccine
Yes
No
Heart diseases
Yes
No

p-value1,2

0.919

0.007

0.109
Reference
0.38

0.11 – 1.24
0.324

Reference
0.71

0.36 – 1.40
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Table 55. Continued
Variable
Diabetes
Yes
No
Prior hospitalizations
Yes
No
1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.059

Reference
2.07

0.97 – 4.41
0.713

Reference
0.89

0.49 – 1.64

Multivariate logistic regression
p-value less than 0.05 was considered significant
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sensitive hospitalizations. The predictor variable was patient perceptions of their doctors
as a binary variable, with “1” indicating positive perceptions and “0” indicating not
positive perceptions. The response variable was number of COPD ambulatory caresensitive hospitalizations as a count variable. Due to possible over dispersion and
“excessive” number of zeros in the response variable, a zero-inflated negative binomial
regression model was selected as the base model for stepwise selection of relevant
covariates. Covariates selected for the main model were marital status, education,
residence, smoking status, perceived health, heart failure, diabetes, depression, prior
hospitalization, and oxygen use. No covariate was selected for the zero-inflated model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Non-significant
Vuong test (p=0.501) indicated that “excessive” number of zeros did not exist and
standard negative binomial model fit data better than zero-inflated negative binomial
model (Vuong 1989, Long and Freese 2006). The results of the standard negative
binomial regression model for association between patient perceptions of their doctors
and number of COPD ambulatory care-sensitive hospitalizations is presented in Table 56.
No association was found between patient perceptions of their doctors and
number of COPD ambulatory care-sensitive hospitalizations after adjusting for covariates
(average marginal effect=0.009, p=0.387). Other significant covariates in the regression
model included marital status, education, smoking status, perceived health, diabetes, and
oxygen use.
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Table 56. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD Ambulatory Care-Sensitive Hospitalizations
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.009

0.011

0.387

Marital status
Married
Non-married

Reference
0.022

0.011

0.041

Reference
-0.020
-0.034

0.014
0.014

0.133
0.012

0.001

0.024

0.960

Residence
Metro area
Non-metro area

Reference
0.019

0.012

0.103

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.046
0.050
Reference

0.013
0.010

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.026
0.033
0.081

0.011
0.012
0.023

0.016
0.004
<0.001

Heart failure
Yes
No

0.023
Reference

0.015

0.127

Diabetes
Yes
No

-0.029
Reference

0.011

0.006

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 56. Continued
Average marginal
effect

Standard
error

p-value1,2

Depression
Yes
No

0.019
Reference

0.012

0.117

Prior hospitalization
Yes
No

0.017
Reference

0.011

0.131

Oxygen use
Yes
No

0.038
Reference

0.014

0.008

Variable

1
2

Standard negative binomial regression.
p-value less than 0.05 was considered significant
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Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and number of COPD ambulatory care-sensitive hospitalizations among oxygen
users, the same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Non-significant likelihood ratio test for alpha=0 (p=0.266) indicated
that over dispersion did not exist in the response variable and Poisson model fit data
better than negative binomial model (Cameron and Trivedi 1986, Vuong 1989). Nonsignificant Vuong test (p=0.358) indicated that “excessive” number of zeros did not exist
and standard Poisson model fit data better than zero-inflated Poisson model (Vuong
1989, Long and Freese 2006). The results of the standard Poisson regression model for
association between patient perceptions of their doctors and number of COPD
ambulatory care-sensitive hospitalizations among oxygen users is presented in Table 57.
No association was found between patient perceptions of their doctors and
number of COPD ambulatory care-sensitive hospitalizations among oxygen users after
adjusting for covariates (average marginal effect=0.026, p=0.343). Other significant
covariates in the regression model included education and prior hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and number of COPD ambulatory care-sensitive hospitalizations among nonoxygen users, the same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that

183
Table 57. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD Ambulatory Care-Sensitive Hospitalizations (Oxygen Users
Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.026

0.028

0.343

Marital status
Married
Non-married

Reference
0.036

0.027

0.187

Reference
-0.042
-0.073

0.035
0.034

0.229
0.030

-0.026

0.060

0.665

Residence
Metro area
Non-metro area

Reference
0.041

0.029

0.149

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.033
0.059
Reference

0.037
0.031

0.373
0.058

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.025
0.059
0.099

0.037
0.038
0.047

0.495
0.116
0.035

Heart failure
Yes
No

0.018
Reference

0.032

0.582

Diabetes
Yes
No

-0.027
Reference

0.028

0.336

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 57. Continued
Average marginal
effect

Standard
error

p-value1,2

Depression
Yes
No

0.059
Reference

0.032

0.063

Prior hospitalization
Yes
No

0.079
Reference

0.028

0.006

Variable

1
2

Standard Poisson regression.
p-value less than 0.05 was considered significant
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over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Non-significant
Vuong test (p=0.208) indicated that “excessive” number of zeros did not exist and
standard negative binomial model fit data better than zero-inflated negative binomial
model (Vuong 1989, Long and Freese 2006). The results of the standard negative
binomial regression model for association between patient perceptions of their doctors
and number of COPD ambulatory care-sensitive hospitalizations among non-oxygen
users is presented in Table 58.
No association was found between patient perceptions of their doctors and
number of COPD ambulatory care-sensitive hospitalizations among non-oxygen users
after adjusting for covariates (average marginal effect=0.003, p=0.766). Other significant
covariates in the regression model included smoking status, perceived health, and
diabetes.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospital days. The predictor variable was patient perceptions of their doctors as a binary
variable, with “1” indicating positive perceptions and “0” indicating not positive
perceptions. The response variable was COPD ambulatory care-sensitive hospital days as
a count variable. Due to possible over dispersion and “excessive” number of zeros in the
response variable, we selected zero-inflated negative binomial regression model as the
base model for stepwise selection of relevant covariates. Covariates selected for the main
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Table 58. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD Ambulatory Care-Sensitive Hospitalizations (Non-Oxygen
Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.003

0.010

0.766

Marital status
Married
Non-married

Reference
0.014

0.010

0.180

Reference
-0.015
-0.022

0.013
0.014

0.248
0.102

0.004

0.023

0.850

Residence
Metro area
Non-metro area

Reference
0.011

0.012

0.355

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.044
0.044
Reference

0.012
0.009

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.022
0.024
0.076

0.010
0.012
0.032

0.024
0.040
0.019

Heart failure
Yes
No

0.017
Reference

0.017

0.311

Diabetes
Yes
No

-0.026
Reference

0.010

0.007

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 58. Continued
Average marginal
effect

Standard
error

p-value1,2

Depression
Yes
No

0.007
Reference

0.012

0.580

Prior hospitalization
Yes
No

-0.001
Reference

0.011

0.892

Variable

1
2

Standard negative binomial regression
p-value less than 0.05 was considered significant
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model were gender, education, and depression. Covariates selected for the zero-inflated
model were marital status, residence, smoking status, perceived health, pneumococcal
vaccine, heart failure, diabetes, prior hospitalization, and oxygen use.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days is presented in Table 59.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days after adjusting for covariates (average marginal
effect=-0.030, p=0.374). Other significant covariates in the regression model included
education, smoking status, perceived health, pneumococcal vaccine, diabetes, depression,
prior hospitalization, and oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospital days among oxygen users, the
same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
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Table 59. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospital Days
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-0.030

0.033

0.374

Gender
Man
Woman

Reference
-0.064

0.035

0.067

Marital status
Married
Non-married

Reference
0.070

0.039

0.070

Reference
-0.019
-0.113

0.043
0.041

0.665
0.006

-0.029

0.058

0.617

Residence
Metro area
Non-metro area

Reference
0.067

0.042

0.109

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.180
0.191
Reference

0.049
0.038

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.068
0.150
0.260

0.041
0.049
0.073

0.097
0.002
<0.001

Pneumococcal vaccine
Yes
No

0.112
Reference

0.048

0.020

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 59. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.080
Reference

0.052

0.121

Diabetes
Yes
No

-0.091
Reference

0.039

0.020

Depression
Yes
No

0.129
Reference

0.043

0.002

Prior hospitalization
Yes
No

0.087
Reference

0.042

0.036

Oxygen use
Yes
No

0.163
Reference

0.052

0.002

Variable

1
2

Zero-inflated negative binomial regression.
p-value less than 0.05 was considered significant
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over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days among oxygen users is presented in Table 60.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days among oxygen users after adjusting for covariates
(average marginal effect=-0.181, p=0.075). Other significant covariates in the regression
model included gender, smoking status, perceived health, depression, and prior
hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospital days among non-oxygen users, the
same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
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Table 60. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospital Days (Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-0.181

0.102

0.075

Gender
Man
Woman

Reference
-0.249

0.107

0.020

Marital status
Married
Non-married

0.239
Reference

0.125

0.055

Reference
-0.064
-0.079

0.107
0.129

0.551
0.540

-0.039

0.164

0.812

Residence
Metro area
Non-metro area

Reference
0.250

0.133

0.061

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.160
0.304
Reference

0.167
0.138

0.338
0.027

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.091
0.327
0.498

0.150
0.162
0.204

0.546
0.044
0.015

Pneumococcal vaccine
Yes
No

0.151
Reference

0.215

0.482

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 60. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.119
Reference

0.146

0.414

Diabetes
Yes
No

-0.138
Reference

0.126

0.272

Depression
Yes
No

0.280
Reference

0.111

0.012

Prior hospitalization
Yes
No

0.336
Reference

0.132

0.011

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant

194
regression model for association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days among non-oxygen users is presented in Table
61.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days among non-oxygen users after adjusting for
covariates (average marginal effect=0.010, p=0.772). Other significant covariates in the
regression model included education, smoking status, perceived health, pneumococcal
vaccine, diabetes, and depression.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization expenditures. The predictor variable was patient perceptions of their
doctors as a binary variable, with “1” indicating positive perceptions and “0” indicating
not positive perceptions. The response variable was COPD ambulatory care-sensitive
hospitalization expenditures as a count variable. Due to possible over dispersion and
“excessive” number of zeros in the response variable, we selected zero-inflated negative
binomial regression model as the base model for stepwise selection of relevant
covariates. Covariates selected for the main model were gender, marital status, and
number of doctor visits. Covariates selected for the zero-inflated model were marital
status, education, residence, smoking status, perceived health, pneumococcal vaccine,
heart failure, diabetes, prior hospitalization, and oxygen use.
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Table 61. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospital Days (Non-Oxygen Users
Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.010

0.033

0.772

Gender
Man
Woman

Reference
0.013

0.034

0.705

Marital status
Married
Non-married

0.019
Reference

0.037

0.615

Reference
-0.026
-0.131

0.047
0.041

0.581
0.002

-0.030

0.059

0.609

Residence
Metro area
Non-metro area

Reference
0.017

0.040

0.679

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.182
0.163
Reference

0.048
0.035

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.059
0.097
0.223

0.037
0.047
0.088

0.111
0.041
0.011

Pneumococcal vaccine
Yes
No

0.090
Reference

0.040

0.024

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 61. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.070
Reference

0.057

0.221

Diabetes
Yes
No

-0.084
Reference

0.037

0.024

Depression
Yes
No

0.104
Reference

0.048

0.029

Prior hospitalization
Yes
No

0.017
Reference

0.039

0.668

Variable

1
2

Zero-inflated negative binomial regression.
p-value less than 0.05 was considered significant
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Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p=0.045) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures is presented in Table 62.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures after adjusting for covariates
(average marginal effect=-25.08, p=0.582). Other significant covariates in the regression
model included gender, marital status, education, smoking status, perceived health,
pneumococcal vaccine, diabetes, prior hospitalization, number of doctor visits, and
oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospitalization expenditures among oxygen
users, the same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
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Table 62. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Expenditures
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-25.1

45.5

0.582

Gender
Man
Woman

Reference
-96.5

47.4

0.042

Marital status
Married
Non-married

Reference
223.5

76.2

0.003

Reference
-91.1
-191.0

86.1
82.1

0.272
0.021

-13.2

132.3

0.920

Residence
Metro area
Non-metro area

Reference
107.6

70.9

0.129

Smoking status
Current smoker
Ex-smoker
Non-smoker

293.9
321.2
Reference

82.1
62.8

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
114.1
254.5
429.8

71.0
84.5
125.1

0.108
0.003
0.001

Pneumococcal vaccine
Yes
No

182.4
Reference

80.1

0.023

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 62. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

136.3
Reference

86.0

0.113

Diabetes
Yes
No

-138.9
Reference

65.5

0.034

Prior hospitalization
Yes
No

156.6
Reference

69.0

0.023

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
184.6
80.1

58.9
50.5

0.002
0.113

Oxygen use
Yes
No

260.2
Reference

85.5

0.002

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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test (p=0.043) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures among oxygen users is presented
in Table 63.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures among oxygen users after
adjusting for covariates (average marginal effect=-203.89, p=0.136). Other significant
covariates in the regression model included gender, marital status, education, smoking
status, perceived health, and prior hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD ambulatory care-sensitive hospitalization expenditures among nonoxygen users, the same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Non-significant
Vuong test (p=0.145) indicated that “excessive” number of zeros did not exist and
standard negative binomial model fit data better than zero-inflated negative binomial
model (Vuong 1989, Long and Freese 2006). The results of the standard negative
binomial regression model for association between patient perceptions of their doctors
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Table 63. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Expenditures (Oxygen
Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-203.9

136.8

0.136

Gender
Man
Woman

Reference
-267.5

135.2

0.048

Marital status
Married
Non-married

Reference
463.1

215.7

0.032

Reference
-248.8
-496.3

240.0
229.6

0.300
0.031

-72.2

407.8

0.860

Residence
Metro area
Non-metro area

Reference
375.7

202.3

0.063

Smoking status
Current smoker
Ex-smoker
Non-smoker

202.2
475.9
Reference

242.1
204.4

0.404
0.020

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
114.7
484.4
705.4

246.0
262.3
322.2

0.641
0.065
0.029

Pneumococcal vaccine
Yes
No

212.3
Reference

324.7

0.513

Variable

Education
Less than high school
High school graduates
Post high school excluding
college
College grad/Post grad
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Table 63. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

203.2
Reference

222.5

0.361

Diabetes
Yes
No

-166.0
Reference

189.4

0.381

Prior hospitalization
Yes
No

546.9
Reference

199.2

0.006

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
297.2
116.7

173.3
154.4

0.086
0.450

Variable

1
2

Zero-inflated negative binomial regression.
p-value less than 0.05 was considered significant
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and COPD ambulatory care-sensitive hospitalization expenditures among non-oxygen
users is presented in Table 64.
No association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization expenditures among non-oxygen users after
adjusting for covariates (average marginal effect=55.58, p=0.821). None of the
covariates in the regression model was significant.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Risk
A multivariate logistic regression model was developed to assess association
between patient perceptions of their doctors and COPD-related hospitalization risk. The
predictor variable was patient perceptions of their doctors as a binary variable, with “1”
indicating positive perceptions and “0” indicating not positive perceptions. The response
variable was COPD-related hospitalization risk as a binary variable, with “1” indicating
having at least one COPD-related hospitalization and “0” indicating having no COPDrelated hospitalization. Covariates selected from stepwise selection procedure were age,
marital status, smoking status, perceived health, pneumococcal vaccine, heart failure,
diabetes, osteoporosis, prior hospitalization, number of doctor visits, and oxygen use.
The global likelihood ratio test was significant indicating good model fit
(p<0.001). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.981). The results of the multiple logistic regression model for association
between patient perceptions of their doctors and COPD-related hospitalization risk is
presented in Table 65.
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Table 64. Multivariate Association between Patient Perceptions of Their Doctors and
COPD Ambulatory Care-Sensitive Hospitalization Expenditures (Non-Oxygen
Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
55.6

245.8

0.821

Gender
Man
Woman

Reference
-107.4

269.8

0.690

Marital status
Married
Non-married

Reference
179.8

243.6

0.460

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
207.7
174.1

269.3
271.9

0.441
0.522

Variable

1
2

Standard negative binomial regression
p-value less than 0.05 was considered significant
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Table 65. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Risk
Variable

Odds ratio

Patient perceptions of their
doctors
Positive
Not positive

Reference
1.23

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
1.34
1.95
1.67

Marital status
Married
Non-married

0.77
Reference

95% Confidence
interval

0.101
0.96 – 1.56
0.006
0.88 – 2.02
1.30 – 2.94
1.00 – 2.80
0.043
0.60 – 0.99

Smoking status
Current smoker
Ex-smoker
Non-smoker

2.55
2.20
Reference

1.64 – 3.97
1.51 – 3.19

Perceived health
Excellent/Very good
Good
Fair
Poor

0.31
0.46
0.66
Reference

0.20 – 0.47
0.32 – 0.67
0.46 – 0.94

Pneumococcal vaccine
Yes
No
Heart failure
Yes
No

p-value1,2

<0.001

<0.001

0.006
Reference
0.51

0.31 – 0.83
<0.001

Reference
0.58

0.44 – 0.76
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Table 65. Continued
Variable
Diabetes
Yes
No

1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.008

Reference
1.46

Osteoporosis
Yes
No

Reference
1.23

Prior hospitalizations
Yes
No

Reference
0.71

Number of doctor visits
Less than 15
15 to 30
More than 30

0.65
0.92
Reference

Oxygen use
Yes
No

Reference
0.53

1.10 – 1.93
0.145
0.93 – 1.63
0.012
0.55 – 0.93
0.049
0.46 – 0.93
0.69 – 1.23
<0.001
0.41 – 0.68

Multivariate logistic regression
p-value less than 0.05 was considered significant
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No association was found between patient perceptions of their doctors and
COPD-related hospitalization risk after adjusting for covariates (odds ratio=1.23,
p=0.101). Other significant covariates in the regression model included age, marital
status, smoking status, perceived health, pneumococcal vaccine, heart failure, diabetes,
prior hospitalization, number of doctor visits, and oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospitalization risk among oxygen users, the same covariates
except oxygen use were used in the regression model.
The global likelihood ratio test was significant indicating good model fit
(p<0.001). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.155). The results of the multiple logistic regression model for association
between patient perceptions of their doctors and COPD-related hospitalization risk
among oxygen users is presented in Table 66.
Individuals who did not have positive perceptions of their doctors were more
likely to be hospitalized due to COPD reasons as compared to those who had positive
perceptions of their doctors (odds ratio=1.73, p=0.010). Other significant covariates in
the regression model included marital status, perceived health, pneumococcal vaccine,
heart failure, and prior hospitalization.
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Table 66. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Risk (Oxygen Users Subgroup)
Variable

Odds ratio

Patient perceptions of their
doctors
Positive
Not positive

Reference
1.73

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
1.24
1.54
0.99

Marital status
Married
Non-married

0.57
Reference

95% Confidence
interval

0.011
1.13 – 2.63
0.467
0.62 – 2.46
0.77 – 3.06
0.40 – 2.42
0.013
0.36 – 0.89

Smoking status
Current smoker
Ex-smoker
Non-smoker

1.73
1.97
Reference

0.78 – 3.85
1.04 – 3.73

Perceived health
Excellent/Very good
Good
Fair
Poor

0.23
0.38
0.55
Reference

0.09 – 0.55
0.21 – 0.68
0.32 – 0.93

Pneumococcal vaccine
Yes
No
Heart failure
Yes
No

p-value1,2

0.114

0.002

0.040
Reference
0.29

0.09 – 0.94
0.013

Reference
0.56

0.36 – 0.89
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Table 66. Continued
Variable
Diabetes
Yes
No

1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.150

Reference
1.39

Osteoporosis
Yes
No

Reference
1.14

Prior hospitalizations
Yes
No

Reference
0.63

Number of doctor visits
Less than 15
15 to 30
More than 30

0.65
0.72
Reference

0.989 – 2.19
0.573
0.72 – 1.82
0.041
0.40 – 0.98
0.269
0.36 – 1.15
0.44 – 1.19

Multivariate logistic regression
p-value less than 0.05 was considered significant
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Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospitalization risk among non-oxygen users, the same
covariates except oxygen use were used in the regression model.
The global likelihood ratio test was significant indicating good model fit
(p<0.001). The Hosmer and Lemeshow test was not significant further confirming good
model fit (p=0.997). The results of the multiple logistic regression model for association
between patient perceptions of their doctors and COPD-related hospitalization risk
among non-oxygen users is presented in Table 67.
No association was found between patient perceptions of their doctors and
COPD-related hospitalization risk among non-oxygen users after adjusting for covariates
(odds ratio=1.06, p=0.712). Other significant covariates in the regression model included
age, smoking status, perceived health, pneumococcal vaccine, heart failure, and diabetes.

Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and number of COPD-related
hospitalizations. The predictor variable was patient perceptions of their doctors as a
binary variable, with “1” indicating positive perceptions and “0” indicating not positive
perceptions. The response variable was number of COPD-related hospitalizations as a
count variable. Due to possible over dispersion and “excessive” number of zeros in the
response variable, we selected zero-inflated negative binomial regression model as the
base model for stepwise selection of relevant covariates. Covariates selected for the main
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Table 67. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Risk (Non-Oxygen Users Subgroup)
Variable

Odds ratio

Patient perceptions of their
doctors
Positive
Not positive

Reference
1.06

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
1.29
2.15
2.22

Marital status
Married
Non-married

0.87
Reference

95% Confidence
interval

0.712
0.78 – 1.43
0.005
0.76 – 2.19
1.29 – 3.60
1.18 – 4.16
0.388
0.64 – 1.19

Smoking status
Current smoker
Ex-smoker
Non-smoker

3.09
2.43
Reference

1.79 – 5.32
1.52 – 3.90

Perceived health
Excellent/Very good
Good
Fair
Poor

0.33
0.50
0.73
Reference

0.19 – 0.58
0.31 – 0.81
0.45 – 1.17

Pneumococcal vaccine
Yes
No
Heart failure
Yes
No

p-value1,2

<0.001

<0.001

0.027
Reference
0.55

0.32 – 0.93
0.005

Reference
0.59

0.41 – 0.85
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Table 67. Continued
Variable
Diabetes
Yes
No

1
2

Odds ratio

95% Confidence
interval

p-value1,2
0.013

Reference
1.58

Osteoporosis
Yes
No

Reference
1.36

Prior hospitalizations
Yes
No

Reference
0.78

Number of doctor visits
Less than 15
15 to 30
More than 30

0.64
1.02
Reference

1.10 – 2.27
0.092
0.95 – 1.94
0.148
0.60 – 1.09
0.063
0.41 – 1.00
0.71 – 1.46

Multivariate logistic regression
p-value less than 0.05 was considered significant
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model were marital status, perceived health, heart diseases, diabetes, and prior
hospitalization. Covariates selected for the zero-inflated model included age, smoking
status, influenza vaccine, pneumococcal vaccine, heart failure, and oxygen use.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and number
of COPD-related hospitalizations is presented in Table 68.
No association was found between patient perceptions of their doctors and
number of COPD-related hospitalizations after adjusting for covariates (average marginal
effect=0.035, p=0.198). Other significant covariates in the regression model included
age, marital status, smoking status, perceived health, heart failure, diabetes, prior
hospitalization, and oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and number of COPD-related hospitalizations among oxygen users, the same
covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
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Table 68. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD-Related Hospitalizations
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.035

0.027

0.198

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.044
0.104
0.093

0.030
0.030
0.042

0.141
<0.001
0.027

Marital status
Married
Non-married

Reference
0.068

0.027

0.011

Influenza vaccine
Yes
No

0.051
Reference

0.026

0.052

Pneumococcal vaccine
Yes
No

0.056
Reference

0.036

0.123

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.153
0.125
Reference

0.030
0.024

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.093
0.173
0.336

0.026
0.032
0.060

<0.001
<0.001
<0.001

Heart diseases
Yes
No

0.052
Reference

0.028

0.063

Variable
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Table 68. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.101
Reference

0.029

0.001

Diabetes
Yes
No

-0.097
Reference

0.027

<0.001

Prior hospitalization
Yes
No

0.126
Reference

0.029

<0.001

Oxygen use
Yes
No

0.128
Reference

0.029

<0.001

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and number
of COPD-related hospitalizations among oxygen users is presented in Table 69.
Individuals who did not have positive perceptions of theirs doctors on average had
0.16 more COPD-related hospitalization as compared to those who had positive
perceptions of their doctors (average marginal effect=0.155, p=0.028). Other significant
covariates in the regression model included marital status, smoking status, perceived
health, pneumococcal vaccine, heart failure, and prior hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and number of COPD-related hospitalizations among non-oxygen users, the same
covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Non-significant likelihood ratio test for alpha=0 (p=0.106) indicated
that over dispersion did not exist in the response variable and Poisson model fit data
better than negative binomial model (Cameron and Trivedi 1986, Vuong 1989).
Significant Vuong test (p<0.001) indicated that “excessive” number of zeros existed and
zero-inflated Poisson model fit data better than standard Poisson model (Vuong 1989,
Long and Freese 2006). The results of the zero-inflated Poisson regression model for
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Table 69. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD-Related Hospitalizations (Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.155

0.071

0.028

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.038
-0.006
-0.065

0.025
0.029
0.064

0.140
0.839
0.309

Marital status
Married
Non-married

Reference
0.173

0.068

0.011

Influenza vaccine
Yes
No

-0.007
Reference

0.025

0.771

Pneumococcal vaccine
Yes
No

0.250
Reference

0.030

<0.001

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.131
0.123
Reference

0.041
0.041

0.001
0.003

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.172
0.202
0.426

0.087
0.082
0.117

0.047
0.014
<0.001

Heart diseases
Yes
No

0.116
Reference

0.071

0.100

Variable
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Table 69. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.038
Reference

0.018

0.038

Diabetes
Yes
No

-0.136
Reference

0.070

0.052

Prior hospitalization
Yes
No

0.263
Reference

0.073

<0.001

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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association between patient perceptions of their doctors and number of COPD-related
hospitalizations among non-oxygen users is presented in Table 70.
No association was found between patient perceptions of their doctors and
number of COPD-related hospitalizations among non-oxygen users after adjusting for
covariates (average marginal effect=0.003, p=0.916). Other significant covariates in the
regression model included age, smoking status, perceived health, influenza vaccine, heart
failure, diabetes, and prior hospitalization.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospital Days
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD-related hospital days. The
predictor variable was patient perceptions of their doctors as a binary variable, with “1”
indicating positive perceptions and “0” indicating not positive perceptions. The response
variable was COPD-related hospital days as a count variable. Due to possible over
dispersion and “excessive” number of zeros in the response variable, we selected zeroinflated negative binomial regression model as the base model for stepwise selection of
relevant covariates. Covariates selected for the main model were marital status, region,
smoking status, perceived health, diabetes, and prior hospitalization. Covariates selected
for the zero-inflated model included age, smoking status, perceived health, pneumococcal
vaccine, heart failure, diabetes, prior hospitalization, number of doctor visits, and oxygen
use.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
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Table 70. Multivariate Association between Patient Perceptions of Their Doctors and
Number of COPD-Related Hospitalizations (Non-Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.003

0.025

0.916

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.030
0.104
0.106

0.031
0.033
0.048

0.338
0.002
0.027

Marital status
Married
Non-married

Reference
0.047

0.024

0.054

Influenza vaccine
Yes
No

0.060
Reference

0.029

0.035

Pneumococcal vaccine
Yes
No

0.054
Reference

0.035

0.123

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.154
0.114
Reference

0.035
0.025

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.073
0.184
0.320

0.023
0.037
0.064

0.001
<0.001
<0.001

Heart diseases
Yes
No

0.025
Reference

0.027

0.362

Variable
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Table 70. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.094
Reference

0.035

0.007

Diabetes
Yes
No

-0.082
Reference

0.025

0.001

Prior hospitalization
Yes
No

0.088
Reference

0.027

0.001

Variable

1
2

Zero-inflated Poisson regression
p-value less than 0.05 was considered significant
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over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPDrelated hospital days is presented in Table 71.
No association was found between patient perceptions of their doctors and
COPD-related hospital days after adjusting for covariates (average marginal
effect=0.004, p=0.979). Other significant covariates in the regression model included
age, marital status, smoking status, perceived health, pneumococcal vaccine, heart failure,
diabetes, prior hospitalization, number of doctor visits, and oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospital days among oxygen users, the same covariates except
oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
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Table 71. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospital Days
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.004

0.158

0.979

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.227
0.570
0.474

0.153
0.162
0.208

0.137
<0.001
0.030

Marital status
Married
Non-married

Reference
0.482

0.124

<0.001

Region
Midwest
Northeast
South
West

Reference
0.087
0.293
-0.203

0.183
0.147
0.215

0.635
0.046
0.345

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.455
0.696
Reference

0.210
0.180

0.030
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.321
0.820
1.665

0.156
0.202
0.351

0.040
<0.001
<0.001

Pneumococcal vaccine
Yes
No

0.514
Reference

0.157

0.001

Variable
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Table 71. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.526
Reference

0.152

0.001

Diabetes
Yes
No

-0.601
Reference

0.153

<0.001

Prior hospitalization
Yes
No

0.497
Reference

0.171

0.004

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
0.284
0.333

0.137
0.151

0.038
0.028

Oxygen use
Yes
No

0.644
Reference

0.144

<0.001

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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regression model for association between patient perceptions of their doctors and COPDrelated hospital days among oxygen users is presented in Table 72.
No association was found between patient perceptions of their doctors and
COPD-related hospital days among oxygen users after adjusting for covariates (average
marginal effect=0.713, p=0.119). Other significant covariates in the regression model
included marital status, perceived health, pneumococcal vaccine, heart failure, diabetes,
and prior hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospital days among non-oxygen users, the same covariates
except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPDrelated hospital days among non-oxygen users is presented in Table 73.
No association was found between patient perceptions of their doctors and
COPD-related hospital days among non-oxygen users after adjusting for covariates
(average marginal effect=-0.145, p=0.364). Other significant covariates in the regression
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Table 72. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospital Days (Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
0.713

0.458

0.119

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.416
0.694
0.186

0.449
0.453
0.566

0.353
0.126
0.742

Marital status
Married
Non-married

Reference
1.176

0.384

0.002

Region
Midwest
Northeast
South
West

Reference
-0.209
0.435
-0.376

0.536
0.442
0.719

0.697
0.325
0.601

Smoking status
Current smoker
Ex-smoker
Non-smoker

-0.401
0.634
Reference

0.654
0.640

0.534
0.321

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
1.115
1.012
2.601

0.584
0.478
0.709

0.056
0.034
<0.001

Pneumococcal vaccine
Yes
No

1.224
Reference

0.490

0.012

Variable
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Table 72. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.915
Reference

0.363

0.012

Diabetes
Yes
No

-0.890
Reference

0.426

0.036

Prior hospitalization
Yes
No

1.335
Reference

0.462

0.004

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
0.157
0.452

0.380
0.398

0.679
0.257

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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Table 73. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospital Days (Non-Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-0.145

0.160

0.364

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
0.135
0.510
0.544

0.152
0.168
0.237

0.376
0.002
0.022

Marital status
Married
Non-married

Reference
0.347

0.122

0.005

Region
Midwest
Northeast
South
West

Reference
0.124
0.200
-0.228

0.182
0.144
0.191

0.498
0.165
0.233

Smoking status
Current smoker
Ex-smoker
Non-smoker

0.562
0.686
Reference

0.198
0.166

0.004
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
0.215
0.884
1.537

0.139
0.246
0.462

0.122
<0.001
0.001

Pneumococcal vaccine
Yes
No

0.380
Reference

0.149

0.011

Variable
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Table 73. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart failure
Yes
No

0.433
Reference

0.171

0.011

Diabetes
Yes
No

-0.574
Reference

0.153

<0.001

Prior hospitalization
Yes
No

0.257
Reference

0.175

0.143

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
0.304
0.290

0.140
0.158

0.030
0.066

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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model included age, marital status, smoking status, perceived health, pneumococcal
vaccine, heart failure, diabetes, and number of doctor visits.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Expenditures
Multivariate generalized linear models were developed to assess association
between patient perceptions of their doctors and COPD-related hospitalization
expenditures. The predictor variable was patient perceptions of their doctors as a binary
variable, with “1” indicating positive perceptions and “0” indicating not positive
perceptions. The response variable was COPD-related hospitalization expenditures as a
count variable. Due to possible over dispersion and “excessive” number of zeros in the
response variable, we selected zero-inflated negative binomial regression model as the
base model for stepwise selection of relevant covariates. Covariates selected for the main
model were race, marital status, residence, perceived health, heart diseases, diabetes,
prior hospitalization, and oxygen use. Covariates selected for the zero-inflated model
included age, marital status, smoking status, perceived health, pneumococcal vaccine,
heart failure, diabetes, prior hospitalization, number of doctor visits, and oxygen use.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
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regression model for association between patient perceptions of their doctors and COPDrelated hospitalization expenditures is presented in Table 74.
No association was found between patient perceptions of their doctors and
COPD-related hospitalization expenditures after adjusting for covariates (average
marginal effect=183.0, p=0.508). Other significant covariates in the regression model
included age, marital status, smoking status, perceived health, pneumococcal vaccine,
heart diseases, heart failure, diabetes, prior hospitalization, number of doctor visits, and
oxygen use.

Subgroup Analysis: Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospitalization expenditures among oxygen users, the same
covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPDrelated hospitalization expenditures among oxygen users is presented in Table 75.
No association was found between patient perceptions of their doctors and
COPD-related hospitalization expenditures among oxygen users after adjusting for
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Table 74. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Expenditures
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
183.0

276.6

0.508

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
481.2
1,116.7
874.5

278.8
296.4
394.7

0.084
<0.001
0.027

Race
White
Non-White

-440.0
Reference

226.5

0.052

Marital status
Married
Non-married

Reference
828.1

268.9

0.002

Residence
Metro area
Non-metro area

Reference
-252.1

192.0

0.189

Smoking status
Current smoker
Ex-smoker
Non-smoker

1,309.8
1,141.6
Reference

319.3
229.3

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
444.9
1,730.5
2,765.1

269.0
385.5
580.8

0.098
<0.001
<0.001

Pneumococcal vaccine
Yes
No

959.1
Reference

286.5

0.001

Variable
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Table 74. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart diseases
Yes
No

438.3
Reference

190.6

0.021

Heart failure
Yes
No

946.8
Reference

276.1

0.001

Diabetes
Yes
No

-1,019.6
Reference

270.4

<0.001

Prior hospitalization
Yes
No

983.3
Reference

307.8

0.001

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
511.2
611.4

250.6
275.7

0.041
0.027

Oxygen use
Yes
No

665.7
Reference

318.6

0.037

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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Table 75. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Expenditures (Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
839.7

650.7

0.197

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
664.0
1,247.4
281.3

701.6
719.2
894.2

0.344
0.083
0.753

Race
White
Non-White

-1,404.7
Reference

458.4

0.002

Marital status
Married
Non-married

Reference
1,901.2

625.8

0.002

Residence
Metro area
Non-metro area

Reference
-621.4

457.7

0.175

Smoking status
Current smoker
Ex-smoker
Non-smoker

1,075.6
1,330.7
Reference

793.9
590.1

0.175
0.024

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
358.7
1,094.6
2,583.0

1,097.1
1,093.6
1,232.9

0.744
0.317
0.036

Pneumococcal vaccine
Yes
No

1,964.9
Reference

764.4

0.010

Variable
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Table 75. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart diseases
Yes
No

578.5
Reference

490.9

0.239

Heart failure
Yes
No

1,412.4
Reference

548.2

0.013

Diabetes
Yes
No

-1,456.1
Reference

635.2

0.022

Prior hospitalization
Yes
No

2,140.3
Reference

702.3

0.002

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
205.8
875.5

599.4
639.5

0.731
0.171

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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covariates (average marginal effect=839.7, p=0.197). Other significant covariates in the
regression model included race, marital status, perceived health, pneumococcal vaccine,
heart failure, diabetes, and prior hospitalization.

Subgroup Analysis: Non-Oxygen Users
In the subgroup analysis of association between patient perceptions of their
doctors and COPD-related hospitalization expenditures among non-oxygen users, the
same covariates except oxygen use were used in the regression model.
Assessment of potential generalized linear models were conducted to select an
appropriate model. Significant likelihood ratio test for alpha=0 (p<0.001) indicated that
over dispersion existed in the response variable and negative binomial model fit data
better than Poisson model (Cameron and Trivedi 1986, Vuong 1989). Significant Vuong
test (p<0.001) indicated that “excessive” number of zeros existed and zero-inflated
negative binomial model fit data better than standard negative binomial model (Vuong
1989, Long and Freese 2006). The results of the zero-inflated negative binomial
regression model for association between patient perceptions of their doctors and COPDrelated hospitalization expenditures among non-oxygen users is presented in Table 76.
No association was found between patient perceptions of their doctors and
COPD-related hospitalization expenditures among non-oxygen users after adjusting for
covariates (average marginal effect=-22.7, p=0.940). Other significant covariates in the
regression model included age, smoking status, perceived health, pneumococcal vaccine,
heart failure, diabetes, and number of doctor visits.
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Table 76. Multivariate Association between Patient Perceptions of Their Doctors and
COPD-Related Hospitalization Expenditures (Non-Oxygen Users Subgroup)
Average marginal
effect

Standard
error

p-value1,2

Patient perceptions of their doctors
Positive
Not positive

Reference
-22.7

303.0

0.940

Age
Less than 65 years
65 to 74 years
75 to 84 years
85 years or older

Reference
318.6
1,048.1
1,086.4

301.7
331.1
463.0

0.291
0.002
0.019

Race
White
Non-White

-171.5
Reference

269.2

0.524

Marital status
Married
Non-married

Reference
528.2

296.5

0.075

Residence
Metro area
Non-metro area

Reference
-175.8

213.3

0.410

Smoking status
Current smoker
Ex-smoker
Non-smoker

1,358.7
1,092.3
Reference

344.3
242.0

<0.001
<0.001

Perceived health
Excellent/Very good
Good
Fair
Poor

Reference
359.3
1,940.8
2,962.5

250.4
486.5
840.7

0.151
<0.001
<0.001

Pneumococcal vaccine
Yes
No

760.7
Reference

292.0

0.009

Variable
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Table 76. Continued
Average marginal
effect

Standard
error

p-value1,2

Heart diseases
Yes
No

370.5
Reference

207.9

0.075

Heart failure
Yes
No

800.3
Reference

328.1

0.015

Diabetes
Yes
No

-1,033.0
Reference

294.7

<0.001

Prior hospitalization
Yes
No

590.3
Reference

339.2

0.082

Number of doctor visits
Less than 15
15 to 30
More than 30

Reference
598.0
545.7

272.5
306.4

0.028
0.075

Variable

1
2

Zero-inflated negative binomial regression
p-value less than 0.05 was considered significant
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SUMMARY AND CONCLUSIONS
Background
Medicare beneficiaries with COPD incur significant incremental health care costs
compared to those without COPD, which is primarily due to hospitalizations (Menzin,
Boulanger et al. 2008). Ambulatory care-sensitive conditions, which include COPD, are
conditions for which good outpatient care can potentially prevent the need for
hospitalization (Agency for Healthcare Research and Quality 2001). Since most patients
seek usual medical care at an outpatient setting, patient-doctor relationship is crucial to
the effective management of disease. Patients who perceive their doctors as effective and
knowledgeable communicators are more likely to adhere to their therapy and use
preventive services (Parchman and Burge 2004, Schoenthaler, Allegrante et al. 2012).
However, evidence is lacking on associations between patient perceptions of doctors and
hospitalizations for ambulatory care sensitive conditions.

Objectives
1. To determine one-year incidence of ambulatory care-sensitive hospitalizations for
COPD in a Medicare population.
2. To assess association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization.
2a) To assess association between patient perception of doctors and risk of having
a COPD ambulatory care-sensitive hospitalization.
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2b) To access association between patient perception of doctors and number of
COPD ambulatory care-sensitive hospitalizations.
2c) To assess association between patient perception of doctors and COPD
ambulatory care-sensitive hospital days.
2d) To assess association between patient perception of doctors and COPD
ambulatory care-sensitive hospitalization expenditures.
3. To assess association between patient perceptions of their doctors and COPD-related
hospitalization.
3a) To assess association between patient perception of doctors and risk of having
a COPD-related hospitalization.
3b) To access association between patient perception of doctors and number of
COPD-related hospitalizations.
3c) To assess association between patient perception of doctors and COPD-related
hospital days.
3d) To assess association between patient perception of doctors and COPDrelated hospitalization expenditures.

Methods
An observational, retrospective cohort study of Medicare beneficiaries with a
diagnosis of COPD was conducted to assess associations between patient perceptions of
their doctors and hospitalization. Data from the 2007 to 2012 Medicare Current
Beneficiary Survey (MCBS) were used for the analyses. Survey items assessing patient
perceptions of their doctors were linked to Medicare claims data using unique beneficiary
identifiers. Patient perceptions of their doctor and hospitalization were assessed during
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the study period, defined as 12 months following the year in which COPD diagnosis was
identified.
Individuals were included if they had a diagnosis of COPD, had continuous
coverage in Medicare Part A and Medicare Part B during the 12-month study period and
the preceding year, and had identified a usual source of care. Individuals were excluded
if they had any missing data on items used to create the patient perceptions of doctors
index, had a proxy responder, or had a diagnosis of Alzheimer’s disease or dementia.
Patient perceptions of their doctors was assessed using a previously validated
index created using the MCBS survey items (Ward 2013). All questions included in the
index must have been answered by the beneficiary. The response to each question was
coded so that one indicated strongly disagree, two indicated disagree, three indicated
agree, and four indicated strongly agree. The responses were reverse coded for
negatively worded questions. The index had a theoretical range of 12 to 48 and a higher
score indicated more positive perceptions of doctors. Individuals with an overall score
for the patient perceptions of their doctors greater or equal to the median value were
categorized as having positive perceptions of their doctors, while those with an overall
score below median value were categorized as not having positive perceptions of their
doctors.
COPD ambulatory care-sensitive hospitalization risk was based on hospital
inpatient events with a primary discharge ICD-9-CM diagnosis code for COPD. A binary
variable was created based on whether the individual had any COPD ambulatory caresensitive hospitalization during the 12-month study period. The number of COPD
ambulatory care-sensitive hospitalizations that occurred during the 12-month study
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period was assessed for all COPD ambulatory care-sensitive hospitalizations and was
calculated by summing all qualified hospitalizations for each individual. COPD
ambulatory care sensitive hospital days was assessed for all COPD ambulatory caresensitive hospitalizations that occurred during the 12-month study period and was
calculated by summing hospital days from all qualified admissions for each individual.
COPD ambulatory care-sensitive hospitalization expenditures were assessed for all
COPD ambulatory care-sensitive hospitalizations during the 12-month study period and
were calculated by summing expenditures for each qualified hospitalization.
Expenditures were adjusted to reflect 2012 US dollars using the medical component of
the Consumer Price Index.
COPD-related hospitalization risk was based on hospital inpatient events with a
primary or secondary discharge ICD-9-CM diagnosis code for COPD. A binary variable
was created based on whether the individual had any COPD-related hospitalization
during the 12-month study period. The number of COPD-related hospitalizations that
occurred during the 12-month study period was assessed for all COPD-related
hospitalizations and was calculated by summing all qualified hospitalizations for each
individual. COPD-related hospital days was assessed for all COPD-related
hospitalizations that occurred during the 12-month study period and was calculated by
summing hospital days from all qualified admissions for each individual. COPD-related
hospitalization expenditures were assessed for all COPD-related hospitalizations during
the 12-month study period and were calculated by summing expenditures for each
qualified hospitalization. Expenditures were adjusted for inflation to reflect 2012 US
dollars using the medical component of the Consumer Price Index.
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Demographic covariates included age, gender, race, marital status, education,
income, region, and residence. Clinical covariates included smoking status, perceived
health, influenza vaccine, pneumococcal vaccine, Charlson Comorbidity Index,
individual clinical conditions, prior hospitalization, number of doctor visits, and oxygen
use.
SAS 9.4 for Unix and STATA 12.1 for Unix were used for data analyses. An a
priori alpha of 0.05 was used to evaluate significance for all analyses. Chi-square tests
were used to examine bivariate associations with hospitalization risk. Wilcoxon-MannWhitney tests were used to examine bivariate associations with number of
hospitalizations, hospital days, and hospitalization expenditures. Multivariate logistic
regression models were used to assess association between patient perceptions of their
doctors and hospitalization risk. Multivariate generalized linear models were used to
assess association between patient perceptions of their doctors and number of
hospitalizations, association between patient perceptions of their doctors and hospital
days, and association between patient perceptions of their doctors and hospitalization
expenditures.

Results and Discussion
Sample Characteristics
A total of 2,306 Medicare beneficiaries met all study selection criteria and were
included in the sample. Approximately fifty-two percent were aged 75 years or older.
The majority of the sample was female, White, non-married, and resided in metro area.
Only twenty percent of the sample was non-smokers. Approximately forty percent rated
their health as fair or poor. Common comorbid conditions were heart diseases, heart
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failure, diabetes, depression, and osteoporosis. Approximately one-third had a Charlson
Comorbidity Index score of 4 or higher. Nearly forty percent had a hospitalization during
the year prior to study period. Approximately twenty-three percent used supplemental
oxygen, which implied very severe COPD.

One-Year Incidence of Ambulatory Care-Sensitive Hospitalizations for COPD
One-year incidence of COPD ambulatory care-sensitive hospitalizations was
determined using data from the 12-month study period from January 1 through December
31. The proportion of individuals having COPD ambulatory care-sensitive
hospitalizations was calculated by dividing the total number of individuals having at least
one COPD ambulatory care-sensitive hospitalization by the total number of individuals in
the study sample. The incidence estimate was 4.1 percent (95% confidence
interval=3.3% to 4.9%). Only primary discharge ICD-9-CM codes for COPD were used
to identify hospitalizations could be a reason for low incidence estimate.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization Risk
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Risk
Demographic and clinical variables were examined for associations with COPD
ambulatory care-sensitive hospitalization risk. Three demographic variables and eight
clinical variables were associated with COPD ambulatory care-sensitive hospitalization
risk in the bivariate analyses. They included education, income, residence status,
smoking status, perceived health, pneumococcal vaccine, heart diseases, heart failure,
depression, prior hospitalization, and oxygen use.
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Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
Prior to controlling for covariates in a multivariate logistic regression model, the
bivariate association between patient perceptions of their doctors and COPD ambulatory
care-sensitive hospitalization risk was examined. Even though the percentage of
individuals who had one or more COPD ambulatory care-sensitive hospitalization was
higher than the percentage of individuals who had no COPD ambulatory care-sensitive
hospitalization for those who did not have positive perceptions of their doctors (56
percent versus 48 percent), a p-value of 0.090 from the Chi-square test indicated that
there was no association between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospitalization risk.

Bivariate Associations with Number of COPD Ambulatory Care-Sensitive
Hospitalizations
Bivariate Associations between Study Covariates and Number of COPD Ambulatory
Care-Sensitive Hospitalizations
Demographic and clinical variables were examined for associations with number
of COPD ambulatory care-sensitive hospitalizations. Three demographic variables and
eight clinical variables were associated with number of COPD ambulatory care-sensitive
hospitalizations in the bivariate analyses. They included education, income, residence
status, smoking status, perceived health, pneumococcal vaccine, heart diseases, heart
failure, depression, prior hospitalization, and oxygen use.
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Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
Prior to controlling for covariates in a multivariate generalized linear model, the
bivariate association between patient perceptions of their doctors and number of COPD
ambulatory care-sensitive hospitalizations was examined. Individuals who did not have
positive perceptions of their doctors had higher mean number of COPD ambulatory caresensitive hospitalizations than those who had positive perceptions of their doctors (0.059
versus 0.040), but the difference was not significant as indicated by a p-value of 0.089.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospital Days
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospital Days
Demographic and clinical variables were examined for associations with COPD
ambulatory care-sensitive hospital days. Three demographic variables and nine clinical
variables were associated with COPD ambulatory care-sensitive hospital days in the
bivariate analyses. They included education, income, residence status, smoking status,
perceived health, pneumococcal vaccine, heart diseases, heart failure, depression, prior
hospitalization, number of doctor visits, and oxygen use.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
Prior to controlling for covariates in a multivariate generalized linear model, the
bivariate association between patient perceptions of their doctors and COPD ambulatory
care-sensitive hospital days was examined. Individuals who did not have positive
perceptions of their doctors had higher mean COPD ambulatory care-sensitive hospital
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days than those who had positive perceptions of their doctors (0.25 versus 0.17), but the
difference was not significant as indicated by a p-value of 0.087.

Bivariate Associations with COPD Ambulatory Care-Sensitive Hospitalization
Expenditures
Bivariate Associations between Study Covariates and COPD Ambulatory Care-Sensitive
Hospitalization Expenditures
Demographic and clinical variables were examined for associations with COPD
ambulatory care-sensitive hospitalization expenditures. Four demographic variables and
nine clinical variables were associated with COPD ambulatory care-sensitive
hospitalization expenditures in the bivariate analyses. They included marital status,
education, income, residence status, smoking status, perceived health, pneumococcal
vaccine, heart diseases, heart failure, depression, prior hospitalization, number of doctor
visits, and oxygen use.

Bivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
Prior to controlling for covariates in a multivariate generalized linear model, the
bivariate association between patient perceptions of their doctors and COPD ambulatory
care-sensitive hospitalization expenditures was examined. Individuals who did not have
positive perceptions of their doctors had higher mean COPD ambulatory care-sensitive
hospitalization expenditures than those who had positive perceptions of their doctors
($381 versus $310), but the difference was not significant as indicated by a p-value of
0.110.
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Bivariate Associations with COPD-Related Hospitalization Risk
Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Risk
Demographic and clinical variables were examined for associations with COPDrelated hospitalization risk. Four demographic variables and ten clinical variables were
associated with COPD-related hospitalization risk in the bivariate analyses. They
included age, marital status, education, income, smoking status, perceived health,
influenza vaccine, pneumococcal vaccine, Charlson Comorbidity Index score, heart
diseases, heart failure, prior hospitalization, number of doctor visits, and oxygen use.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Risk
Prior to controlling for covariates in a multivariate logistic regression model, the
bivariate association between patient perceptions of their doctors and COPD-related
hospitalization risk was examined. A Chi-square test revealed that individuals who did
not have positive perceptions of their doctors had significantly higher risk for COPDrelated hospitalization than those who had positive perceptions of their doctors (p=0.027).
This was consistent with the hypothesis that individuals with more positive perceptions of
their doctors are likely to have lower risk of having a COPD-related hospitalization.

Bivariate Associations with Number of COPD-Related Hospitalizations
Bivariate Associations between Study Covariates and Number of COPD-Related
Hospitalizations
Demographic and clinical variables were examined for associations with number
of COPD-related hospitalizations. Three demographic variables and ten clinical variables
were associated with number of COPD-related hospitalizations in the bivariate analyses.
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They included marital status, education, income, smoking status, perceived health,
influenza vaccine, pneumococcal vaccine, Charlson Comorbidity Index score, heart
diseases, heart failure, prior hospitalization, number of doctor visits, and oxygen use.

Bivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
Prior to controlling for covariates in a multivariate generalized linear model,
bivariate association between the patient perceptions of their doctors and number of
COPD-related hospitalizations was examined. Wilcoxon-Mann-Whitney test revealed
that individuals who did not have positive perceptions of their doctors had significantly
higher number of COPD-related hospitalizations than those who had positive perceptions
of their doctors (p=0.029). This was consistent with the hypothesis that individuals with
more positive perceptions of their doctors are likely to have lower number of COPDrelated hospitalizations.

Bivariate Associations with COPD-Related Hospital Days
Bivariate Associations between Study Covariates and COPD-Related Hospital Days
Demographic and clinical variables were examined for associations with COPDrelated hospital days. Three demographic variables and ten clinical variables were
associated with COPD-related hospital days in the bivariate analyses. They included
marital status, education, income, smoking status, perceived health, influenza vaccine,
pneumococcal vaccine, Charlson Comorbidity Index score, heart diseases, heart failure,
prior hospitalization, number of doctor visits, and oxygen use.
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Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospital Days
Prior to controlling for covariates in a multivariate generalized linear model, the
bivariate association between the patient perceptions of their doctors and COPD-related
hospital days was examined. Wilcoxon-Mann-Whitney test revealed that individuals
who did not have positive perceptions of their doctors had significantly higher number of
COPD-related hospital days than those who had positive perceptions of their doctors
(p=0.031). This was consistent with the hypothesis that individuals with more positive
perceptions of their doctors are likely to have lower number of COPD-related hospital
days.

Bivariate Associations with COPD-Related Hospitalization Expenditures
Bivariate Associations between Study Covariates and COPD-Related Hospitalization
Expenditures
Demographic and clinical variables were examined for associations with COPDrelated hospitalization expenditures. Two demographic variables and ten clinical
variables were associated with COPD-related hospitalization expenditures in the bivariate
analyses. They included marital status, income, smoking status, perceived health,
influenza vaccine, pneumococcal vaccine, Charlson Comorbidity Index score, heart
diseases, heart failure, prior hospitalization, number of doctor visits, and oxygen use.

Bivariate Association between Patient Perceptions of Their Doctors and COPD-Related
Hospitalization Expenditures
Prior to controlling for covariates in a multivariate generalized linear model, the
bivariate association between patient perceptions of their doctors and COPD-related
hospitalization expenditures was examined. Wilcoxon-Mann-Whitney test revealed that
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individuals who did not have positive perceptions of their doctors had significantly higher
COPD-related hospitalization expenditures than those who had positive perceptions of
their doctors (p=0.031). This was consistent with the hypothesis that individuals with
more positive perceptions of their doctors are likely to have lower COPD-related
hospitalization expenditures.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Risk
A multivariate logistic regression model was developed to assess association
between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalization risk. The stepwise procedure was used to select relevant covariates. They
included marital status, education, smoking status, perceived health, pneumococcal
vaccine, heart diseases, diabetes, prior hospitalization, and oxygen use. No association
was found between patient perceptions of their doctors and COPD ambulatory caresensitive hospitalization risk after adjusting for selected covariates. This was consistent
with the bivariate analysis result. Significant covariates included smoking status,
perceived health, diabetes, prior hospitalization, and oxygen use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and COPD ambulatory care-sensitive hospitalization
risk after adjusting for the same covariates. However, the odds ratio estimate from this
model was higher than the estimate from the full model (1.56 versus 1.28). In subgroup
analysis among non-oxygen users, no association was found between patient perceptions
of their doctors and COPD ambulatory care-sensitive hospitalization risk after adjusting
for the same covariates.
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Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD Ambulatory Care-Sensitive Hospitalizations
A multivariate standard negative binomial regression model was developed to
assess association between patient perceptions of their doctors and number of COPD
ambulatory care-sensitive hospitalizations. The stepwise procedure was used to select
relevant covariates. They included marital status, education, residence, smoking status,
perceived health, heart failure, diabetes, depression, prior hospitalization, and oxygen
use. No association was found between patient perceptions of their doctors and number
of COPD ambulatory care-sensitive hospitalizations after adjusting for selected
covariates. This was consistent with the bivariate analysis result. Significant covariates
included marital status, education, smoking status, perceived health, diabetes, and oxygen
use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and number of COPD ambulatory care-sensitive
hospitalizations after adjusting for the same covariates. However, the marginal effect
estimate from this model was higher than the estimate from the full model (0.03 versus
0.01). In the non-oxygen users subgroup, no association was found between patient
perceptions of their doctors and number of COPD ambulatory care-sensitive
hospitalizations after adjusting for the same covariates.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospital Days
A multivariate zero-inflated negative binomial regression model was developed to
assess association between patient perceptions of their doctors and COPD ambulatory
care-sensitive hospital days. The stepwise procedure was used to select relevant
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covariates. Covariates selected for the main model were gender, education, and
depression. Covariates selected for the zero-inflated model were marital status,
residence, smoking status, perceived health, pneumococcal vaccine, heart failure,
diabetes, prior hospitalization, and oxygen use. No association was found between
patient perceptions of their doctors and COPD ambulatory care-sensitive hospital days
after adjusting for selected covariates. This was consistent with the bivariate analysis
result. Significant covariates included education, smoking status, perceived health,
pneumococcal vaccine, diabetes, depression, prior hospitalization, and oxygen use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and COPD ambulatory care-sensitive hospital days
after adjusting for the same covariates. In subgroup analysis among non-oxygen users,
no association was found between patient perceptions of their doctors and COPD
ambulatory care-sensitive hospital days after adjusting for the same covariates.

Multivariate Association between Patient Perceptions of Their Doctors and COPD
Ambulatory Care-Sensitive Hospitalization Expenditures
A multivariate zero-inflated negative binomial regression model was developed to
assess association between patient perceptions of their doctors and COPD ambulatory
care-sensitive hospitalization expenditures. The stepwise procedure was used to select
relevant covariates. Covariates selected for the main model were gender, marital status,
and number of doctor visits. Covariates selected for the zero-inflated model were marital
status, education, residence, smoking status, perceived health, pneumococcal vaccine,
heart failure, diabetes, prior hospitalization, and oxygen use. No association was found
between patient perceptions of their doctors and COPD ambulatory care-sensitive
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hospitalization expenditures after adjusting for selected covariates. This was consistent
with the bivariate analysis result. Significant covariates included gender, marital status,
education, smoking status, perceived health, pneumococcal vaccine, diabetes, prior
hospitalization, number of doctor visits, and oxygen use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and COPD ambulatory care-sensitive hospitalization
expenditures after adjusting for the same covariates. In subgroup analysis among nonoxygen users, no association was found between patient perceptions of their doctors and
COPD ambulatory care-sensitive hospitalization expenditures after adjusting for the same
covariates.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Risk
A multivariate logistic regression model was developed to assess association
between patient perceptions of their doctors and COPD-related hospitalization risk. The
stepwise procedure was used to select relevant covariates. They included age, marital
status, smoking status, perceived health, pneumococcal vaccine, heart failure, diabetes,
osteoporosis, prior hospitalization, number of doctor visits, and oxygen use. No
association was found between patient perceptions of their doctors and COPD-related
hospitalization risk after adjusting for selected covariates. This was not consistent with
the bivariate analysis result. Significant covariates included age, marital status, smoking
status, perceived health, pneumococcal vaccine, heart failure, diabetes, prior
hospitalization, number of doctor visits, and oxygen use.
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In subgroup analysis among oxygen users, the multivariate model revealed that
individuals who did not have positive perceptions of their doctors were more likely to be
hospitalized for COPD reasons as compared to those who had positive perceptions of
their doctors (odds ratio=1.73, p=0.010). In subgroup analysis among non-oxygen users,
no association was found between patient perceptions of their doctors and COPD-related
hospitalization risk after adjusting for the same covariates.

Multivariate Association between Patient Perceptions of Their Doctors and Number of
COPD-Related Hospitalizations
A multivariate zero-inflated negative binomial regression model was developed to
assess association between patient perceptions of their doctors and number of COPDrelated hospitalizations. The stepwise procedure was used to select relevant covariates.
Covariates selected for the main model were marital status, perceived health, heart
diseases, diabetes, and prior hospitalization. Covariates selected for the zero-inflated
model included age, smoking status, influenza vaccine, pneumococcal vaccine, heart
failure, and oxygen use. No association was found between patient perceptions of their
doctors and number of COPD-related hospitalizations after adjusting for selected
covariates. This was not consistent with the bivariate analysis result. Significant
covariates included age, marital status, smoking status, perceived health, heart failure,
diabetes, prior hospitalization, and oxygen use.
In subgroup analysis among oxygen users, the multivariate model revealed that
individuals who did not have positive perceptions of theirs doctors on average had 0.16
more COPD-related hospitalizations as compared to those who had positive perceptions
of their doctors (average marginal effect=0.155, p=0.028). In subgroup analysis among
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non-oxygen users, no association was found between patient perceptions of their doctors
and number of COPD-related hospitalizations after adjusting for the same covariates.

Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospital Days
A multivariate zero-inflated negative binomial regression model was developed to
assess association between patient perceptions of their doctors and COPD-related hospital
days. The stepwise procedure was used to select relevant covariates. Covariates selected
for the main model were marital status, region, smoking status, perceived health,
diabetes, and prior hospitalization. Covariates selected for the zero-inflated model
included age, smoking status, perceived health, pneumococcal vaccine, heart failure,
diabetes, prior hospitalization, number of doctor visits, and oxygen use. No association
was found between patient perceptions of their doctors and COPD-related hospital days
after adjusting for selected covariates. This was not consistent with the bivariate analysis
result. Significant covariates included age, marital status, smoking status, perceived
health, pneumococcal vaccine, heart failure, diabetes, prior hospitalization, number of
doctor visits, and oxygen use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and COPD-related hospital days after adjusting for the
same covariates. However, the marginal effect estimate from this model was much
higher than the estimate from the full model (0.71 versus 0.004). In subgroup analysis
among non-oxygen users, no association was found between patient perceptions of their
doctors and COPD-related hospital days after adjusting for the same covariates.
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Multivariate Association between Patient Perceptions of Their Doctors and COPDRelated Hospitalization Expenditures
A multivariate zero-inflated negative binomial regression model was developed to
assess association between patient perceptions of their doctors and COPD-related
hospitalization expenditures. The stepwise procedure was used to select relevant
covariates. Covariates selected for the main model were race, marital status, residence,
perceived health, heart diseases, diabetes, prior hospitalization, and oxygen use.
Covariates selected for the zero-inflated model included age, marital status, smoking
status, perceived health, pneumococcal vaccine, heart failure, diabetes, prior
hospitalization, number of doctor visits, and oxygen use. No association was found
between patient perceptions of their doctors and COPD-related hospitalization
expenditures after adjusting for selected covariates. This was not consistent with the
bivariate analysis result. Significant covariates included age, marital status, smoking
status, perceived health, pneumococcal vaccine, heart diseases, heart failure, diabetes,
prior hospitalization, number of doctor visits, and oxygen use.
In subgroup analysis among oxygen users, no association was found between
patient perceptions of their doctors and COPD-related hospitalization expenditures after
adjusting for the same covariates. However, the marginal effect estimate from this model
was much higher than the estimate from the full model ($839.7 versus -$183.0). In
subgroup analysis among non-oxygen users, no association was found between patient
perceptions of their doctors and COPD-related hospitalization expenditures after
adjusting for the same covariates.
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Limitations
Several limitations should be noted when interpreting the results. ICD-9-CM
codes were used to identify individuals with COPD and to compute Charlson
Comorbidity Index scores. Use of diagnosis codes in claims data is known to be
imperfect due to coding variations (Romano and Mark 1994). Individuals with missing
data on items used to create the patient perceptions of their doctors index were excluded,
which could introduce selection bias. The study sample was limited to community
dwelling Medicare beneficiaries. The study results may be not generalizable beyond this
population.

Conclusions and Implications
This study determined one-year incidence of COPD ambulatory care-sensitive
hospitalization among Medicare beneficiaries with COPD and assessed associations
between patient perceptions of their doctors and hospitalization outcomes. The incidence
of COPD ambulatory care-sensitive hospitalization was estimated at 4.1 percent.
Primary ICD-9-CM discharge diagnosis codes were used to identify COPD ambulatory
care-sensitive hospitalizations, whereas primary and secondary ICD-9-CM discharge
diagnosis codes were used to identify COPD-related hospitalizations. No association was
found between patient perceptions of their doctors and COPD ambulatory care-sensitive
hospitalizations. However, significant associations were found between negative patient
perceptions of their doctors and higher COPD-related hospitalization risk, and between
negative patient perceptions of their doctors and higher number of COPD-related
hospitalizations among oxygen users.
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The findings indicated that patient perceptions of their doctors was associated
with COPD-related hospitalization utilization among more severe COPD patients. The
findings provide some evidence that the patient-doctor relationship is important in
managing severe COPD. COPD-related hospitalization measures were better for the
research question than ACSH measures because they captured more potentially relevant
hospitalizations related to COPD management.
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Table A. MCBS Survey Items Used in Patient Perceptions of Their Doctors Index
Patient Perceptions of Their Doctors Items
Your doctor answers all of your questions.
Your doctor often does not explain your medical problems to you.
You often have health problems that should be discussed but are not.
Your doctor often acts as though he/she was doing you a favor by talking to you.
Your doctor tells you all you want to know about your condition and treatment.
Your doctor has a good understanding of your medical history.
Your doctor has a complete understanding of the things that are wrong with you.
Your doctor is very careful to check everything when examining you.
Your doctor is competent and well trained.
You depend on your doctor to feel better physically and emotionally.
You have great confidence in your doctor.
Your doctor seems to be in a hurry.
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Table B. AHRQ Prevention Quality Indicator Algorithm for COPD
ICD-9-CM code

Description

4910

Simple chronic bronchitis

4911

Mucopurulent chronic bronchitis

49120

Obstructive chronic bronchitis without exacerbation

49121

Obstructive chronic bronchitis with (acute) exacerbation

49122

Obstructive chronic bronchitis with acute bronchitis

4918

Other chronic bronchitis

4919

Unspecified chronic bronchitis

4920

Emphysematous bleb

4928

Other emphysema

494

Bronchiectasis

4940

Bronchiectasis without acute exacerbation

4941

Bronchiectasis with acute exacerbation

496

Chronic airway obstruction, not elsewhere classified

Reference:
Agency for Healthcare Research and Quality. (2016). "Prevention Quality Indicators 05
(PQI 05) Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults
Admission Rate." Retrieved September 24, 2017, from
https://www.qualityindicators.ahrq.gov/Downloads/Modules/PQI/V60ICD09/TechSpecs/PQI_05_Chronic_Obstructive_Pulmonary_Disease_(COPD)_or_Asth
ma_in_Older_Adults_Admission_Rate.pdf.
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Table C. Coding Algorithms for Charlson Comorbidity Index
Comorbidities

Weight

ICD-9-CM codes

MCBS variable

Myocardial
infarction

1

410.x, 412.x

OCMYOCAR

Congestive heart
failure

1

398.91, 402.01, 402.11, 402.91,
404.01, 404.03, 404.11, 404.13,
404.91, 404.93, 425.4-425.9,
428.x

OCCFAIL

Peripheral
vascular disease

1

093.0, 437.3, 440.x, 441.x,
443.1-443.9, 47.1, 557.1, 557.9,
V43.4

OCARTERY

Cerebrovascular
disease

1

362.34, 430.x-438.x

OCSTROKE

Dementia

1

290.x, 294.1, 331.2

OCALZMER
OCDEMENT

Chronic
pulmonary
disease

1

416.8, 416.9, 490.x-505.x,
506.4, 508.1, 508.8

OCEMPHYS

Rheumatic
disease

1

446.5, 710.0-710.4, 714.0-714.2,
714.8, 725.x

OCARTHRH

Peptic ulcer
disease

1

531.x-534.x

Mild liver
disease

1

070.22, 070.23, 070.32, 070.33,
070.44, 070.54, 070.6, 070.9,
570.x, 571.x, 573.3, 573.4,
573.8, 573.9, V42.7

Diabetes
without
complication

1

250.0-250.3, 250.8, 250.9

OCBETES
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Table C. Continued
Comorbidities

Weight

ICD-9-CM codes

Diabetes with
complication

2

250.4-250.7

Hemiplegia or
paraplegia

2

334.1, 342.x, 343.x, 344.0344.6, 344.9

Renal disease

2

403.01, 403.11, 403.91, 404.02,
404.03, 404.12, 404.13, 404.92,
404.93, 582.x, 583.0-583.7,
585.x, 586.x, 588.0, V42.0,
V45.1, V56.x

Any cancer
except skin
cancer

2

140.x-172.x, 174.x-195.8, 200.x208.x, 238.6

Moderate to
severe liver
disease

3

456.0-456.2, 572.2-572.8

Metastatic solid
tumor

6

196.x-199.x

AIDS/HIV

6

042.x-044.x

MCBS variable

OCPPARAL

OCCANCER

Reference:
Quan, H., V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J. C. Luthi, L. D. Saunders,
C. A. Beck, T. E. Feasby and W. A. Ghali (2005). "Coding algorithms for defining
comorbidities in ICD-9-CM and ICD-10 administrative data." Med Care 43(11): 11301139.

